<SEC-DOCUMENT>0001193125-25-272592.txt : 20251107
<SEC-HEADER>0001193125-25-272592.hdr.sgml : 20251107
<ACCEPTANCE-DATETIME>20251107171752
ACCESSION NUMBER:		0001193125-25-272592
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		26
CONFORMED PERIOD OF REPORT:	20251104
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251107
DATE AS OF CHANGE:		20251107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardant Health, Inc.
		CENTRAL INDEX KEY:			0001576280
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				454139254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38683
		FILM NUMBER:		251463626

	BUSINESS ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		855-698-8887

	MAIL ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d66171d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gh="http://guardanthealth.com/20251104" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-440">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-11-04_to_2025-11-04">0001576280</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="gh-20251104.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-11-04_to_2025-11-04"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001576280</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-11-04</xbrli:startDate> <xbrli:endDate>2025-11-04</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-451">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt:datemonthdayyearen" id="ixv-452">November&#160;4, 2025</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-453">GUARDANT HEALTH, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:stateprovnameen" id="ixv-454">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-455">001-38683</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-456">45-4139254</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-457">3100 Hanover Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-458">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:stateprovnameen" id="ixv-459">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-460">94304</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-461">855</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-462">698-8887</ix:nonNumeric></span></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, include area code)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:boolballotbox" id="ixv-463">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:boolballotbox" id="ixv-464">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:boolballotbox" id="ixv-465">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:boolballotbox" id="ixv-466">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-467">Common Stock, $0.00001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-468">GH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:exchnameen" id="ixv-469">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-11-04_to_2025-11-04" format="ixt-sec:boolballotbox" id="ixv-470">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Underwriting Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;4, 2025, Guardant Health, Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Goldman Sachs&#160;&amp; Co. LLC and Jefferies LLC, as representatives of the several underwriters named therein (collectively, the &#8220;Underwriters&#8221;), relating to the public offering of 3,833,332 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.00001 per share (the &#8220;common stock&#8221;), at a public offering price of $90.00 per share (the &#8220;Common Stock Offering&#8221;). The Shares include the exercise in full by the Underwriters of their option to purchase an additional 499,999 shares of common stock. The size of the Common Stock Offering was increased from the previously announced $250.0&#160;million of shares of common stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Common Stock Offering is being made pursuant to the Company&#8217;s shelf registration statement on Form <span style="white-space:nowrap">S-3,</span> which was filed with the U.S. Securities and Exchange Commission (the&#160;&#8220;SEC&#8221;) on May&#160;22, 2023 and became effective immediately upon filing (File <span style="white-space:nowrap">No.&#160;333-272121),</span> including the related prospectus dated May&#160;22, 2023, as supplemented by a preliminary prospectus supplement, dated November&#160;4, 2025, and prospectus supplement, dated November&#160;4, 2025, filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The closing of the Common Stock Offering occurred on November&#160;7, 2025. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The net proceeds from the Common Stock Offering, after deducting the underwriting discounts and estimated offering expenses, were approximately $327.2&#160;million. The Company expects that the net proceeds from the Common Stock Offering, together with the net proceeds from the Convertible Notes Offering (as defined below), will be used for general corporate purposes, which may include, depending on market conditions, repurchasing a portion of the Company&#8217;s 0% convertible senior notes due 2027 (the &#8220;2027 notes&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act, other obligations of the parties and termination provisions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by reference to the text of the Underwriting Agreement, which is attached as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gunderson Dettmer Stough Villeneuve Franklin&#160;&amp; Hachigian, LLP, counsel to the Company, has issued an opinion regarding the validity of the Shares in connection with the Common Stock Offering. A copy of the opinion is filed as Exhibit 5.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Indenture and Notes </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;7, 2025, the Company completed its previously announced private offering (the &#8220;Convertible Notes Offering&#8221;) of $402.5&#160;million aggregate principal amount of 0.00% Convertible Senior Notes due 2033 (the &#8220;Notes&#8221;), which includes the exercise in full of the initial purchasers&#8217; option to purchase up to an additional $52.5&#160;million principal amount of Notes. The size of the Convertible Notes Offering was increased from the previously announced $300.0&#160;million aggregate principal amount of Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes were issued pursuant to an indenture, dated November&#160;7, 2025 (the &#8220;Indenture&#8221;), between the Company and U.S. Bank Trust Company, National Association, as trustee. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured obligations of the Company and will mature on May&#160;15, 2033, unless earlier converted, redeemed, or repurchased. The Notes do not bear regular interest, and the principal amount of the Notes does not accrete. Special interest and additional interest, if any, will accrue on the notes in the circumstances and at the rates described in the Indenture. The Notes are convertible at the option of the holders only in the following circumstances: (1)&#160;during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March&#160;31, 2026, if the last reported sale price (as defined in the Indenture) per share of the common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(2)&#160;during the five consecutive business day period after any ten consecutive trading day period (the &#8220;Measurement Period&#8221;) if the trading price (as defined in the Indenture) per $1,000 principal amount of Notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate for the Notes on each such trading day; (3)&#160;if the Company calls such Notes for redemption; (4)&#160;upon the occurrence of certain corporate events or distributions on the common stock as set forth in the Indenture; or (5) at any time from, and including, February&#160;15, 2033 until the close of business on the second scheduled trading day immediately before the maturity date. On or after February&#160;15, 2033, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing conditions. The Company will settle conversions by paying or delivering, as applicable, cash, shares of the common stock or a combination of cash and shares of the common stock, at its election, based on the applicable conversion rate(s). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conversion rate for the Notes is initially 8.2305 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $121.50 per share of common stock, and is subject to adjustment in accordance with the terms of the Indenture. The initial conversion price of the Notes represents a premium of approximately 35% above the public offering price per share of the common stock in the Common Stock Offering. If a <span style="white-space:nowrap">&#8220;make-whole</span> fundamental change&#8221; (as defined in the Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may not redeem the Notes at its option at any time before November&#160;20, 2029. The Notes will be redeemable, in whole or in part (subject to the partial redemption limitation described below), at the Company&#8217;s option at any time, and from time to time, on a redemption date on or after November&#160;20, 2029 and on or before the 25th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Notes to be redeemed, plus accrued and unpaid additional interest and special interest, if any, to, but excluding, the redemption date, but only if the last reported sale price per share of the common stock exceeds 130% of the conversion price on (1)&#160;each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (2)&#160;the trading day immediately before the date the Company sends such notice. In addition, calling any Note for redemption will constitute a <span style="white-space:nowrap">make-whole</span> fundamental change with respect to that Note, in which case the conversion rate applicable to the conversion of that note will be increased in certain circumstances if it is converted after it is called for redemption. Pursuant to the partial redemption limitation, the Company may not elect to redeem less than all of the outstanding notes unless at least $75.0&#160;million aggregate principal amount of notes are outstanding and not subject to redemption as of the time the Company sends the related redemption notice. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a &#8220;fundamental change&#8221; (as defined in the Indenture) occurs, then, except as described in the Indenture, noteholders may require the Company to repurchase their Notes at a cash repurchase price equal to the principal amount of the Notes to be repurchased, plus accrued and unpaid additional interest and special interest, if any, to, but excluding, the fundamental change repurchase date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The following events are considered &#8220;events of default&#8221; under the Indenture: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">default in the payment when due (whether at maturity, upon redemption, upon repurchase upon fundamental change or otherwise) of the principal of, or the redemption price or fundamental change repurchase price for, any Note; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">default for 30 consecutive days in the payment when due of additional interest or special interest, if any, that has accrued on any note; </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">failure by the Company to deliver, when required by the indenture, (i)&#160;a fundamental change notice or (ii)&#160;notice of certain specified corporate events, and, other than in the case of a notice pursuant to (ii), such failure is not cured within three business days after its occurrence; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">default in the Company&#8217;s obligation to convert a note in accordance with the Indenture upon the exercise of the conversion right with respect thereto, if such default is not cured within two business days after its occurrence; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">failure by the Company to comply with its obligations in respect of any consolidation, merger or sale of assets; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">default in any of the Company&#8217;s other obligations or agreements under the Indenture or the Notes (other than those specified above) where such default is not cured or waived within 60 days after receipt of written notice of such failure from the trustee or the holders of at least 25% in principal amount of the Notes then outstanding; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">default by the Company or any of its significant subsidiaries (as defined in the Indenture) with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed with principal amount in excess of $100.0&#160;million (or its foreign currency equivalent), in the aggregate of the Company and/or any of the Company&#8217;s significant subsidiaries, whether such indebtedness now exists or shall hereafter be created, (i)&#160;resulting in such indebtedness becoming or being declared due and payable prior to its stated maturity date or (ii)&#160;constituting a failure to pay the principal of any such indebtedness when due and payable (after the expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise, and in the cases of clauses&#160;(i) and (ii), where such default is not cured or waived within 30&#160;days after notice to the Company by the trustee or to the Company and the trustee by holders of at least 25% in aggregate principal amount of the Notes then outstanding in accordance with the Indenture; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">certain events of bankruptcy, insolvency or reorganization of the Company or any of the Company&#8217;s significant subsidiaries. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If certain bankruptcy and insolvency-related events of default occur with respect to the Company, the principal of, and accrued and unpaid additional interest and special interest, if any, on, all of the Notes then outstanding shall automatically become due and payable without any further action by any person. If an event of default with respect to the Notes, other than certain bankruptcy and insolvency-related events of default with respect to the Company, occurs and is continuing, the trustee, by notice to the Company, or the holders of at least 25% in principal amount of the outstanding Notes by notice to the Company and the trustee, may declare 100% of the principal of, and accrued and unpaid additional interest and special interest, if any, on, all the outstanding Notes to be due and payable. Notwithstanding the foregoing, the Indenture provides that, to the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after the occurrence of such an event of default, consist exclusively of the right to receive special interest on the Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture provides that the Company shall not consolidate with or merge with or into, or sell, convey, transfer or lease all or substantially all of the consolidated properties and assets of the Company and its subsidiaries, taken as a whole, to, another person (other than any such sale, conveyance, transfer or lease to one or more of the Company&#8217;s direct or indirect wholly owned subsidiaries), unless: (i)&#160;the resulting, surviving or transferee person (if not the Company) is a &#8220;qualified successor entity&#8221; (as defined in the Indenture) organized and existing under the laws of the United States of America, any State thereof or the District of Columbia, and such qualified successor entity (if not the Company) expressly assumes by supplemental indenture all of the Company&#8217;s obligations under the Notes and the Indenture; and (ii)&#160;immediately after giving effect to such transaction, no default or event of default has occurred and is continuing under the Indenture. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The net proceeds from the Convertible Notes Offering, after deducting the initial purchasers&#8217; discounts and estimated offering expenses, were approximately $390.0&#160;million. The Company expects to use the net proceeds from the Convertible Notes Offering, together with the net proceeds from the Common Stock Offering, for general corporate purposes, which may include, depending on market conditions, repurchasing a portion of the 2027 notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by reference to the text of the Indenture and the form of the Notes, which are attached as Exhibits&#160;4.1 and 4.2, respectively, to this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> and are incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;2.03</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth under Item 1.01 under the heading &#8220;Indenture and Notes&#8221; of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth under Item 1.01 under the heading &#8220;Indenture and Notes&#8221; of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company offered and sold the Notes to the initial purchasers in reliance on the exemption from registration provided by Section&#160;4(a)(2) of the Securities Act. The Notes were resold by the initial purchasers to persons reasonably believed to be qualified institutional buyers pursuant to the exemption from registration provided by Section&#160;4(a)(2) and Rule 144A under the Securities Act. The Company relied on these exemptions from registration based in part on representations made by the initial purchasers in the purchase agreement dated November&#160;4, 2025 by and among the Company and the representative of the initial purchasers. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes and the shares of common stock issuable upon conversion of the Notes, if any, have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that any shares of common stock are issued upon conversion of the Notes, they will be issued in transactions anticipated to be exempt from registration under the Securities Act by virtue of Section&#160;3(a)(9) thereof because no commission or other remuneration is expected to be paid in connection with conversion of the Notes and any resulting issuance of shares of Class&#160;A common stock. Initially, a maximum of 4,472,217 shares of common stock may be issued upon conversion of the Notes based on the initial maximum conversion rate of 11.1111 shares of Class&#160;A common stock per $1,000 principal amount of Notes, which is subject to customary anti-dilution adjustment provisions. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&#160;5, 2025, the Company issued a press release announcing the pricing of the Common Stock Offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, on November&#160;5, 2025, the Company issued a press release announcing the pricing of the Convertible Notes Offering. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span>. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex11.htm">Underwriting Agreement, dated November&#160;4, 2025, among Guardant Health, Inc. and Goldman Sachs&#160;&amp; Co. LLC and Jefferies LLC, as representatives of the several underwriters</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex41.htm">Indenture, dated November&#160;7, 2025, between Guardant Health, Inc. and U.S. Bank Trust Company, National Association</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex41.htm">Form of 0.00% Convertible Senior Note due 2033 (included in Exhibit 4.1)</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex51.htm">Opinion of Gunderson Dettmer Stough Villeneuve Franklin&#160;&amp; Hachigian, LLP</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex51.htm">Consent of Gunderson Dettmer Stough Villeneuve Franklin&#160;&amp; Hachigian, LLP (included in Exhibit 5.1)</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex991.htm">Press release issued by Guardant Health, Inc. dated November&#160;5, 2025</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d66171dex992.htm">Press release issued by Guardant Health, Inc. dated November&#160;5, 2025</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">GUARDANT HEALTH, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: November&#160;7, 2025</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Bell</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Michael Bell</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Financial Officer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">(Principal Accounting Officer and Principal Financial Officer)</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d66171dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GUARDANT HEALTH, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3,333,333
Shares of Common Stock, par value $0.00001 per share </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Underwriting Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">November 4, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co.
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jefferies LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">several Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule 1 hereto </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Goldman Sachs&nbsp;&amp; Co. LLC </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">200 West Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, New
York 10282 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jefferies LLC </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">520 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New York, New
York 10022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Guardant
Health, Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the &#8220;Underwriters&#8221;), for whom you are acting as representatives (the
&#8220;Representatives&#8221;), an aggregate of 3,333,333 shares of common stock, par value $0.00001 per share (&#8220;Common Stock&#8221;), of the Company (the &#8220;Underwritten Shares&#8221;). In addition, the Company proposes to issue and sell,
at the option of the Underwriters, up to an additional 499,999 shares of Common Stock (the &#8220;Option Shares&#8221;). The Underwritten Shares and the Option Shares are herein referred to as the &#8220;Shares&#8221;. The shares of Common Stock of
the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the &#8220;Stock&#8221;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company hereby confirms its agreement with the several Underwriters concerning the purchase and sale of the Shares, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>Registration Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder
(collectively, the &#8220;Securities Act&#8221;), a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-272121),</FONT> including a prospectus, relating to the Shares. Such
registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430B under the Securities Act to be part of the registration statement at the time of its effectiveness (&#8220;Rule 430
Information&#8221;), is referred to herein as the &#8220;Registration Statement&#8221;; and as used herein, the term &#8220;Preliminary Prospectus&#8221; means each prospectus included in such registration statement (and any amendments thereto)
before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term
&#8220;Prospectus&#8221; means the prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. Any reference in this
underwriting agreement (this &#8220;Agreement&#8221;) to the Registration Statement, any Preliminary Prospectus or the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities
Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#8220;amend&#8221;, &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect
to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the
Commission thereunder (collectively, the &#8220;Exchange Act&#8221;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and
the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the Applicable Time (as defined below), the Company had prepared the following information (collectively
with the pricing information set forth on Annex A, the &#8220;Pricing Disclosure Package&#8221;): a Preliminary Prospectus dated November 4, 2025 and each &#8220;free-writing prospectus&#8221; (as defined pursuant to Rule 405 under the Securities
Act) listed on Annex A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Applicable Time&#8221; means 9:25 P.M., New York City time, on November&nbsp;4, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company agrees to issue and sell the Underwritten Shares to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to purchase at a price per share of $85.50 (the &#8220;Purchase
Price&#8221;) from the Company the respective number of Underwritten Shares set forth opposite such Underwriter&#8217;s name in Schedule 1 hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Company agrees to issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the
Underwriters, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase, severally and not jointly, from the Company the Option Shares at the
Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Option Shares are to be purchased, the number of Option Shares to be purchased by each Underwriter shall be the number of Option Shares
which bears the same ratio to the aggregate number of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name of such Underwriter in Schedule 1 hereto (or such number increased as set forth in Section&nbsp;12
hereof) bears to the aggregate number of Underwritten Shares being purchased from the Company by the several Underwriters, subject, however, to such adjustments to eliminate any fractional Shares as the Representatives in their sole discretion shall
make. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriters may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before
the thirtieth day following the date of the Prospectus, by written notice from the Representatives to the Company. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when
the Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter defined)
after the date of such notice (unless such time and date are postponed in accordance with the provisions of Section&nbsp;12 hereof). Any such notice shall be given at least one business day prior to the date and time of delivery specified therein;
provided that, if any of such business days is a Friday, any such notice shall be given at least two business days prior to the date and time of delivery specified therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the Underwriters intend to make a public offering of the
Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any affiliate of an Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the
Representatives, in the case of the Underwritten Shares, at the offices of Cooley LLP, counsel for the Underwriters, at 3 Embarcadero Center, 20th Floor, San Francisco, California 94111, at 10:00 A.M., New York City time, on November 7, 2025, or at
such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing or, in the case of the Option Shares, on the date and at the time and place
specified by the Representatives in the written notice of the Underwriters&#8217; election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the &#8220;Closing Date&#8221;, and the
time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#8220;Additional Closing Date&#8221;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against
delivery to the Representatives for the respective accounts of the several Underwriters of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of
such Shares duly paid by the Company. Delivery of the Shares shall be made through the facilities of The Depository Trust Company (&#8220;DTC&#8221;) unless the Representatives shall otherwise instruct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company acknowledges and agrees that the Representatives and the other Underwriters are acting solely in the capacity of an
arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent
of, the Company or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company
shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and neither the Representatives nor the other Underwriters shall
have any responsibility or liability to the Company with respect thereto. Any review of the Company by the Representatives and any other Underwriters, the transactions contemplated hereby or other matters relating to such transactions will be
performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of
the Company</U>. The Company represents and warrants to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Preliminary Prospectus. </I>No order
preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the
Securities Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the
information described as such in Section&nbsp;9(b) hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Pricing Disclosure Package</I>. The Pricing Disclosure Package as of
the Applicable Time did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Pricing Disclosure Package, it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in Section&nbsp;9(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package and no statement of material fact included in
the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer
Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made,
used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#8220;written communication&#8221; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of
an offer to buy the Shares (each such communication by the Company or its agents and representatives (other than a communication referred to in clause (i)&nbsp;below) an &#8220;Issuer Free Writing Prospectus&#8221;) other than (i)&nbsp;any document
not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act or (ii)&nbsp;the documents listed on Annex A hereto, each electronic road show and any other written communications
approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with
the Securities Act (to the extent required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure Package, and, when taken together with the Preliminary Prospectus accompanying, or
delivered prior to delivery of, such Issuer Free Writing Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions
made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly
for use in such Issuer Free Writing Prospectus or Preliminary Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;9(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Materials. </I>The
Company (i)&nbsp;has not engaged in any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications and (ii)&nbsp;has not authorized anyone to engage in <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications in connection
with the offering of the Shares. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#8220;Testing-the-Waters</FONT></FONT> Communication&#8221; means any communication undertaken in reliance on Rule 163B under the Securities Act, and
&#8220;Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication&#8221; means any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication that is a written communication within the meaning of Rule 405 under the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Registration Statement and Prospectus. </I>The Registration Statement
is an &#8220;automatic shelf registration statement&#8221; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to
the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued
by the Commission, and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of the Shares has been initiated or, to the knowledge of the Company, threatened by the
Commission; as of the applicable effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective amendment complied and will comply in all material respects with the
Securities Act, and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the
Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation
or warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the
Registration Statement and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;9(b) hereof.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Incorporated Documents. </I>When they were filed with the Commission, the documents incorporated by reference in
the Registration Statement, the Pricing Disclosure Package and the Prospectus conformed in all material respects to the requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, the
Prospectus or the Pricing Disclosure Package, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Financial Statements. </I>The financial statements (including the related notes thereto) of the Company and its
consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange
Act, as applicable, and present fairly in all material respects the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the results of their operations and the changes in their cash flows for the periods
specified; such financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) applied on a consistent basis throughout the periods covered thereby, except in the case of
unaudited financial statements, which are subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments and do </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
not contain certain footnotes as permitted by the applicable rules of the Commission; and any supporting schedules included or incorporated by reference in the Registration Statement present
fairly in all material respects the information required to be stated therein; the other financial information included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus has been derived
from the accounting records of the Company and its consolidated subsidiaries and presents fairly in all material respects the information shown thereby; and all disclosures included or incorporated by reference in the Registration Statement, the
Pricing Disclosure Package and the Prospectus regarding <FONT STYLE="white-space:nowrap">&#8220;non-GAAP</FONT> financial measures&#8221; (as such term is defined by the rules and regulations of the Commission) comply in all material respects with
Regulation G of the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> of the Securities Act, to the extent applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>No Material Adverse Change. </I>Since the date of the most recent financial statements of the Company included or
incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (i)&nbsp;there has not been any material change in the capital stock (other than the issuance of shares of Common Stock upon exercise of
stock options or vesting of awards described as outstanding in, and the grant of options and awards under existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt
or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development
involving a prospective material adverse change, in or affecting the business, properties, management, financial position, stockholders&#8217; equity, results of operations or prospects of the Company and its subsidiaries taken as a whole;
(ii)&nbsp;neither the Company nor any of its subsidiaries has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries taken as a whole or incurred any
liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken as a whole; and (iii)&nbsp;neither the Company nor any of its subsidiaries has sustained any loss or interference with its business that is
material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court
or arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Organization and Good Standing. </I>The Company and each of its subsidiaries have been duly organized and are validly
existing and in good standing under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct
of their respective businesses requires such qualification, and have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, except where the failure to be so qualified or
in good standing or have such power or authority would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the business, properties, management, financial position, stockholders&#8217; equity, results
of operations or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement (a &#8220;Material Adverse Effect&#8221;). Except as listed in Exhibit 21.1 to the
Company&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for its most recently completed fiscal year, the Company has no significant subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Capitalization. </I>The Company has an authorized capitalization as
set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus; all the outstanding shares of capital stock of the Company have been duly and validly authorized and issued and are fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> and are not subject to any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> or similar rights that have not been duly waived or satisfied; except as described in or expressly contemplated by the
Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding rights (including, without limitation, <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights), warrants or options to acquire, or instruments
convertible into or exchangeable for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement of any kind relating to the issuance of any
capital stock of the Company or any such subsidiary, any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material respects to the description thereof contained in
the Registration Statement, the Pricing Disclosure Package and the Prospectus; and all the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly and validly
authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (except, in the case of any foreign subsidiary, for directors&#8217; qualifying shares) and are owned directly or indirectly by the Company, free and
clear of any lien, charge, encumbrance, security interest, restriction on voting or transfer or any other claim of any third party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Stock Options. </I>With respect to the stock options (the &#8220;Stock Options&#8221;) granted pursuant to the
stock-based compensation plans of the Company (the &#8220;Company Stock Plans&#8221;), (i) each Stock Option intended to qualify as an &#8220;incentive stock option&#8221; under Section&nbsp;422 of the Code so qualifies, (ii)&nbsp;each grant of a
Stock Option was duly authorized no later than the date on which the grant of such Stock Option was by its terms to be effective (the &#8220;Grant Date&#8221;) by all necessary corporate action, including, as applicable, approval by the board of
directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and
delivered by each party thereto, (iii)&nbsp;each such grant was made in accordance with the terms of the Company Stock Plans and all other applicable laws and regulatory rules or requirements, and (iv)&nbsp;each such grant was properly accounted for
in accordance with GAAP in the financial statements (including the related notes) of the Company. Each Company Stock Plan is accurately described in all material respects in the Registration Statement, the Pricing Disclosure Package and the
Prospectus.<I> </I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Due Authorization. </I>The Company has full right, power and authority to execute and deliver
this Agreement and to perform its obligations hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and the consummation by it of the transactions contemplated hereby has
been duly and validly taken. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Underwriting Agreement. </I>This Agreement has been duly authorized, executed and
delivered by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>The Shares. </I>The Shares to be issued and sold by the Company hereunder have been duly
authorized by the Company and, when issued and delivered and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform in all material respects to the descriptions thereof in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject to any preemptive or similar rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Listing. </I>The Stock is registered pursuant to Section&nbsp;12(b)
or 12(g) of the Exchange Act and is listed on The Nasdaq Global Select Market (&#8220;Nasdaq&#8221;), and the Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Stock under the Exchange Act
or delisting the Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the Company&#8217;s knowledge, it is in compliance with all applicable
listing requirements of Nasdaq. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>No Violation or Default. </I>Neither the Company nor any of its subsidiaries is
(i)&nbsp;in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default,
in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the
Company or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or
arbitrator or governmental or regulatory authority, except, in the case of clauses (ii)&nbsp;and (iii) above, for any such default or violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>No Conflicts. </I>The execution, delivery and performance by the Company of this Agreement, the issuance
and sale of the Shares and the consummation of the transactions contemplated by this Agreement or the Pricing Disclosure Package and the Prospectus will not (i)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions
of, or constitute a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge or encumbrance upon any property, right or asset of the Company or any of its subsidiaries
pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any property,
right or asset of the Company or any of its subsidiaries is subject, (ii)&nbsp;result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents of the Company or any of
its subsidiaries or (iii)&nbsp;result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (i)&nbsp;and (iii) above, for
any such conflict, breach, violation, default, lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>No Consents Required. </I>No consent, filing, approval, authorization, order, license, registration or qualification of
or with any court or arbitrator or governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares and the consummation of the transactions
contemplated by this Agreement, except for the registration of the Shares under the Securities Act and such consents, approvals, authorizations, orders and registrations or qualifications as may be required by Nasdaq and under applicable state
securities laws in connection with the purchase and distribution of the Shares by the Underwriters. The Company is an &#8220;experienced issuer&#8221; as defined in Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;)
Rule&nbsp;5110(j)(6). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>Legal Proceedings. </I>Except as described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, there are no legal, governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&#8220;Actions&#8221;) pending to which the Company or any of its
subsidiaries is or may reasonably be expected to become a party or to which any property of the Company or any of its subsidiaries is or may reasonably be expected to become the subject that, individually or in the aggregate, if determined adversely
to the Company or any of its subsidiaries, would reasonably be expected to have a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Material Adverse Effect; to the knowledge of the Company, no such Actions are threatened or contemplated by any governmental or regulatory authority or threatened by others; and (i)&nbsp;there
are no current or pending Actions that are required under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus and (ii)&nbsp;there are no statutes, regulations or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described in the Registration
Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Independent Accountants</I>. Ernst&nbsp;&amp; Young LLP, who has certified the financial statements of the Company for
the year ended December&nbsp;31, 2022, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting
Oversight Board (United States) and as required by the Securities Act. Deloitte&nbsp;&amp; Touche LLP, who has certified the Company&#8217;s financial statements for the years ended December&nbsp;31, 2023 and December&nbsp;31, 2024 and audited the
Company&#8217;s internal control over financial reporting, is an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public
Company Accounting Oversight Board (United States) and as required by the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <I>Title to Real and
Personal Property</I>. The Company and its subsidiaries have good and marketable title in fee simple (in the case of real property) to, or have valid rights to lease or otherwise use, all items of real and personal property and assets that are
material to the respective businesses of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that (i)&nbsp;do not materially interfere with the use made
and proposed to be made of such property by the Company and its subsidiaries or (ii)&nbsp;would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>Title to Intellectual Property</I>. The Company and its subsidiaries own, or possess valid and enforceable licensed
rights to use, all patents, patent applications, trademarks and trademark registrations, service marks, trade names, service mark registrations, trade dress, designs, data, database rights, Internet domain names, copyrights, works of authorship,
licenses, proprietary information and <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) necessary for the conduct of
their respective businesses as currently conducted and as proposed to be conducted (collectively, &#8220;Intellectual Property&#8221;), or to the development, manufacture, operation, and sale of any products and services sold or proposed to be sold
by the Company, and, to the Company&#8217;s knowledge, the conduct of their respective businesses has not, does not and will not infringe, misappropriate or otherwise conflict in any material respect with any such valid rights of others. The
Intellectual Property has not been adjudged by a court of competent jurisdiction to be invalid or unenforceable, in whole or in part, and the Company is unaware of any facts which would form a reasonable basis for any such adjudication. Except as
disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and its subsidiaries have not received any notice of any claim of infringement, misappropriation or conflict with any intellectual property
rights of another, and the Company is unaware of any facts which would form a reasonable basis for any such notice or claim. To the Company&#8217;s knowledge: (i)&nbsp;there are no third parties who have rights to any Intellectual Property,
including no liens, security interests, or other encumbrances, except for customary reversionary rights of third-party licensors with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
respect to Intellectual Property that is disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus as owned by or licensed to the Company or its subsidiaries; and
(ii)&nbsp;except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is no infringement by third parties of any Intellectual Property. Except as disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others: (A)&nbsp;challenging the Company&#8217;s or any of its subsidiaries&#8217; rights in or to any
Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; (B)&nbsp;challenging the validity, enforceability or scope of any Intellectual Property, and the
Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim; or (C)&nbsp;asserting that the Company or its subsidiaries infringe, misappropriate, or otherwise violate, or would, upon the
commercialization of any product or service described in the Registration Statement, the Pricing Disclosure Package and the Prospectus as under development, infringe, misappropriate, or otherwise violate, any intellectual property rights of others,
and the Company is unaware of any facts which would form a reasonable basis for any such action, suit, proceeding or claim. The Company and its subsidiaries are in material compliance with the terms of each agreement pursuant to which Intellectual
Property has been licensed to the Company or its subsidiaries, and all such agreements are in full force and effect. To the Company&#8217;s knowledge, there are no material defects in any of the patents or patent applications included in the
Intellectual Property, the patents included in the Intellectual Property are subsisting and have not lapsed, and the patent applications included in the Intellectual Property are subsisting and have not been abandoned. The Company and its
subsidiaries have taken all reasonable steps to protect, maintain and safeguard their Intellectual Property, including the execution of appropriate nondisclosure, confidentiality agreements and invention assignment agreements and invention
assignments with their employees, and to the Company&#8217;s knowledge, no employee of the Company or any of its subsidiaries is in or has been in violation of any term of any employment contract, patent disclosure agreement, invention assignment
agreement, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, nondisclosure agreement, or any restrictive covenant to or with a former employer where the basis of
such violation relates to such employee&#8217;s employment with the Company or any of its subsidiaries, except as could not reasonably be expected to have a Material Adverse Effect. To the Company&#8217;s knowledge, the duty of candor and good faith
as required by the United States Patent and Trademark Office during the prosecution of the Company-owned or any subsidiary-owned United States patents and patent applications included in the Intellectual Property have been complied with; and in all
foreign offices having similar requirements, all such requirements have been complied with. None of the Company-owned or subsidiary-owned Intellectual Property or technology (including information technology and outsourced arrangements) employed by
the Company or its subsidiaries has been obtained or is being used by the Company or its subsidiaries in violation of any contractual obligation binding on the Company or its subsidiaries or any of their respective officers, directors or employees
or otherwise in violation of the rights of any persons. The products described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and the product candidates described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus as under development by the Company or its subsidiaries fall within the scope of the claims of one or more patents or patent applications owned by, or exclusively licensed to, the Company or its subsidiaries.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Trade Secrets</I>. The Company and its subsidiaries have taken reasonable and customary actions to protect their
rights in and prevent the unauthorized use and disclosure of material trade secrets and confidential business information (including confidential source code, ideas, research and development information,
<FONT STYLE="white-space:nowrap">know-how,</FONT> formulas, compositions, technical data, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
designs, drawings, specifications, research records, records of inventions, test information, financial, marketing and business data, customer and supplier lists and information, pricing and cost
information, business and marketing plans and proposals) owned by the Company and its subsidiaries, and, to the knowledge of the Company, there has been no unauthorized use or disclosure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>IT Assets</I>. Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect, (i)&nbsp;the computers, software, servers, networks, data communications lines, and other information technology systems owned, licensed, leased or otherwise used by the Company or its subsidiaries (excluding any public networks)
(collectively, the &#8220;IT Assets&#8221;) operate and perform as is necessary for the operation of the business of the Company and its subsidiaries as currently conducted and as proposed to be conducted as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, and (ii)&nbsp;such IT Assets are not infected by viruses, disabling code or other harmful code. The Company and its subsidiaries have implemented and maintained commercially reasonable controls,
policies, procedures, and safeguards necessary to maintain and protect their confidential information and the integrity, continuous operation, redundancy and security of all IT Assets and data (including all Personal Data (defined below) sensitive,
confidential or regulated data (&#8220;Confidential Data&#8221;) used in connection with their businesses. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without
material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are presently in material compliance with all applicable laws or
statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Confidential Data and
to the protection of such IT Assets and Confidential Data from unauthorized use, access, misappropriation or modification. &#8220;Personal Data&#8221; means &#8220;personal data&#8221; as defined by GDPR (as defined below). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <I>Data Privacy and Security Laws</I>. Except where <FONT STYLE="white-space:nowrap">non-compliance</FONT> would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, the Company and its subsidiaries are in compliance with all applicable data privacy and security laws and regulations, including without limitation the
Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;) (42 U.S.C. Section&nbsp;1320d et seq.), as amended by the Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;) (42 U.S.C.
Section&nbsp;17921 et seq.); the European Union General Data Protection Regulation (&#8220;GDPR&#8221;) (EU 2016/679) (collectively, the &#8220;Privacy Laws&#8221;); and the California Consumer Protection Act of 2018 (&#8220;CCPA&#8221;). Neither
the Company nor any subsidiary: (i)&nbsp;has received written notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would
reasonably be expected to result in any such notice and, to the Company&#8217;s knowledge, no such notices are threatened; (ii)&nbsp;is currently conducting or paying for, in whole or in part, any material investigation, remediation, or other
corrective action pursuant to any Privacy Law; or (iii)&nbsp;is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law, except, in the case of (i), (ii), or (iii), where such violation,
investigation, remediation, order, decree or agreement would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>FDA Compliance</I>. Except as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect in the case of clauses (A), (C), (E) and (F), the Company: (A)&nbsp;is in compliance with the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167; 301 et seq.) and the regulations
promulgated thereunder ( the &#8220;FDCA&#8221;) as currently enforced by the FDA taking into account the FDA&#8217;s application of enforcement discretion and with comparable applicable laws and regulations of other governmental entities
(collectively &#8220;FDA Laws&#8221;); (B) has not received any FDA Form 483, written notice of adverse finding, warning letter, untitled letter or other correspondence or written notice from the FDA or any other material applicable governmental
entity (each a &#8220;Regulatory Authority&#8221;) alleging or asserting noncompliance with FDA Laws or with any material licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto
required by the Regulatory Authorities to be obtained by the Company to conduct its business as currently conducted (&#8220;Authorizations&#8221;); (C) possesses all Authorizations and such Authorizations are valid and in full force and effect and
the Company is not in violation of any term of any such Authorizations; (D)&nbsp;has not received written notice of any Action from the Regulatory Authorities alleging that any product, operation or activity is in material violation of any FDA Laws
or the terms of any Authorization and has no knowledge that any Regulatory Authority is considering any such Action; (E)&nbsp;has not received written notice that a Regulatory Authority has taken, is taking or intends to take action to limit,
suspend, modify or revoke any material Authorizations and, to the Company&#8217;s knowledge, no Regulatory Authority has threatened such action; and (F)&nbsp;has filed, obtained, maintained or submitted all reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments thereto to the Regulatory Authorities as required under the FDA Laws or pursuant to any Authorization and that all such reports, documents, forms, notices, applications,
records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected or supplemented by a subsequent submission). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Tests and Preclinical and Clinical Trials</I>. The studies, tests and preclinical and clinical trials conducted by or,
to the Company&#8217;s knowledge, on behalf of the Company were and, if still ongoing, are being conducted in all material respects in compliance with applicable laws, including, without limitation, the FDA Laws, and any applicable rules and
regulations of the jurisdiction in which such trials and studies are being conducted; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies, tests or
trials, the results of which the Company believes reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in
which such results are described and the clinical state of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written
correspondence from the FDA or any governmental entity requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect
to modifications in connection with the design and implementation of such trials. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>Compliance with Health Care
Laws</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and its subsidiaries are in compliance with all Health Care Laws, except where failure to be in compliance would not
reasonably be expected to have a Material Adverse Effect. For purposes of this Agreement, &#8220;Health Care Laws&#8221; means: (i)&nbsp;all applicable federal, state, local and foreign clinical laboratory licensing, permitting and registration
laws, including, without limitation, the Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Section&nbsp;263a et seq.); (ii) all applicable federal, state, local and foreign health care fraud and abuse laws, including, without limitation,
the U.S. Anti-Kickback Statute (42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7b(b)),</FONT> the U.S. Civil False Claims Act (31 U.S.C. Section&nbsp;3729 et seq.), the criminal False Statements Law (42 U.S.C. <FONT
STYLE="white-space:nowrap">Section&nbsp;1320a-7b(a)),</FONT> 18 U.S.C. Sections 286, and 287, the health care fraud criminal provisions under HIPAA, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Stark Law (42 U.S.C. Section&nbsp;1395nn), the Civil Monetary Penalties Laws (42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7a),</FONT> the exclusion law (42 U.S.C. <FONT
STYLE="white-space:nowrap">Section&nbsp;1320a-7);</FONT> (iii) HIPAA, as amended by the HITECH Act; (iv)&nbsp;the Patient Protection and Affordable Care Act; (v)&nbsp;licensure, quality, safety and accreditation requirements under applicable
federal, state, local and foreign laws and regulatory bodies; and (vi)&nbsp;the regulations promulgated pursuant to such statutes and any state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> counterpart thereof. Neither the Company nor any of
its subsidiaries has received written notice of any Action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product, operation or activity is in material violation of any Health Care Laws nor, to
the Company&#8217;s knowledge, is any such Action threatened, except where such Action would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, the Company and its subsidiaries have filed, maintained or submitted all reports, documents, forms, notices, applications, records, claims submissions and supplements or amendments as
required by any Health Care Laws, and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed in all material respects (or were corrected or
supplemented by a subsequent submission). Neither the Company nor any of its subsidiaries is a party to any corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any
governmental or regulatory authority. Additionally, neither the Company, any of its subsidiaries nor any of their respective employees, officers, directors, or to the Company&#8217;s knowledge, their agents has been excluded, suspended or debarred
from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to
result in debarment, suspension, or exclusion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>No Undisclosed Relationships</I>. No relationship, direct or
indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries, on the other, that is required
by the Securities Act to be described in each of the Registration Statement and the Prospectus and that is not so described in such documents and in the Pricing Disclosure Package. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>Investment Company Act</I>. The Company is not and, after giving effect to the issuance and sale of the Shares, the
issuance and sale of the convertible senior notes due 2033 (the &#8220;Convertible Notes&#8221;) pursuant to a purchase agreement dated the date hereof with certain initial purchasers relating to an offering under Rule 144A of the Securities Act
occurring substantially concurrently with the transactions contemplated hereby, and the application of the proceeds thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be required to
register as an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder (collectively, the &#8220;Investment Company Act&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>Taxes. </I>The Company and each of its
subsidiaries have filed all U.S. federal, state, local and foreign tax returns required to be filed through the date hereof and have paid all taxes required to be paid whether or not reported thereon and, if due and payable, any related or similar
assessment, fine or penalty levied against any of them, except as may be being contested in good faith and by appropriate proceedings and for which adequate reserves have been established in the financial statements and as would not individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect; and there is no tax deficiency that has been, or could reasonably </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
be expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets, except as would not, individually or in the aggregate, reasonably be
expected to result in a Material Adverse Effect. To the knowledge of the Company, none of the tax returns or taxes of the Company or any of its Subsidiaries is currently under audit or other examination and there are no outstanding agreements or
waivers extending the statutory period of limitation applicable to any federal, state, local or foreign tax return for any period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>Licenses and Permits. </I>The Company and its subsidiaries possess all licenses,
<FONT STYLE="white-space:nowrap">sub-licenses,</FONT> certificates, permits and other authorizations issued by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities
that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, except where the
failure to possess or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and neither the Company nor any of its subsidiaries has received written notice of any revocation or
modification of any such license, <FONT STYLE="white-space:nowrap">sub-license,</FONT> certificate, permit or authorization or has any reason to believe that any such license, <FONT STYLE="white-space:nowrap">sub-license,</FONT> certificate, permit
or authorization will not be renewed in the ordinary course, except where such revocation or modification would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. To the Company&#8217;s knowledge, no
party granting any such licenses, certificates, permits and other authorizations has taken any action to limit, suspend or revoke the same in any material respect. The Company and its subsidiaries have filed, obtained, maintained or submitted all
material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or
amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission) as required for maintenance of their licenses, certificates, permits and other authorizations that are necessary for the
conduct of their respective businesses, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <I>No Labor Disputes. </I>No labor disturbance by or dispute with employees of the Company or any of its subsidiaries
exists or, to the knowledge of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute with, the employees of any of its or its subsidiaries&#8217; principal suppliers,
contractors or customers, except in any event as would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of cancellation or termination with respect to any
collective bargaining agreement that is material to the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>Certain Environmental Matters. </I>(i)&nbsp;The
Company and its subsidiaries (x)&nbsp;are in compliance with all, and have not violated any, applicable federal, state, local and foreign laws, rules, regulations, requirements, decisions, judgments, decrees, orders and other legally enforceable
requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;Environmental Laws&#8221;); (y) have
received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any Environmental Laws to conduct their respective businesses; and (z)&nbsp;have not
received written notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for the investigation or remediation of any disposal or release of hazardous
or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reasonably be expected to result in any such notice, and (ii)&nbsp;there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except
in the case of each of (i)&nbsp;and (ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and (iii)&nbsp;(x) there is no proceeding that is pending, or that is known
by the Company to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which the Company reasonably believes no monetary
sanctions of $300,000 or more will be imposed, (y)&nbsp;the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning
hazardous or toxic substances or wastes, pollutants or contaminants, that would, individually or in the aggregate, reasonably be excepted to have a Material Adverse Effect, and (z)&nbsp;none of the Company or its subsidiaries anticipates material
capital expenditures relating to any Environmental Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Compliance with ERISA. </I>Except as would not, in the
aggregate, have a Material Adverse Effect: (i)&nbsp;each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), for which the Company would have any
liability (each, a &#8220;Plan&#8221;) has been maintained in compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as
amended (the &#8220;Code&#8221;); (ii) neither the Company nor any member of its &#8220;Controlled Group&#8221; (defined as any entity, whether or not incorporated, that is under common control with the Company within the meaning of
Section&nbsp;4001(a)(14) of ERISA or any entity that would be regarded as a single employer with the Company under Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code) maintains a Plan or an &#8220;employee benefit plan&#8221; (within the meaning
of Section&nbsp;3(3) of ERISA) that is subject to Title IV of ERISA; and (iii)&nbsp;to the Company&#8217;s knowledge, there has not been a material increase in the Company and its subsidiaries&#8217; &#8220;accumulated post-retirement benefit
obligations&#8221; (within the meaning of Accounting Standards Codification Topic <FONT STYLE="white-space:nowrap">715-60)</FONT> compared to the amount of such obligations in the Company and its subsidiaries&#8217; most recently completed fiscal
year, and no such increase is reasonably likely to occur. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <I>Disclosure Controls</I>. The Company and its
subsidiaries maintain an effective system of &#8220;disclosure controls and procedures&#8221; (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> of the Exchange Act) that complies with the requirements of the Exchange Act and that
has been designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the
Commission&#8217;s rules and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure.
The Company has carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>Accounting Controls. </I>The Company and its subsidiaries maintain systems of &#8220;internal control over financial
reporting&#8221; (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that are designed to comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their
respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific
authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific
authorization; (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&nbsp;interactive data in eXtensible Business
Reporting Language included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the
Commission&#8217;s rules and guidelines applicable thereto. Based on the Company&#8217;s most recent evaluation of its internal controls over financial reporting pursuant to Rule <FONT STYLE="white-space:nowrap">13a-15(c)</FONT> of the Exchange Act,
there are no material weaknesses in the Company&#8217;s internal controls. The Company&#8217;s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i)&nbsp;all significant deficiencies and material
weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial
information; and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <I>eXtensible Business Reporting Language.</I> The interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and
guidelines applicable thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) <I>Insurance. </I>The Company and its subsidiaries have insurance covering their
respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are generally maintained by similarly situated companies and which the
Company believes are reasonably adequate to protect the Company and its subsidiaries and their respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from any insurer or agent of such insurer that
capital improvements or other expenditures are required or necessary to be made in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage at reasonable cost from similar insurers as may be necessary to continue its business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) <I>No Unlawful Payments. </I>Neither the Company nor any of its subsidiaries nor any director, officer, or employee of the
Company or any of its subsidiaries nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expense relating to political activity; (ii)&nbsp;made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or
domestic government or regulatory official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any
political party or party official or candidate for political office; (iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD
Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom, or any other applicable anti-bribery or anti-corruption laws; or
(iv)&nbsp;made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or
benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <I>Compliance with Anti-Money Laundering Laws</I>. The operations of
the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or
enforced by any governmental or regulatory agency (collectively, the &#8220;Anti-Money Laundering Laws&#8221;) and no action, suit or proceeding by or before any court or governmental or regulatory agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <I>No Conflicts with Sanctions Laws. </I>Neither the Company nor any of its subsidiaries, directors, officers or
employees, nor, to the knowledge of the Company, any agent, or affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced
by the U.S. Government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated
national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury, or other relevant sanctions authority (collectively, &#8220;Sanctions&#8221;), nor is the Company or any of its
subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Syria, and the Crimea region, the
<FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#8217;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#8217;s Republic or any other Covered Region of Ukraine identified pursuant to Executive Order
14065 (each, a &#8220;Sanctioned Country&#8221;); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint
venture partner or other person or entity (i)&nbsp;to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii)&nbsp;to fund or facilitate any
activities of or business in any Sanctioned Country or (iii)&nbsp;in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of
Sanctions. Since April&nbsp;24, 2019, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the
subject or the target of Sanctions or with any Sanctioned Country. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <I>No Restrictions on Subsidiaries</I>. No
subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary&#8217;s capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or from transferring any of such subsidiary&#8217;s properties or assets to the Company or any
other subsidiary of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <I>No Broker&#8217;s Fees. </I>Neither the Company nor any of its subsidiaries is a
party to any contract, agreement or understanding with any person (other than this Agreement) that would give rise to a valid claim against the Company or any of its subsidiaries or any Underwriter for a brokerage commission, finder&#8217;s fee or
like payment in connection with the offering and sale of the Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) <I>No Registration Rights</I>. No person has the right to require the
Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) <I>No Stabilization. </I>Neither the Company nor any of its subsidiaries or, to the Company&#8217;s knowledge, affiliates
have taken, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(uu) <I>Margin Rules</I>. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by
the Company as described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of
Governors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vv) <I>Forward-Looking Statements. </I>No forward-looking statement (within the meaning of Section&nbsp;27A of
the Securities Act and Section&nbsp;21E of the Exchange Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(ww)</I> <I>Statistical and Market Data. </I>Nothing has come to the attention
of the Company that has caused the Company to believe that the statistical and market-related data included or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on or
derived from sources that are reliable and accurate in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx) <I>Sarbanes-Oxley Act</I>. There is and
has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply with any applicable provision of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations
promulgated in connection therewith (the &#8220;Sarbanes-Oxley Act&#8221;), including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(yy) <I>Status under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment
thereto, at the earliest time thereafter that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company is and was
(i)&nbsp;a &#8220;well-known seasoned issuer&#8221; and (ii)&nbsp;not an &#8220;ineligible issuer,&#8221; and, in each case as defined in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule
456(b)(1) under the Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in any event prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(zz) <I>No Ratings</I>. There are (and prior to the Closing Date, will be) no debt securities, convertible securities or
preferred stock issued or guaranteed by the Company or any of its subsidiaries that are rated by a &#8220;nationally recognized statistical rating organization&#8221;, as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aaa) <I>Outbound Investment Security Program</I>. Neither the Company nor
any of its subsidiaries is a &#8220;covered foreign person&#8221;, as that term is defined in 31 C.F.R. &#167; 850.209. Neither the Company nor any of its subsidiaries currently engages, or has plans to engage, directly or indirectly, in a
&#8220;covered activity&#8221;, as that term is defined in in 31 C.F.R. &#167; 850.208 (&#8220;Covered Activity&#8221;). The Company does not have any joint ventures that engages in or plans to engage in any Covered Activity. The Company also does
not, directly or indirectly, hold a board seat on, have a voting or equity interest in, or have any contractual power to direct or cause the direction of the management or policies of any person or persons that engages or plans to engage in any
Covered Activity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. [Reserved]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Further Agreements of the Company</U>. The Company covenants and agrees with each Underwriter that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings. </I>The Company will file the final Prospectus with the Commission within the time periods specified
by Rule 424(b) and 430B under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; the Company will file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with
the offering or sale of the Shares; and the Company and will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City
time, on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fee for this offering within the time period required by Rule 456(b)(1)
under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<I>Delivery of Copies. </I>The Company will deliver, without charge, (i)&nbsp;to the Representatives, three signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents
filed therewith and documents incorporated by reference therein; and (ii)&nbsp;to each Underwriter (A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B)&nbsp;during the
Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Representatives may
reasonably request. As used herein, the term &#8220;Prospectus Delivery Period&#8221; means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriters a prospectus relating to the
Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or Supplements, Issuer Free Writing Prospectuses. </I>Before making, preparing, using, authorizing,
approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish to the Representatives and
counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such
proposed amendment or supplement to which the Representatives reasonably object. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Representatives. </I>The Company will advise the
Representatives promptly, and confirm such advice in writing (which may be by electronic mail), (i) when the Registration Statement has become effective; (ii)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective;
(iii)&nbsp;when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or any amendment to the Prospectus has been filed or distributed; (iv)&nbsp;of any request by the Commission for any amendment to
the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information including,
but not limited to, any request for information concerning any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication; (v)&nbsp;of the issuance by the Commission or any other governmental or
regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, the Prospectus or the initiation or, to the
knowledge of the Company, threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (vi)&nbsp;of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the
Prospectus, the Pricing Disclosure Package or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, or any such Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; (vii)&nbsp;of the receipt by the Company of any notice
of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (viii)&nbsp;of the receipt by the Company of any notice with respect to any
suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation or, to the knowledge of the Company, threatening of any proceeding for such purpose; and the Company will use its best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or suspending any such qualification of
the Shares and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Ongoing
Compliance. </I>(1)&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event or development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a
material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or
supplement the Prospectus to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as
the Representatives may designate such amendments or supplements to the Prospectus (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Prospectus as so amended or
supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will
comply with law and (2)&nbsp;if at any time prior to the Closing Date (i)&nbsp;any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue
statement of a material fact or omit to state any material fact necessary in order to make the statements therein, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Pricing
Disclosure Package to comply with law, the Company will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representatives may designate such amendments or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in
the Pricing Disclosure Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply
with law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Blue Sky Compliance. </I>The Company will qualify the Shares for offer and sale under the securities or
Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; <U>provided</U> that the Company shall not be required to
(i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction
or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Earnings
Statement. </I>The Company will make generally available to its securityholders and the Representatives as soon as practicable an earnings statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the
Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#8220;effective date&#8221; (as defined in Rule 158) of the Registration Statement, provided
that the Company will be deemed to have furnished such statements to its securityholders and the Representatives to the extent they are filed on the Commission&#8217;s Electronic Data Gathering, Analysis and Retrieval system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Clear Market. </I>For a period of 60 days after the date of the Prospectus (the &#8220;Restricted Period&#8221;), the
Company will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, hedge, lend, or otherwise transfer or dispose of,
directly or indirectly, or submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock, or publicly disclose
the intention to undertake any of the foregoing, or (ii)&nbsp;enter into any swap, hedging, or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether any
such transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written consent of Goldman Sachs&nbsp;&amp; Co. LLC and Jefferies LLC, other than
(A)&nbsp;the Shares to be sold hereunder, (B)&nbsp;any shares of Stock of the Company issued upon the exercise of options or settlement of awards granted under a Company Stock Plan described in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, (C)&nbsp;any options and other awards granted under a Company Stock Plan described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (D)&nbsp;the filing by the Company of any registration
statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> or a successor form thereto relating to a Company Stock Plan described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (E)&nbsp;the issuance and sale of
the Convertible Notes, the issuance of Stock upon the conversion of any Convertible Notes and (F)&nbsp;shares of Stock or other securities issued in connection with a transaction with an unaffiliated third party that includes a bona fide commercial
relationship (including joint ventures, marketing or distribution arrangements, collaboration agreements or licensing agreements) or any acquisition of assets of not less than a majority or controlling
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
portion of the equity of another entity, provided that (x)&nbsp;the aggregate number of shares issued pursuant to clause (F)&nbsp;shall not exceed more than five percent (5%) of the total number
of outstanding shares of Stock immediately following the issuance and sale of the Underwritten Shares pursuant to this Agreement and (y)&nbsp;each newly appointed director or executive officer that is a recipient of any such shares of Stock or
securities issued pursuant to clauses (B), (C) or (F)&nbsp;during the first 30 days of the Restricted Period shall enter into an agreement substantially in the form of <U>Exhibit A</U> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Use of Proceeds. </I>The Company will apply the net proceeds from the sale of the Shares as described in each of the
Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#8220;Use of proceeds&#8221;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Stabilization. </I>Neither the Company nor its subsidiaries or controlled affiliates will take, directly or
indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Exchange Listing. </I>The Company will use its best efforts to list, subject to notice of issuance, the Shares on
Nasdaq. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Reports. </I>During a period of three years from the date of this Agreement, the Company will furnish to
the Representatives, as soon as commercially reasonable after the date they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements
furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be deemed to have furnished such reports and financial statements to the Representatives to the extent they
are filed on the Commission&#8217;s Electronic Data Gathering, Analysis, and Retrieval system. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Record
Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Shelf Renewal</I>. If immediately prior to the third anniversary (the &#8220;Renewal Deadline&#8221;) of the initial
effective date of the Registration Statement, any of the Shares remain unsold by the Underwriters, the Company will, prior to the Renewal Deadline, file, if it has not already done so and is eligible to do so, a new automatic shelf registration
statement relating to the Shares, in a form satisfactory to the Representatives. If the Company is not eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal Deadline, if it has not already done so, file a
new shelf registration statement relating to the Shares, in a form satisfactory to the Representatives, and will use its best efforts to cause such registration statement to be declared effective within 180 days after the Renewal Deadline. The
Company will take all other action necessary or appropriate to permit the issuance and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References herein to the Registration Statement shall
include such new automatic shelf registration statement or such new shelf registration statement, as the case may be. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)
<I>Filings.</I> The Company will file with the Commission such reports as may be required by Rule 463 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.
[Reserved]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Certain Agreements of the Underwriters</U>. Each Underwriter hereby represents and
agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not used, authorized use of, referred to or participated in the planning for use of, and will not
use, authorize use of, refer to or participate in the planning for use of, any &#8220;free writing prospectus&#8221;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by
the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that contains no &#8220;issuer information&#8221; (as defined in Rule 433(h)(2)
under the Securities Act) that was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii)&nbsp;any Issuer Free Writing Prospectus listed on Annex A or
prepared pursuant to Section&nbsp;3(c) or Section&nbsp;5(c) above (including any electronic road show), or (iii)&nbsp;any free writing prospectus prepared by such Underwriter and approved by the Company in advance in writing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains
the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I> that Underwriters may use a term sheet substantially in the form of Annex B hereto without the
consent of the Company; <I>provided further</I> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the first use of such term
sheet. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect to the
offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.
<U>Conditions of Underwriters</U><U>&#8217;</U><U> Obligations. </U>The obligation of each Underwriter to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided
herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order. </I>No order suspending the effectiveness of the Registration Statement shall be
in effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with
the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;5(a) hereof; and all requests by the Commission for
additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<I>Representations and Warranties. </I>The representations and warranties of the Company and its officers contained herein shall be true and correct on the date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may
be; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Material Adverse Change. </I>No event or condition of a type
described in Section&nbsp;3(h) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or
supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may
be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
<I>Officers</I><I>&#8217;</I><I> Certificate. </I>The Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, a certificate of the chief financial officer or chief accounting officer of
the Company and one additional senior executive officer of the Company who is satisfactory to the Representatives, on behalf of the Company and not in their individual capacities, (i)&nbsp;confirming that such officers have carefully reviewed the
Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in Sections 3(b) and 3(f) hereof are true and correct, (ii)&nbsp;confirming that the other
representations and warranties of the Company in this Agreement are true and correct and that the Company has complied in all material respects with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or
prior to the Closing Date or the Additional Closing Date, as the case may be, and (iii)&nbsp;to the effect set forth in paragraphs (a), (b) and (c)&nbsp;above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) (i)<I> Comfort Letters. </I>Ernst&nbsp;&amp; Young LLP, on the date of this Agreement, and Deloitte&nbsp;&amp; Touche LLP,
on the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information of the type customarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with
respect to the financial statements and certain financial information contained or incorporated by reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing
Date or the Additional Closing Date, as the case may be, shall use a <FONT STYLE="white-space:nowrap">&#8220;cut-off&#8221;</FONT> date no more than three business days prior to such Closing Date or such Additional Closing Date, as the case may be.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Chief Financial Officer Certificate</I>. On the date of this Agreement and on the Closing Date or the Additional
Closing Date, as the case may be, the Company shall have furnished to the Representatives a certificate, dated the respective dates of delivery thereof and addressed to the Underwriters, of its chief financial officer with respect to certain
financial data contained in the Pricing Disclosure Package and the Prospectus, providing &#8220;management comfort&#8221; with respect to such information, in form and substance reasonably satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Opinion and Negative Assurance Letter of Counsel for the Company. </I>Gunderson Dettmer Stough Villeneuve
Franklin&nbsp;&amp; Hachigian, LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and negative assurance letter, dated the Closing Date or the Additional Closing Date, as
the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Opinion of Intellectual Property Counsel for the Company</I>. (i)&nbsp;Wilson Sonsini Goodrich&nbsp;&amp; Rosati,
Professional Corporation, intellectual property counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion, dated the Closing Date or the Additional Closing Date, as the case may be,
and addressed to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Underwriters, in form and substance reasonably satisfactory to the Representatives. (ii)&nbsp;The Company&#8217;s <FONT STYLE="white-space:nowrap">in-house</FONT> intellectual property counsel
shall have furnished to the Representatives, at the request of the Company, his/her written opinion, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably
satisfactory to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(h)</I> <I>Regulatory Certificate of Chief Legal Officer. </I>The Chief Legal
Officer of the Company, shall have furnished to the Representatives a regulatory certificate, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriters, in form and substance reasonably satisfactory
to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion and Negative Assurance Letter of Counsel for the Underwriters. </I>The
Representatives shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, an opinion and negative assurance letter of Cooley LLP, counsel for the Underwriters, with respect to such matters as the
Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) [Reserved]. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>No Legal Impediment to Issuance and Sale. </I>No action shall have been taken and no statute, rule, regulation or order
shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares; and
no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance or sale of the Shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Good Standing</I>. The Representatives shall have received on and as of the Closing Date or the Additional Closing Date,
as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization and their good standing as foreign entities in such other jurisdictions as the Representatives may
reasonably request, in each case in writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Exchange Listing. </I>The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be,
shall have been approved for listing on Nasdaq. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</I>. The
<FONT STYLE="white-space:nowrap">&#8220;lock-up&#8221;</FONT> agreements, each substantially in the form of <U>Exhibit A</U> hereto, between you and all officers and directors of the Company relating to sales and certain other dispositions of shares
of Stock or certain other securities, delivered to you on or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Additional Documents. </I>On or prior to the Closing Date or the Additional Closing Date, as the case may be, the
Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriters. </I>The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors
and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities (including,
without limitation, legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several, that arise out of, or are based upon, (i)&nbsp;any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the
statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing
Prospectus, any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any road show as defined in Rule 433(h) under the Securities Act (a &#8220;road show&#8221;) or any Pricing Disclosure
Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon
and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information furnished
by any Underwriter consists of the information described as such in paragraph (b)&nbsp;below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Company.
</I>Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of
Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are
based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the
Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any road show or any Pricing Disclosure Package (including any
Pricing Disclosure Package that has subsequently been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each
Underwriter: the concession and reallowance figures appearing in the sixth paragraph under the caption &#8220;Underwriting&#8221;, and the information contained in the ninth, tenth and eleventh paragraphs under the caption
&#8220;Underwriting.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures. </I>If any suit, action, proceeding (including any governmental or regulatory
investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section&nbsp;9, such person (the &#8220;Indemnified Person&#8221;) shall
promptly notify the person against whom such indemnification may be sought (the &#8220;Indemnifying Person&#8221;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may
have under the preceding paragraphs of this Section&nbsp;9 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure
to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section&nbsp;9. If any such proceeding shall be brought or asserted against an
Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the
Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the reasonable and documented fees and expenses in such proceeding and shall pay the
reasonable and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably
satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or
(iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one
separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers
and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company
shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, the Indemnifying Person agrees to indemnify each
Indemnified Person from and against any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person
for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30 days after
receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the
written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such
Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of
such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution. </I>If the indemnification provided for in paragraphs (a)&nbsp;or (b) above is unavailable to an Indemnified Person or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable
by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters on the other, from
the offering of the Shares or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;but also the
relative fault of the Company, on the one hand, and the Underwriters on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Company, on the one hand, and the Underwriters on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the
Shares and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate
offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriters on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement
or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability. </I>The Company and the Underwriters agree that it would not be just and equitable if
contribution pursuant to paragraph (d)&nbsp;above were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be deemed to include,
subject to the limitations set forth above, any legal or other expenses reasonably incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d)&nbsp;and (e), in no event shall an
Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Shares exceeds the amount of any damages that such
Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#8217; obligations to contribute pursuant to paragraphs (d)&nbsp;and (e) are several in proportion to their respective
purchase obligations hereunder and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies. </I>The remedies
provided for in this Section&nbsp;9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Effectiveness of Agreement</U>. This Agreement shall become effective as of the date first written above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after
the execution and delivery of this Agreement and prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date: (i)&nbsp;trading generally shall have been suspended or materially limited on or by any of the New
York Stock Exchange or The Nasdaq Stock Market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or
(iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and
adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the
Pricing Disclosure Package and the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Defaulting Underwriter</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If, on the Closing Date or the Additional Closing Date, as the case may be, any Underwriter defaults on its obligation to purchase the
Shares that it has agreed to purchase hereunder on such date, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Shares by other persons satisfactory to the Company on the
terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Shares, then the Company shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Shares on such terms. If other persons become obligated or agree
to purchase the Shares of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the case may be, for up to five full
business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company
agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#8220;Underwriter&#8221; includes, for all purposes of this Agreement unless
the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;12, purchases Shares that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be,
does not exceed <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate number of Shares to be purchased on such date, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT>
Underwriter to purchase the number of Shares that such Underwriter agreed to purchase hereunder on such date plus such Underwriter&#8217;s pro rata share (based on the number of Shares that such Underwriter agreed to purchase on such date) of the
Shares of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any
arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate number of
Shares that remain unpurchased on the Closing Date or the Additional Closing Date, as the case may be, exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate amount of Shares to be purchased on such date, or if the Company
shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement or, with respect to any Additional Closing Date, the obligation of the Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall
terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;12 shall be without liability on the part of the Company, except that
the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;13 hereof and except that the provisions of Section&nbsp;9 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained in this Section&nbsp;12 shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Payment of Expenses</U><I>.</I>
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay
or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes
payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package
and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&#8217;s counsel and independent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accountants; (iv)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Shares under the state or foreign
securities or blue sky laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum; (v)&nbsp;the cost of preparing stock certificates; (vi)&nbsp;the costs and charges of any
transfer agent and any registrar; (vii)&nbsp;all expenses and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA (including the related documented fees and expenses of counsel for the Underwriters,
in an aggregate amount not to exceed $20,000 (excluding filing fees)); (viii) all expenses incurred by the Company in connection with any &#8220;road show&#8221; presentation to potential investors (provided, however, that the Underwriters and the
Company shall each pay 50% of the cost of chartering any aircraft to be used in connection with the road show by the Company and the Underwriters, and all lodging, commercial airfare and individual expenses of the Underwriters shall be the
responsibility of the Underwriters); and (ix)&nbsp;all expenses and application fees related to the listing of the Shares on Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;11(ii), (ii) the Company for any reason fails to tender the Shares required to be tendered by it or on its behalf pursuant to this Agreement for delivery to the Underwriters or
(iii)&nbsp;the Underwriters decline to purchase the Shares for any reason permitted under this Agreement, the Company agrees to reimburse the Underwriters for all
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the reasonable and documented fees and expenses of their counsel) reasonably incurred by the Underwriters in connection with
this Agreement and the offering contemplated hereby; provided, however, that no additional amounts will be owed to the Underwriters other than under Section&nbsp;9 hereof. For the avoidance of doubt, it is understood that the Company shall not pay
or reimburse any costs, fees or expenses incurred by any Underwriter that defaults on its obligations to purchase the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.
<U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and
the affiliates of each Underwriter referred to in Section&nbsp;9 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any
provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the
Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in
full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters or the directors, officers, controlling persons or affiliates referred to in Section&nbsp;9 hereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where otherwise expressly provided, the term
&#8220;affiliate&#8221; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be closed in New York City; (c)&nbsp;the
term &#8220;subsidiary&#8221; has the meaning set forth in Rule 405 under the Securities Act; and (d)&nbsp;the term &#8220;significant subsidiary&#8221; has the meaning set forth in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Compliance with USA Patriot Act</U>. In accordance with the
requirements of the USA Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to obtain, verify and record information that identifies their
respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to properly identify their respective clients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Notices. </I>All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed
or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o Goldman Sachs&nbsp;&amp; Co. LLC, 200 West Street, New York, New York 10282-2198, Attention: Registration
Department; or c/o Jefferies LLC, 520 Madison Avenue, New York, New York 10022, Attention: Global Head of Syndicate Notices to the Company shall be given to it at Guardant Health, Inc., 3100 Hanover Street, Palo Alto, California 94304; Attention:
Chief Legal Officer (email: jsaia@guardanthealth.com), with a copy (which shall not constitute notice) to Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian, LLP, 1 Bush St #1200, San Francisco, California 94104; Attention: Andrew D.
Thorpe, Esq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Governing Law. </I>This Agreement and any claim, controversy or dispute arising under or related to this Agreement
shall be governed by and construed in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Submission to Jurisdiction</I>. The
Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in
such court shall be conclusive and binding upon the Company, and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Waiver of Jury Trial</I>. Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of
or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Recognition of the U.S. Special Resolution Regimes</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) As used in this Section&nbsp;18(e): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in
accordance with, 12 U.S.C. &#167; 1841(k). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Covered Entity&#8221; means any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted
in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;U.S. Special Resolution
Regime&#8221; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Counterparts. </I>This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of
telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S.
federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been
duly and validly delivered and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Amendments or Waivers. </I>No amendment or waiver of any
provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Headings. </I>The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Integration. </I>This Agreement supersedes all prior agreements and understandings
(whether written or oral) between the Company and the Underwriters, or any of them, with respect to the subject matter hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUARDANT HEALTH, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ John Saia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">John Saia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Legal Officer and Corporate Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement] </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted: As of the date first written above</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GOLDMAN SACHS&nbsp;&amp; CO. LLC</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JEFFERIES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For themselves and on behalf of the several Underwriters listed in Schedule 1 hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GOLDMAN SACHS&nbsp;&amp; CO. LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Lyla Bibi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Lyla Bibi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JEFFERIES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Charlie Glazer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement] </I></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jefferies LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,166,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leerink Partners LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guggenheim Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>ANNEX A </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Issuer Free Writing Prospectuses Not Included in the Pricing Disclosure Package</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Free Writing Prospectus, dated November 4, 2025, filed pursuant to Rule 433 under the Securities Act </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Free Writing Prospectus, dated November&nbsp;4, 2025, filed pursuant to Rule 433 under the Securities Act </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Pricing Information Provided Orally by Underwriters</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Price per share: $90.00 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number
of Underwritten Shares to be sold by the Company: 3,333,333 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number of Option Shares to be sold by the Company: 499,999 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guardant Health, Inc. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing
Term Sheet </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">None. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">__________, 2025 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS&nbsp;&amp; CO.
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JEFFERIES LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the several Underwriters listed in </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule 1 to the
Underwriting </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Agreement referred to below </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Goldman Sachs&nbsp;&amp; Co. LLC </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">200 West Street </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, New York 10282 </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Jefferies LLC </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">520 Madison Avenue </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#8201;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, New York 10022 </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Re:&#8195;Guardant Health, Inc. &#8212;Public Offering </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
understands that you, as representatives (the &#8220;Representatives&#8221;) of the several Underwriters, propose to enter into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Guardant Health, Inc., a Delaware corporation
(the &#8220;Company&#8221;), providing for the public offering (the &#8220;Public Offering&#8221;) by the several Underwriters named in Schedule 1 to the Underwriting Agreement (the &#8220;Underwriters&#8221;), of common stock, par value $0.00001
per share (&#8220;Common Stock&#8221;), of the Company (the &#8220;Securities&#8221;). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the Underwriters&#8217; agreement to purchase and make the Public Offering of the Securities, and for other good and
valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of Goldman Sachs&nbsp;&amp; Co. LLC and Jefferies LLC on behalf of the Underwriters, the undersigned will not,
subject to the exceptions set forth in this letter agreement (this &#8220;Letter Agreement&#8221;), during the period beginning on the date of this Letter Agreement and ending 30 days after the date of the final prospectus supplement relating to the
Public Offering (the &#8220;Prospectus&#8221;) (such period, the &#8220;Restricted Period&#8221;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (including, without limitation, Common Stock or
such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and securities which may be issued upon exercise of
a stock option or warrant), (2) engage in any hedging or other transactions designed or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
intended to lead to or result in, or which could reasonably be expected to lead to or result in, a sale or disposition of any shares of Common Stock, or securities convertible into or exercisable
or exchangeable for Common Stock, even if any such sale or disposition transaction or transactions would be made or executed by or on behalf of someone other than the undersigned, or enter into any swap or other agreement that transfers, in whole or
in part, any of the economic consequences of ownership of the Common Stock or such other securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of Common Stock or such other securities, in
cash or otherwise, (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock, or (4)&nbsp;publicly disclose the
intention to do any of the foregoing, in each case other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Securities to be sold by the undersigned pursuant to the Underwriting Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as a bona fide gift or gifts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to partners, members, beneficiaries (or the estates thereof) or stockholders of the undersigned;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any trust for the direct or indirect benefit of the undersigned or the immediate family (as defined below)
of the undersigned; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any corporation, partnership, limited liability company, trust or other entity that controls, or is
controlled by or is under common control with, the undersigned or the immediate family of the undersigned or is otherwise a direct or indirect affiliate (as defined (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by testate succession or intestate succession to a legal representative, heir, beneficiary or a member of the
immediate family of the undersigned, <U>provided</U> that any filing under Section&nbsp;16 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), shall clearly indicate in the footnotes thereto that the filing relates
to the circumstances described in this clause and no other public announcement shall be required or shall be made voluntarily during the Restricted Period in connection with such transfer or disposition; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(G)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by operation of law, including pursuant to an order of a court (including a domestic order or a negotiated
divorce settlement) or regulatory agency, <U>provided</U> that any filing under Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and no other
public announcement shall be required or shall be made voluntarily during the Restricted Period in connection with such transfer or disposition; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(H)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pursuant to a merger, consolidation or other similar transaction or bona fide third party tender offer made to
all holders of the Company&#8217;s capital stock involving a Change of Control of the Company (including voting in favor of any such transaction or taking any other action in connection with such transaction), that, in each case, has been approved
by the board of directors of the Company, provided that in the event that such transaction is not completed, the undersigned&#8217;s Common Stock and securities convertible into or exercisable or exchangeable for Common Stock shall remain subject to
the restrictions contained in this Letter Agreement, and provided further that &#8220;Change of Control&#8221; shall mean the transfer, in one transaction or in a series of related transactions, to a person or group of affiliated persons (other than
an Underwriter pursuant to the Public Offering), of the Company&#8217;s voting securities if, after such transfer, such person or group of affiliated persons would hold more than 50% of the outstanding voting securities of the Company (or the
surviving entity); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(I)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pursuant to a trading plan established in accordance with Rule
<FONT STYLE="white-space:nowrap">10b5-1(c)(1)(i)(B)</FONT> under the Exchange Act; <U>provided</U> that (i)&nbsp;such plan was established and disclosed to the Underwriters prior to the execution of this Letter Agreement by the undersigned, and
(ii)&nbsp;any filing under Section&nbsp;16(a) of the Exchange Act that is made in connection with any such transfer during the Restricted Period shall state that such transfer has been executed under a <FONT STYLE="white-space:nowrap">10b5-1</FONT>
trading plan and the date such plan was adopted; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(J)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in &#8220;sell to cover&#8221; or open market transactions by the undersigned of up to 10,500 shares of Common
Stock (in the aggregate for all directors and executive officers of the Company) during the Restricted Period to satisfy (a)&nbsp;income tax payment obligations as a result of the vesting and/or settlement of Company restricted stock units held by
the undersigned and issued pursuant to a plan or arrangement described in the Registration Statement, the Pricing Disclosure Package and the Prospectus or (b)&nbsp;in connection with tax planning purposes, provided that any remaining shares of
Common Stock issued as a result of clause (a)&nbsp;shall be subject to the restrictions set forth herein, and provided, further, that any filing under Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes thereto that the
filing relates to the circumstances described in this clause, as applicable, and no other public announcement shall be required or shall be made voluntarily during the Restricted Period in connection with such transfer or disposition;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U> that in the case of any transfer or distribution pursuant to clauses (B)&#8211;(F), each transferee, donee or
distributee, as applicable, shall execute and deliver to the Representatives a <FONT STYLE="white-space:nowrap">lock-up</FONT> letter in the form of this Letter Agreement and such transfer or distribution shall not involve a disposition for value;
and <U>provided further</U> that in the case of any transfer or distribution pursuant to clauses (C)&#8211;(E), no filing by any party (donor, donee, transferor or transferee) under Section&nbsp;16(a) of the Exchange Act or other public announcement
shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above). For purposes of this Letter Agreement,
&#8220;immediate family&#8221; shall mean any relationship by blood, marriage, domestic partnership or adoption, not more remote than first cousin. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the foregoing restrictions shall not apply to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the exercise (including by net or cashless exercise) of stock options granted pursuant to the Company&#8217;s
equity incentive plans that are described in the Prospectus (including the documents incorporated by reference therein) or warrants or any other securities existing as of the date of the Underwriting Agreement, which securities are convertible into
or exchangeable or exercisable for Common Stock, <U>provided</U> that such restrictions shall apply to any shares of Common Stock issued upon such exercise, exchange or conversion, and <U>provided further</U> if the undersigned is required to file a
report under Section&nbsp;16(a) of the Exchange Act reporting a change in the aggregate beneficial ownership of the shares of Common Stock during the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing
relates to the circumstances described in this paragraph (i)&nbsp;and no other public filing or announcement shall be made voluntarily in connection with such exercise (other than a filing on a Form 5 made after the expiration of the Restricted
Period referred to above); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer or surrender to the Company of any shares of Common Stock to cover tax withholdings upon a vesting
event or settlement, as applicable, of any equity award under any of the Company&#8217;s equity incentive plans existing as of the date of the Underwriting Agreement that are described in the Prospectus (including the documents incorporated by
reference therein) or in an exhibit filed with the registration statement related to the Public Offering (the &#8220;Registration Statement&#8221;), <U>provided</U> that the underlying shares of Common Stock shall continue to be subject to the
restrictions on transfer set forth in this Letter Agreement and <U>provided further</U> that if the undersigned is required to file a report under Section&nbsp;16(a) of the Exchange Act reporting a change in the aggregate beneficial ownership of the
shares of Common Stock during the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this paragraph (ii)&nbsp;and no other public filing or announcement shall
be made voluntarily in connection with such transfer or surrender (other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer or disposition of any shares of Common Stock purchased by the undersigned on the open market
following the Public Offering, <U>provided</U> that no filing by the undersigned under Section&nbsp;16(a) of the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer or disposition
(other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the transfer of shares of Common Stock to the Company pursuant to any contractual arrangement that provides the
Company with an option to repurchase such shares of Common Stock in connection with the termination of the undersigned&#8217;s employment with the Company, <U>provided</U> that, if such transfer is made on or after the date of the Prospectus, such
contractual arrangement (or a form thereof) is described in the Prospectus (including the documents incorporated by reference therein) or filed as an exhibit to the Registration Statement, and <U>provided further</U> that if the undersigned is
required to file a report under Section&nbsp;16(a) of the Exchange Act reporting a change in beneficial ownership of shares of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Common Stock during the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing relates to the termination of the undersigned&#8217;s employment or
other services and no other public filing or announcement shall be made voluntarily in connection with such transfer (other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above); or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the establishment of any contract, instruction or plan (a &#8220;Plan&#8221;) that satisfies all of the
applicable requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1(c)(1)(i)(B)</FONT> under the Exchange Act, <U>provided</U> that no sales of the undersigned&#8217;s Securities shall be made pursuant to such a Plan prior to the expiration of
the Restricted Period, and such a Plan may only be established if the undersigned makes no required or voluntary filing under Section&nbsp;16(a) of the Exchange Act or other public announcement of the establishment or existence thereof prior to the
expiration of the Restricted Period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing, the Company, and any duly appointed transfer
agent for the registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All
authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any signature is delivered by facsimile transmission, electronic mail or otherwise by electronic transmission evidencing an
intent to sign this Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a valid and binding obligation of the undersigned with the same force and effect as if such signature were an original.
Execution and delivery of this Letter Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriters have not provided any recommendation or investment advice nor have the
Underwriters solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted their own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The
undersigned further acknowledges and agrees that, although the Representatives may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Representatives and the
other Underwriters are not making a recommendation to you to enter into this Letter Agreement, participate in the Public Offering, or transfer, sell or dispose of, or to refrain from transferring, selling or disposing of, any shares of Common Stock,
and nothing set forth in such disclosures is intended to suggest that the Representatives or any Underwriter is making such a recommendation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned shall automatically be released from all obligations under this Letter
Agreement if: (i)&nbsp;the Underwriting Agreement does not become effective by November&nbsp;30, 2025; (ii) if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment
for and delivery of the Common Stock to be sold thereunder; or (iii)&nbsp;prior to the execution of the Underwriting Agreement, either the Company, on the one hand, or the Representatives, on the other hand, notifies the other in writing that it
does not intend to proceed with the Public Offering. The undersigned understands that the Underwriters are entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Letter Agreement and any claim, controversy or dispute arising under or related to this
Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name of Security Holder (<I>Print exact name</I>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">If not signing in an individual capacity:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Name of Authorized
Signatory (<I>Print</I>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title of Authorized
Signatory (<I>Print</I>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>d66171dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GUARDANT HEALTH, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>U.S. BANK TRUST
COMPANY, NATIONAL ASSOCIATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">as Trustee </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INDENTURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of
November&nbsp;7, 2025 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0% Convertible Senior Notes due 2033 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 1. Definitions; Rules of Construction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 2. The Notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Form, Dating and Denominations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Execution, Authentication and Delivery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Initial Notes and Additional Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Method of Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Regular Interest; Accrual and Payment of Special Interest and Additional Interest; Defaulted Amounts; When Payment Date is Not a Business Day</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Registrar, Paying Agent and Conversion Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Paying Agent and Conversion Agent to Hold Property in Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Holder Lists</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Legends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfers and Exchanges; Certain Transfer Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exchange and Cancellation of Notes to Be Converted or to Be Repurchased Pursuant to a Repurchase Upon Fundamental Change or Redeemed Pursuant to a Redemption</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Removal of Transfer Restrictions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Replacement Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Registered Holders; Certain Rights with Respect to Global Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cancellation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notes Held by the Company or its Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Temporary Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.18.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Outstanding Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.19.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Repurchases by the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.20.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">CUSIP and ISIN Numbers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 3. Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Payment on Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exchange Act Reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rule 144A Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Additional Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compliance and Default Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stay, Extension and Usury Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Acquisition of Notes by the Company and its Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- i - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 4. Repurchase and Redemption</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Sinking Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right of Holders to Require the Company to Repurchase Notes upon a Fundamental Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right of the Company to Redeem the Notes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 5. Conversion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right to Convert</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conversion Procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Settlement upon Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reserve and Status of Common Stock Issued upon Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Adjustments to the Conversion Rate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Voluntary Adjustments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exchange in Lieu of Conversion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Effect of Common Stock Change Event</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 6. Successors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>When the Company May Merge, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successor Entity Substituted</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exclusion for Asset Transfers with Wholly Owned Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 7. Defaults and Remedies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Events of Default</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Acceleration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Sole Remedy for a Failure to Report</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Other Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver of Past Defaults</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Control by Majority</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Suits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absolute Right of Holders to Institute Suit for the Enforcement of the Right to Receive Payment and Conversion Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Collection Suit by Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trustee May File Proofs of Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Priorities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Undertaking for Costs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Cure of Defaults; Ability to Cure or Waive Before Event of Default Occurs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 8. Amendments, Supplements and Waivers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Without the Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>With the Consent of Holders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notice of Amendments, Supplements and Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Revocation, Effect and Solicitation of Consents; Special Record Dates; Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notations and Exchanges</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Trustee to Execute Supplemental Indentures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- ii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 9. Satisfaction and Discharge</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination of Company&#8217;s Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Repayment to Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reinstatement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 10. Trustee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Duties of the Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rights of the Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Individual Rights of the Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Trustee&#8217;s Disclaimer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notice of Defaults</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Compensation and Indemnity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Replacement of the Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Successor Trustee by Merger, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Eligibility; Disqualification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article 11. Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.01.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.02.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Delivery of Officer&#8217;s Certificate and Opinion of Counsel as to Conditions Precedent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.03.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Statements Required in Officer&#8217;s Certificate and Opinion of Counsel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.04.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Rules by the Trustee, the Registrar, the Paying Agent and the Conversion Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.05.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Personal Liability of Directors, Officers, Employees and Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.06.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law; Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.07.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Submission to Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.08.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Adverse Interpretation of Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.09.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Successors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Force Majeure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">U.S.A. PATRIOT Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Calculations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Table of Contents, Headings, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Withholding Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exhibits </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit A: Form of Note</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">A-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">B-1:</FONT> Form of Restricted Note Legend</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">B1-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">B-2:</FONT> Form of Global Note Legend</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">B2-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit <FONT STYLE="white-space:nowrap">B-3:</FONT> Form of Affiliate Resale Legend</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">B3-1</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- iii - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>INDENTURE</B>, dated as of November&nbsp;7, 2025, between Guardant Health, Inc., a
Delaware corporation, as issuer (the &#8220;<B>Company</B>&#8221;), and U.S. Bank Trust Company, National Association, as trustee (the &#8220;<B>Trustee</B>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each party to this Indenture (as defined below) agrees as follows for the benefit of the other party and for the equal and ratable benefit of
the Holders (as defined below) of the Company&#8217;s 0% Convertible Senior Notes due 2033 (the &#8220;<B>Notes</B>&#8221;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 1.
DEFINITIONS; RULES OF CONSTRUCTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.01. D<SMALL>EFINITIONS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Additional Interest</B>&#8221; means any interest that accrues on any Note pursuant to <B>Section</B><B></B><B>&nbsp;3.04</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Affiliate</B>&#8221; has the meaning set forth in Rule 144 as in effect on the Issue Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Affiliate Resale Legend</B>&#8221; means a legend substantially in the form set forth in <B>Exhibit
<FONT STYLE="white-space:nowrap">B-3</FONT></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Authorized Denomination</B>&#8221; means, with respect to a Note, a minimum
principal amount thereof equal to $1,000 and principal amount denominations of any integral multiple of $1,000 in excess thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Bankruptcy Law</B>&#8221; means Title 11, United States Code, or any similar U.S. federal or state or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> law for the relief of debtors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Bid Solicitation Agent</B>&#8221; means the
Person who is required to obtain bids for the Trading Price in accordance with <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(2)</B> and the definition of &#8220;Trading Price.&#8221; The initial Bid Solicitation Agent on the Issue Date will be the
Company; <I>provided</I>, <I>however</I>, that the Company may appoint any other Person (including any of the Company&#8217;s Subsidiaries) to be the Bid Solicitation Agent at any time after the Issue Date without prior notice to the Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Board of Directors</B>&#8221; means the board of directors of the Company or a committee of such board duly authorized to act on
behalf of such board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Business Day</B>&#8221; means any day other than a Saturday, a Sunday or any day on which the Federal
Reserve Bank of New York is authorized or required by law or executive order to close or be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Capital Stock</B>&#8221; of
any Person means any and all shares of, interests in, rights to purchase, warrants or options for, participations in, or other equivalents of, in each case however designated, the equity of such Person, but excluding any debt securities convertible
into such equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Close of Business</B>&#8221; means 5:00 p.m., New York City time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Code</B>&#8221; means the Internal Revenue Code of 1986, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Common Stock</B>&#8221; means the common stock, $0.00001 par value per share, of
the Company, subject to <B>Section</B><B></B><B>&nbsp;5.09</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Company</B>&#8221; means the Person named as such in the first
paragraph of this Indenture and, subject to <B>Article 6</B>, its successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Company Order</B>&#8221; means a
written request or order signed on behalf of the Company by one (1)&nbsp;of its Officers and delivered to the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Conversion Date</B>&#8221; means, with respect to a Note, the first Business Day on which the requirements set forth in
<B>Section</B><B></B><B>&nbsp;5.02(A)</B> to convert such Note are satisfied, subject to <B>Section</B><B></B><B>&nbsp;5.03(C)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Conversion Price</B>&#8221; means, as of any time, an amount equal to (A)&nbsp;one thousand dollars ($1,000) <I>divided by</I>
(B)&nbsp;the Conversion Rate in effect at such time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Conversion Rate</B>&#8221; initially means 8.2305 shares of Common Stock
per $1,000 principal amount of Notes; <I>provided</I>, <I>however</I>, that the Conversion Rate is subject to adjustment pursuant to <B>Article 5</B>; <I>provided</I>, <I>further</I>, that whenever this Indenture refers to the Conversion Rate as of
a particular date without setting forth a particular time on such date, such reference will be deemed to be to the Conversion Rate immediately after the Close of Business on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Conversion Share</B>&#8221; means any share of Common Stock issued or issuable upon conversion of any Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Daily Cash Amount</B>&#8221; means, with respect to any VWAP Trading Day, the lesser of (A)&nbsp;the applicable Daily Maximum Cash
Amount; and (B)&nbsp;the Daily Conversion Value for such VWAP Trading Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Daily Conversion Value</B>&#8221; means, with
respect to any VWAP Trading Day, <FONT STYLE="white-space:nowrap">one-twenty</FONT> fifth (1/25th) of the product of (A)&nbsp;the Conversion Rate on such VWAP Trading Day; and (B)&nbsp;the Daily VWAP per share of Common Stock on such VWAP Trading
Day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Daily Maximum Cash Amount</B>&#8221; means, with respect to the conversion of any Note, the quotient obtained by dividing
(A)&nbsp;the Specified Dollar Amount applicable to such conversion by (B)&nbsp;twenty-five (25). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Daily Share Amount</B>&#8221;
means, with respect to any VWAP Trading Day, the quotient obtained by dividing (A)&nbsp;the excess, if any, of the Daily Conversion Value for such VWAP Trading Day over the applicable Daily Maximum Cash Amount by (B)&nbsp;the Daily VWAP for such
VWAP Trading Day. For the avoidance of doubt, the Daily Share Amount will be zero for such VWAP Trading Day if such Daily Conversion Value does not exceed such Daily Maximum Cash Amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Daily VWAP</B>&#8221; means, for any VWAP Trading Day, the per share
volume-weighted average price of the Common Stock as displayed under the heading &#8220;Bloomberg VWAP&#8221; on Bloomberg page &#8220;GH &lt;EQUITY&gt; AQR&#8221; (or, if such page is not available, its equivalent successor page) in respect of the
period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such VWAP Trading Day (or, if such volume-weighted average price is unavailable, the market value of one share of Common Stock on such
VWAP Trading Day, determined, using a volume-weighted average price method, by a nationally recognized independent investment banking firm selected by the Company, which may include any of the Initial Purchasers). The Daily VWAP will be determined
without regard to after-hours trading or any other trading outside of the regular trading session. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><FONT
STYLE="white-space:nowrap">De-Legending</FONT> Deadline Date</B>&#8221; means, with respect to any Note, the fifteenth (15th) day after the Free Trade Date of such Note; <I>provided</I>, <I>however</I>, that if such fifteenth (15th) day is after an
Interest Record Date and on or before the next Interest Payment Date, then the <FONT STYLE="white-space:nowrap">De-Legending</FONT> Deadline Date for such Note will instead be the Business Day immediately after such Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Default</B>&#8221; means any event that is (or, after notice, passage of time or both, would be) an Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Default Settlement Method</B>&#8221; means initially, Combination Settlement with a Specified Dollar Amount of $1,000 per $1,000
principal amount of Notes; <I>provided</I>, <I>however</I>, that (x)&nbsp;subject to <B>Section</B><B></B><B>&nbsp;5.03(A)(iii)</B>, the Company may, from time to time, change the Default Settlement Method to any Settlement Method that it is then
permitted to elect by sending notice of the new Default Settlement Method to the Holders, the Trustee and the Conversion Agent (if other than the Trustee) (it being understood that no such change will affect any Settlement Method theretofore elected
(or deemed to be elected) with respect to any Note pursuant to this Indenture); and (y)&nbsp;the Default Settlement Method will be subject to <B>Section</B><B></B><B>&nbsp;5.03(A)(ii)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Depositary</B>&#8221; means The Depository Trust Company or its successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Depositary Participant</B>&#8221; means any member of, or participant in, the Depositary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Depositary Procedures</B>&#8221; means, with respect to any conversion, transfer, exchange or other transaction involving a Global
Note or any beneficial interest therein, the rules and procedures of the Depositary applicable to such conversion, transfer, exchange or transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B><FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date</B>&#8221; means, with respect to an issuance, dividend or distribution on
the Common Stock, the first date on which shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such issuance, dividend or distribution (including pursuant to due bills or
similar arrangements required by the relevant stock exchange). For the avoidance of doubt, any alternative trading convention on the applicable exchange or market in respect of the Common Stock under a separate ticker symbol or CUSIP number will not
be considered &#8220;regular way&#8221; for this purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Exchange Act</B>&#8221; means the U.S. Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Exempted Fundamental Change</B>&#8221; means any Fundamental Change with respect
to which, in accordance with <B>Section</B><B></B><B>&nbsp;4.02(I)</B>, the Company does not offer to repurchase any Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Free Trade Date</B>&#8221; means, with respect to any Note, the date that is one (1)&nbsp;year after the Last Original Issue Date of
such Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Freely Tradable</B>&#8221; means, with respect to any Note, that such Note would be eligible to be offered, sold or
otherwise transferred pursuant to Rule 144 or otherwise if held by a Person that is not an Affiliate of the Company, and that has not been an Affiliate of the Company during the immediately preceding three (3)&nbsp;months, without any requirements
as to volume, manner of sale, availability of current public information or notice under the Securities Act (except that, during the six (6)&nbsp;month period beginning on, and including, the date that is six (6)&nbsp;months after the Last Original
Issue Date of such Note, any such requirement as to the availability of current public information will be disregarded if the same is satisfied at that time); <I>provided</I>, <I>however</I>, that from and after the Free Trade Date of such Note,
such Note will not be &#8220;Freely Tradable&#8221; unless such Note (x)&nbsp;is not identified by a &#8220;restricted&#8221; CUSIP or ISIN number; and (y)&nbsp;is not represented by any certificate that bears the Restricted Note Legend. For the
avoidance of doubt, whether a Note is deemed to be identified by a &#8220;restricted&#8221; CUSIP or ISIN number or to bear the Restricted Note Legend is subject to <B>Section</B><B></B><B>&nbsp;2.12</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Fundamental Change</B>&#8221; means any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a &#8220;person&#8221; or &#8220;group&#8221; (within the meaning of Section&nbsp;13(d)(3) of the Exchange Act), other than the Company or
its Wholly Owned Subsidiaries, or their respective employee benefit plans, files any report with the SEC indicating that such person or group has become the direct or indirect &#8220;beneficial owner&#8221; (as defined below) of shares of the Common
Stock representing more than fifty percent (50%) of the voting power of all of the Company&#8217;s Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the consummation of
(i)&nbsp;any sale, lease or other transfer, in one transaction or a series of transactions, of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any Person, other than solely to one or more of the
Company&#8217;s Wholly Owned Subsidiaries; or (ii)&nbsp;any transaction or series of related transactions in connection with which (whether by means of merger, consolidation, share exchange, combination, reclassification, recapitalization,
acquisition, liquidation or otherwise) all of the Common Stock is exchanged for, converted into, acquired for, or constitutes solely the right to receive, other securities, cash or other property; <I>provided</I>, <I>however</I>, that any merger,
consolidation, share exchange or combination of the Company pursuant to which the Persons that directly or indirectly &#8220;beneficially owned&#8221; (as defined below) all classes of the Company&#8217;s common equity immediately before such
transaction directly or indirectly &#8220;beneficially own,&#8221; immediately after such transaction, more than fifty percent (50%) of all classes of common equity of the surviving, continuing or acquiring company or other transferee, as
applicable, or the parent thereof, in substantially the same proportions <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> each other as immediately before such transaction will be deemed not to be a
Fundamental Change pursuant to this <B>clause (B)</B>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the Company&#8217;s stockholders approve any plan or proposal for the
liquidation or dissolution of the Company; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) the Common Stock ceases to be listed on any of The New York Stock Exchange, The Nasdaq
Global Market or The Nasdaq Global Select Market (or any of their respective successors); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that a transaction or event
described in <B>clause (A)</B>&nbsp;or <B>(B)</B> above will not constitute a Fundamental Change if at least ninety percent (90%) of the consideration received or to be received by the holders of Common Stock (excluding cash payments for fractional
shares or pursuant to dissenters rights), in connection with such transaction or event, consists of shares of common stock or other corporate common equity interests listed (or depositary receipts representing shares of common stock or other
corporate common equity interests, which depositary receipts are listed) on any of The New York Stock Exchange, The Nasdaq Global Market or The Nasdaq Global Select Market (or any of their respective successors), or that will be so listed when
issued or exchanged in connection with such transaction or event, and such transaction or event constitutes a Common Stock Change Event whose Reference Property consists of such consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, references in this definition to the Company, the Common Stock and the Company&#8217;s &#8220;common equity&#8221;
will be subject to (x)<B>&nbsp;Article 6</B> and (y)<B>&nbsp;Section</B><B></B><B>&nbsp;5.09(A)(1)(III)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this
definition, (x)&nbsp;any transaction or event described in both <B>clause (A)</B>&nbsp;and in <B>clause (B)(i)</B> or <B>(ii)</B>&nbsp;above (without regard to the proviso in <B>clause (B)</B>) will be deemed to occur solely pursuant to <B>clause
(B)</B>&nbsp;above (subject to such proviso); and (y)&nbsp;whether a Person is a &#8220;<B>beneficial owner</B>,&#8221; whether shares are &#8220;<B>beneficially owned</B>,&#8221; and percentage beneficial ownership, will be determined in accordance
with Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Fundamental Change Repurchase Date</B>&#8221;
means the date fixed for the repurchase of any Notes by the Company pursuant to a Repurchase Upon Fundamental Change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Fundamental Change Repurchase Notice</B>&#8221; means a notice (including a notice substantially in the form of the
&#8220;Fundamental Change Repurchase Notice&#8221; set forth in <B>Exhibit A</B>) containing the information, or otherwise complying with the requirements, set forth in <B>Section</B><B></B><B>&nbsp;4.02(F)(i)</B> and
<B>Section</B><B></B><B>&nbsp;4.02(F)(ii)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Fundamental Change Repurchase Price</B>&#8221; means the cash price payable by
the Company to repurchase any Note upon its Repurchase Upon Fundamental Change, calculated pursuant to <B>Section</B><B></B><B>&nbsp;4.02(D)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Global Note</B>&#8221; means a Note that is represented by a certificate substantially in the form set forth in <B>Exhibit</B>
<B>A</B>, registered in the name of the Depositary or its nominee, duly executed by the Company and authenticated by the Trustee, and deposited with the Trustee, as custodian for the Depositary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Global Note Legend</B>&#8221; means a legend substantially in the form set forth in <B>Exhibit
<FONT STYLE="white-space:nowrap">B-2</FONT></B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Holder</B>&#8221; means a person in whose name a Note is registered on the
Registrar&#8217;s books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Indenture</B>&#8221; means this Indenture, as amended or supplemented from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Initial Purchasers</B>&#8221; means the several initial purchasers listed in Schedule 1 to the Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Interest Payment Date</B>&#8221; means, if and to the extent that Special Interest or Additional Interest is payable on a Note, each
May&nbsp;15 and November&nbsp;15 of each year. For the avoidance of doubt, the Maturity Date is an Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Interest Record Date</B>&#8221; has the following meaning with respect to an Interest Payment Date: (A)&nbsp;if such Interest
Payment Date occurs on May&nbsp;15, the immediately preceding May&nbsp;1 (whether or not a Business Day); and (B)&nbsp;if such Interest Payment Date occurs on November&nbsp;15, the immediately preceding November&nbsp;1 (whether or not a Business
Day). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Issue Date</B>&#8221; means November&nbsp;7, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Last Original Issue Date</B>&#8221; means (A)&nbsp;with respect to any Notes issued pursuant to the Purchase Agreement, and any
Notes issued in exchange therefor or in substitution thereof, the Issue Date; and (B)&nbsp;with respect to any Notes issued pursuant to <B>Section</B><B></B><B>&nbsp;2.03(B)</B>, and any Notes issued in exchange therefor or in substitution thereof,
either (i)&nbsp;the later of (x)&nbsp;the date such Notes are originally issued and (y)&nbsp;the last date any Notes are originally issued as part of the same offering pursuant to the exercise of an option granted to the initial purchaser(s) of such
Notes to purchase additional Notes; or (ii)&nbsp;such other date as is specified in an Officer&#8217;s Certificate delivered to the Trustee before the original issuance of such Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Last Reported Sale Price</B>&#8221; of the Common Stock for any Trading Day means the closing sale price per share (or, if no
closing sale price is reported, the average of the last bid price and the last ask price per share or, if more than one in either case, the average of the average last bid prices and the average last ask prices per share) of Common Stock on such
Trading Day as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock is then listed. If the Common Stock is not listed on a U.S. national or regional securities exchange on such
Trading Day, then the Last Reported Sale Price will be the last quoted bid price per share of Common Stock on such Trading Day in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market as reported
by OTC Markets Group Inc. or a similar organization. If the Common Stock is not so quoted on such Trading Day, then the Last Reported Sale Price will be the average of the <FONT STYLE="white-space:nowrap">mid-point</FONT> of the last bid price and
the last ask price per share of Common Stock on such Trading Day from a nationally recognized independent investment banking firm selected by the Company, which may include any of the Initial Purchasers. The Last Reported Sale Price will be
determined without regard to after-hour trading or any other trading outside of the regular trading session hours. Neither the Trustee nor the Conversion Agent will have any duty to determine the Last Reported Sale Price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Make-Whole Fundamental Change</B>&#8221; means (A)&nbsp;a Fundamental Change
(determined after giving effect to the proviso immediately after <B>clause (D)</B>&nbsp;of the definition thereof, but without regard to the proviso to <B>clause (B)(ii)</B> of such definition); or (B)&nbsp;the sending of a Redemption Notice
pursuant to <B>Section</B><B></B><B>&nbsp;4.03(F)</B>; <I>provided</I>, <I>however</I>, that, subject to <B>Section</B><B></B><B>&nbsp;4.03(I)</B>, the sending of a Redemption Notice will constitute a Make-Whole Fundamental Change only with respect
to the Notes called (or deemed, pursuant to <B>Section</B><B></B><B>&nbsp;4.03(I)</B>, to be called) for Redemption pursuant to such Redemption Notice and not with respect to any other Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Make-Whole Fundamental Change Conversion Period</B>&#8221; has the following meaning: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) in the case of a Make-Whole Fundamental Change pursuant to <B>clause (A)</B>&nbsp;of the definition thereof, the period from, and
including, the Make-Whole Fundamental Change Effective Date of such Make-Whole Fundamental Change to, and including, the thirty fifth (35th) Trading Day after such Make-Whole Fundamental Change Effective Date (or, if such Make-Whole Fundamental
Change also constitutes a Fundamental Change (other than an Exempted Fundamental Change), to, but excluding, the related Fundamental Change Repurchase Date); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) in the case of a Make-Whole Fundamental Change pursuant to <B>clause (B)</B>&nbsp;of the definition thereof, the period from, and
including, the Redemption Notice Date for the related Redemption to, and including, the second (2nd) Business Day immediately before the related Redemption Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if the Conversion Date for the conversion of a Note that has been called (or deemed, pursuant to
<B>Section</B><B></B><B>&nbsp;4.03(I)</B>, to be called) for Redemption occurs during the Make-Whole Fundamental Change Conversion Period for both a Make-Whole Fundamental Change occurring pursuant to <B>clause (A)</B>&nbsp;of the definition of
&#8220;Make-Whole Fundamental Change&#8221; and a Make-Whole Fundamental Change resulting from such Redemption pursuant to <B>clause (B)</B>&nbsp;of such definition, then, notwithstanding anything to the contrary in
<B>Section</B><B></B><B>&nbsp;5.07</B>, solely for purposes of such conversion, (x)&nbsp;such Conversion Date will be deemed to occur solely during the Make-Whole Fundamental Change Conversion Period for the Make-Whole Fundamental Change with the
earlier Make-Whole Fundamental Change Effective Date; and (y)&nbsp;the Make-Whole Fundamental Change with the later Make-Whole Fundamental Change Effective Date will be deemed not to have occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Make-Whole Fundamental Change Effective Date</B>&#8221; means (A)&nbsp;with respect to a Make-Whole Fundamental Change pursuant to
<B>clause (A)</B>&nbsp;of the definition thereof, the date on which such Make-Whole Fundamental Change occurs or becomes effective; and (B)&nbsp;with respect to a Make-Whole Fundamental Change pursuant to <B>clause (B)</B>&nbsp;of the definition
thereof, the applicable Redemption Notice Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Market Disruption Event</B>&#8221; means, with respect to any date, the
occurrence or existence, during the <FONT STYLE="white-space:nowrap">one-half</FONT> hour period ending at the scheduled close of trading on such date on the principal U.S. national or regional securities exchange or other market on which the Common
Stock is listed for trading or trades, of any material suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant exchange or otherwise) in the Common Stock or in any options contracts or
futures contracts relating to the Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Maturity Date</B>&#8221; means May&nbsp;15, 2033. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Note Agent</B>&#8221; means any Registrar, Paying Agent or Conversion Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Notes</B>&#8221; means the 0% Convertible Senior Notes due 2033 issued by the Company pursuant to this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Observation Period</B>&#8221; means, with respect to any Note to be converted, (A)&nbsp;subject to <B>clause (B)</B>&nbsp;below, if
the Conversion Date for such Note occurs before February&nbsp;15, 2033, the twenty five (25)&nbsp;consecutive VWAP Trading Days beginning on, and including, the third (3rd) VWAP Trading Day immediately after such Conversion Date; and (B)&nbsp;if
such Conversion Date occurs on or after the date the Company has sent a Redemption Notice calling all or any Notes for Redemption pursuant to <B>Section</B><B></B><B>&nbsp;4.03(F)</B> and on or before the second (2nd) Business Day before the related
Redemption Date, the twenty five (25)&nbsp;consecutive VWAP Trading Days beginning on, and including, the twenty sixth (26th) Scheduled Trading Day immediately before such Redemption Date; and (C)&nbsp;subject to <B>clause (B)</B>&nbsp;above, if
such Conversion Date occurs on or after February&nbsp;15, 2033, the twenty five (25)&nbsp;consecutive VWAP Trading Days beginning on, and including, the twenty sixth (26th) Scheduled Trading Day immediately before the Maturity Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Officer</B>&#8221; means the Chairman of the Board of Directors, the Chief Executive Officer, the President, the Chief Operating
Officer, the Chief Financial Officer, the Treasurer, any Assistant Treasurer, the Controller, the Secretary or any Vice-President of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Officer&#8217;s Certificate</B>&#8221; means a certificate that is signed on behalf of the Company by one (1)&nbsp;of its Officers
and that meets the requirements of <B>Section</B><B></B><B>&nbsp;11.03</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Open of Business</B>&#8221; means 9:00 a.m., New
York City time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Opinion of Counsel</B>&#8221; means an opinion, from legal counsel (including an employee of, or counsel to,
the Company or any of its Subsidiaries) reasonably acceptable to the Trustee, that meets the requirements of <B>Section</B><B></B><B>&nbsp;11.03</B>, subject to customary qualifications and exclusions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Person</B>&#8221; or &#8220;<B>person</B>&#8221; means any individual, corporation, partnership, limited liability company, joint
venture, association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof. Any division or series of a limited liability company, limited partnership or trust will constitute a
separate &#8220;person&#8221; under this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Physical Note</B>&#8221; means a Note (other than a Global Note) that is
represented by a certificate substantially in the form set forth in <B>Exhibit</B> <B>A</B>, registered in the name of the Holder of such Note and duly executed by the Company and authenticated by the Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Purchase Agreement</B>&#8221; means that certain Purchase Agreement, dated November&nbsp;4, 2025, between the Company and Goldman
Sachs&nbsp;&amp; Co. LLC, as representative of the several Initial Purchasers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Qualified Successor Entity</B>&#8221; means, with respect to a Business
Combination Event, a corporation; provided, however, that a limited liability company, limited partnership or other similar entity will also constitute a Qualified Successor Entity with respect to such Business Combination Event if either
(i)&nbsp;such Business Combination Event is an Exempted Fundamental Change; or (ii)&nbsp;both of the following conditions are satisfied: (1)&nbsp;either (x) such limited liability company, limited partnership or other similar entity, as applicable,
is treated as a corporation or is a direct or indirect, Wholly Owned Subsidiary of, and disregarded as an entity separate from, a corporation, in each case for U.S. federal income tax purposes; or (y)&nbsp;the Company has received an opinion of a
nationally recognized tax counsel to the effect that such Business Combination Event will not be treated as an exchange under Section&nbsp;1001 of the Code, for Holders or beneficial owners of the Notes; and (2)&nbsp;such Business Combination Event
constitutes a Common Stock Change Event whose Reference Property consists solely of any combination of cash in U.S. dollars and shares of common stock or other corporate common equity interests of an entity that is (x)&nbsp;treated as a corporation
for U.S. federal income tax purposes; (y)&nbsp;duly organized and existing under the laws of the United States of America, any State thereof or the District of Columbia; and (z)&nbsp;the direct or indirect parent of such limited liability company,
limited partnership or other similar entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Redemption</B>&#8221; means the repurchase of any Note by the Company pursuant to
<B>Section</B><B></B><B>&nbsp;4.03</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Redemption Date</B>&#8221; means the date fixed, pursuant to
<B>Section</B><B></B><B>&nbsp;4.03(D)</B>, for the settlement of the repurchase of any Notes by the Company pursuant to a Redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Redemption Notice Date</B>&#8221; means, with respect to a Redemption, the date on which the Company sends the Redemption Notice for
such Redemption pursuant to <B>Section</B><B></B><B>&nbsp;4.03(F)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Redemption Price</B>&#8221; means the cash price payable
by the Company to redeem any Note upon its Redemption, calculated pursuant to <B>Section</B><B></B><B>&nbsp;4.03(E)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Repurchase Upon Fundamental Change</B>&#8221; means the repurchase of any Note by the Company pursuant to
<B>Section</B><B></B><B>&nbsp;4.02</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Responsible Officer</B>&#8221; means (A)&nbsp;any officer within the corporate trust
department of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of such officers; and (B)&nbsp;with respect to a particular corporate trust
matter relating to this Indenture, any other officer to whom such matter is referred because of his or her knowledge of, and familiarity with, the particular subject and who, in each case, shall have direct responsibility for the administration of
this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Restricted Note Legend</B>&#8221; means a legend substantially in the form set forth in <B>Exhibit <FONT
STYLE="white-space:nowrap">B-1</FONT></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Restricted Stock Legend</B>&#8221; means, with respect to any Conversion Share, a
legend substantially to the effect that the offer and sale of such Conversion Share have not been registered under the Securities Act and that such Conversion Share cannot be sold or otherwise transferred except pursuant to a transaction that is
registered under the Securities Act or that is exempt from, or not subject to, the registration requirements of the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Rule 144</B>&#8221; means Rule 144 under the Securities Act (or any successor rule
thereto), as the same may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Rule 144A</B>&#8221; means Rule 144A under the Securities Act (or any
successor rule thereto), as the same may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Scheduled Trading Day</B>&#8221; means any day that is
scheduled to be a Trading Day on the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal
other market on which the Common Stock is then traded. If the Common Stock is not so listed or traded, then &#8220;Scheduled Trading Day&#8221; means a Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>SEC</B>&#8221; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Securities Act</B>&#8221; means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Security</B>&#8221; means any Note or Conversion Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Settlement Method</B>&#8221; means Cash Settlement, Physical Settlement or Combination Settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Significant Subsidiary</B>&#8221; means, with respect to any Person, any Subsidiary of such Person that constitutes a
&#8220;significant subsidiary&#8221; (as defined in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act) of such Person; <I>provided</I>, <I>however</I>, that, if a
Subsidiary meets the criteria of clause (1)(iii), but not clause (1)(i) or (1)(ii), of the definition of &#8220;significant subsidiary&#8221; in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> (or, if applicable, the respective successor
clauses to the aforementioned clauses), then such Subsidiary will be deemed not to be a Significant Subsidiary unless such Subsidiary&#8217;s income from continuing operations before income taxes, exclusive of amounts attributable to any <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests, for the last completed fiscal year before the date of determination exceeds sixty million dollars ($60,000,000). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Special Interest</B>&#8221; means any interest that accrues on any Note pursuant to <B>Section</B><B></B><B>&nbsp;7.03</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Specified Dollar Amount</B>&#8221; means, with respect to the conversion of a Note to which Combination Settlement applies, the
maximum cash amount per $1,000 principal amount of such Note deliverable upon such conversion (excluding cash in lieu of any fractional share of Common Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Stock Price</B>&#8221; has the following meaning for any Make-Whole Fundamental Change: (A)&nbsp;if the holders of Common Stock
receive only cash in consideration for their shares of Common Stock in such Make-Whole Fundamental Change and such Make-Whole Fundamental Change is pursuant to <B>clause (B)</B>&nbsp;of the definition of &#8220;Fundamental Change,&#8221; then the
Stock Price is the amount of cash paid per share of Common Stock in such Make-Whole Fundamental Change; and (B) in all other cases, the Stock Price is the average of the Last Reported Sale Prices per share of Common Stock for the five
(5)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before the Make-Whole Fundamental Change Effective Date of such Make-Whole Fundamental Change. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Subsidiary</B>&#8221; means, with respect to any Person, (A)&nbsp;any corporation,
association or other business entity (other than a partnership or limited liability company) of which more than fifty percent (50%) of the total voting power of the Capital Stock entitled (without regard to the occurrence of any contingency, but
after giving effect to any voting agreement or stockholders&#8217; agreement that effectively transfers voting power) to vote in the election of directors, managers or trustees, as applicable, of such corporation, association or other business
entity is owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of such Person; and (B)&nbsp;any partnership or limited liability company where (i)&nbsp;more than fifty percent (50%) of the capital
accounts, distribution rights, equity and voting interests, or of the general and limited partnership interests, as applicable, of such partnership or limited liability company are owned or controlled, directly or indirectly, by such Person or one
or more of the other Subsidiaries of such Person, whether in the form of membership, general, special or limited partnership or limited liability company interests or otherwise; and (ii)&nbsp;such Person or any one or more of the other Subsidiaries
of such Person is a controlling general partner of, or otherwise controls, such partnership or limited liability company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Trading Day</B>&#8221; means any day on which (A)&nbsp;trading in the Common Stock generally occurs on the principal U.S. national
or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal other market on which the Common Stock is then traded; and
(B)&nbsp;there is no Market Disruption Event. If the Common Stock is not so listed or traded, then &#8220;Trading Day&#8221; means a Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Trading Price</B>&#8221; of the Notes on any Trading Day means the average of the secondary market bid quotations, expressed as a
cash amount per $1,000 principal amount of Notes, obtained by the Bid Solicitation Agent for five million dollars ($5,000,000) (or such lesser amount as may then be outstanding) in principal amount of Notes at approximately 3:30 p.m., New York City
time, on such Trading Day from three (3)&nbsp;nationally recognized independent securities dealers selected by the Company, which may include any of the Initial Purchasers; <I>provided</I>, <I>however</I>, that, if three (3)&nbsp;such bids cannot
reasonably be obtained by the Bid Solicitation Agent but two (2)&nbsp;such bids are obtained, then the average of the two (2)&nbsp;bids will be used, and if only one (1)&nbsp;such bid can reasonably be obtained by the Bid Solicitation Agent, then
that one (1)&nbsp;bid will be used. If, on any Trading Day, (A)&nbsp;the Bid Solicitation Agent cannot reasonably obtain at least one (1)&nbsp;bid for five million dollars ($5,000,000) (or such lesser amount as may then be outstanding) in principal
amount of Notes from a nationally recognized independent securities dealer; (B)&nbsp;the Company is not acting as the Bid Solicitation Agent and the Company fails to instruct the Bid Solicitation Agent to obtain bids when required; or (C)&nbsp;the
Bid Solicitation Agent fails to solicit bids when required, then, in each case, the Trading Price per $1,000 principal amount of Notes on such Trading Day will be deemed to be less than ninety eight percent (98%) of the product of the Last Reported
Sale Price per share of Common Stock on such Trading Day and the Conversion Rate on such Trading Day. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Transfer-Restricted Security</B>&#8221; means any Security that constitutes a
&#8220;restricted security&#8221; (as defined in Rule 144); <I>provided</I>, <I>however</I>, that such Security will cease to be a Transfer-Restricted Security upon the earliest to occur of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) such Security is sold or otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to a
registration statement that was effective under the Securities Act at the time of such sale or transfer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) such Security is sold or
otherwise transferred to a Person (other than the Company or an Affiliate of the Company) pursuant to an available exemption (including Rule 144) from the registration and prospectus-delivery requirements of, or in a transaction not subject to, the
Securities Act and, immediately after such sale or transfer, such Security ceases to constitute a &#8220;restricted security&#8221; (as defined in Rule 144); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) such Security is eligible for resale, by a Person that is not an Affiliate of the Company and that has not been an Affiliate of the
Company during the immediately preceding three (3)&nbsp;months, pursuant to Rule 144 without any limitations thereunder as to volume, manner of sale, availability of current public information or notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee is under no obligation to determine whether any Security is a Transfer-Restricted Security and may conclusively rely on an
Officer&#8217;s Certificate with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Trust Indenture Act</B>&#8221; means the U.S. Trust Indenture Act of 1939, as
amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Trustee</B>&#8221; means the Person named as such in the first paragraph of this Indenture until a successor replaces
it in accordance with the provisions of this Indenture and, thereafter, means such successor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>VWAP Market Disruption
Event</B>&#8221; means, with respect to any date, (A)&nbsp;the failure by the principal U.S. national or regional securities exchange on which the Common Stock is then listed, or, if the Common Stock is not then listed on a U.S. national or regional
securities exchange, the principal other market on which the Common Stock is then traded, to open for trading during its regular trading session on such date; or (B)&nbsp;the occurrence or existence, for more than one half hour period in the
aggregate, of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant exchange or otherwise) in the Common Stock or in any options contracts or futures contracts relating to the
Common Stock, and such suspension or limitation occurs or exists at any time before 1:00 p.m., New York City time, on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>VWAP Trading Day</B>&#8221; means a day on which (A)&nbsp;there is no VWAP Market Disruption Event; and (B)&nbsp;trading in the
Common Stock generally occurs on the principal U.S. national or regional securities exchange on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national or regional securities exchange, on the principal
other market on which the Common Stock is then traded. If the Common Stock is not so listed or traded, then &#8220;VWAP Trading Day&#8221; means a Business Day. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Wholly Owned Subsidiary</B>&#8221; of a Person means any Subsidiary of such
Person, determined by reference to the definition of &#8220;Subsidiary&#8221; above but with each reference therein to &#8220;more than fifty percent (50%)&#8221; deemed to be replaced with &#8220;one hundred percent (100%)&#8221; for purposes of
this definition; <I>provided</I>, <I>however</I>, that directors&#8217; qualifying shares will be disregarded for purposes of determining whether any Person is a Wholly Owned Subsidiary of another Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.02. O<SMALL>THER</SMALL> D<SMALL>EFINITIONS</SMALL>. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Defined&nbsp;in<BR>Section</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Additional Shares&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.07(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Business Combination Event&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6.01(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Cash Settlement&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.03(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Combination Settlement&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.03(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Common Stock Change Event&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.09(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Conversion Agent&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.06(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Conversion Consideration&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.03(B)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Default Interest&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.05(B)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Defaulted Amount&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.05(B)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Event of Default&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>7.01(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Expiration Date&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.05(A)(v)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Expiration Time&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.05(A)(v)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Fundamental Change Notice&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4.02(E)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Fundamental Change Repurchase Right&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4.02(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Initial Notes&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.03(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Measurement Period&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.01(C)(i)(2)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Partial Redemption Limitation&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4.03(J)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Paying Agent&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.06(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Physical Settlement&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.03(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Redemption Notice&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4.03(F)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Reference Property&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.09(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Reference Property Unit&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.09(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Register&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.06(B)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Registrar&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2.06(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Reporting Event of Default&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>7.03(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Specified Courts&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>11.07</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">&#8220;Spin-Off&#8221;</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.05(A)(iii)(2)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">&#8220;Spin-Off</FONT> Valuation Period&#8221;</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.05(A)(iii)(2)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Successor Entity&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>6.01(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Successor Person&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.09(A)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Tender/Exchange Offer Valuation Period&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.05(A)(v)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>&#8220;Trading Price Condition&#8221;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5.01(C)(i)(2)</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1.03. R<SMALL>ULES</SMALL> <SMALL>OF</SMALL> C<SMALL>ONSTRUCTION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Indenture: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) &#8220;or&#8221; is not exclusive; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) &#8220;including&#8221; means &#8220;including without limitation&#8221;; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) &#8220;will&#8221; expresses a command; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) the &#8220;average&#8221; of a set of numerical values refers to the arithmetic average of such numerical values; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) a merger involving, or a transfer of assets by, a limited liability company, limited partnership or trust will be deemed to include any
division of or by, or an allocation of assets to a series of, such limited liability company, limited partnership or trust, or any unwinding of any such division or allocation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) words in the singular include the plural and in the plural include the singular, unless the context requires otherwise; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) &#8220;herein,&#8221; &#8220;hereof&#8221; and other words of similar import refer to this Indenture as a whole and not to any particular
Article, Section or other subdivision of this Indenture, unless the context requires otherwise; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) references to currency mean the
lawful currency of the United States of America, unless the context requires otherwise; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) the exhibits, schedules and other attachments
to this Indenture are deemed to form part of this Indenture; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) the term &#8220;<B>interest</B>,&#8221; when used with respect to a
Note, means any Special Interest, Default Interest or Additional Interest, in each case to the extent the same is payable on such Note, unless the context requires otherwise. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 2. THE NOTES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.01. F<SMALL>ORM</SMALL>, D<SMALL>ATING</SMALL> <SMALL>AND</SMALL> D<SMALL>ENOMINATIONS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes and the Trustee&#8217;s certificate of authentication will be substantially in the form set forth in <B>Exhibit A</B>. The Notes
will bear the legends required by <B>Section</B><B></B><B>&nbsp;2.09</B> and may bear notations, legends or endorsements required by law, stock exchange rule or usage or the Depositary. Each Note will be dated as of the date of its authentication.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except to the extent otherwise provided in a Company Order delivered to the Trustee in connection with the issuance and authentication
thereof, the Notes will be issued initially in the form of one or more Global Notes. Global Notes may be exchanged for Physical Notes, and Physical Notes may be exchanged for Global Notes, only as provided in <B>Section</B><B></B><B>&nbsp;2.10</B>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will be issuable only in registered form without interest coupons and only in
Authorized Denominations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each certificate representing a Note will bear a unique registration number that is not affixed to any other
certificate representing another outstanding Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The terms contained in the Notes constitute part of this Indenture, and, to the extent
applicable, the Company and the Trustee, by their execution and delivery of this Indenture, agree to such terms and to be bound thereby; <I>provided</I>, <I>however</I>, that, to the extent that any provision of any Note conflicts with the
provisions of this Indenture, the provisions of this Indenture will control for purposes of this Indenture and such Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.02.
E<SMALL>XECUTION</SMALL>, A<SMALL>UTHENTICATION</SMALL> <SMALL>AND</SMALL> D<SMALL>ELIVERY</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Due Execution by the
Company</I>. At least one (1)&nbsp;duly authorized Officer will sign the Notes on behalf of the Company by manual, electronic or facsimile signature. A Note&#8217;s validity will not be affected by the failure of any Officer whose signature is on
any Note to hold, at the time such Note is authenticated, the same or any other office at the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Authentication by the
Trustee and Delivery</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) No Note will be valid until it is authenticated by the Trustee. A Note will be deemed to be
duly authenticated only when an authorized signatory of the Trustee (or a duly appointed authenticating agent) manually signs the certificate of authentication of such Note. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Trustee will cause an authorized signatory of the Trustee (or a duly appointed authenticating agent) to manually sign
the certificate of authentication of a Note only if (1)&nbsp;the Company delivers such Note to the Trustee; (2)&nbsp;such Note is executed by the Company in accordance with <B>Section</B><B></B><B>&nbsp;2.02(A)</B>; and (3)&nbsp;the Company delivers
a Company Order to the Trustee that (a)&nbsp;requests the Trustee to authenticate such Note; and (b)&nbsp;sets forth the name of the Holder of such Note and the date as of which such Note is to be authenticated. If such Company Order also requests
the Trustee to deliver such Note to any Holder or to the Depositary, then the Trustee will promptly deliver such Note in accordance with such Company Order. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Notes. A duly appointed
authenticating agent may authenticate Notes whenever the Trustee may do so under this Indenture, and a Note authenticated as provided in this Indenture by such an agent will be deemed, for purposes of this Indenture, to be authenticated by the
Trustee. Each duly appointed authenticating agent will have the same rights to deal with the Company as the Trustee would have if it were performing the duties that the authentication agent was validly appointed to undertake. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.03. I<SMALL>NITIAL</SMALL> N<SMALL>OTES</SMALL> <SMALL>AND</SMALL>
A<SMALL>DDITIONAL</SMALL> N<SMALL>OTES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Initial Notes</I>. On the Issue Date, there will be originally issued four
hundred two million five hundred thousand dollars ($402,500,000) aggregate principal amount of Notes, subject to the provisions of this Indenture (including <B>Section</B><B></B><B>&nbsp;2.02</B>). Notes issued pursuant to this
<B>Section</B><B></B><B>&nbsp;2.03(A)</B>, and any Notes issued in exchange therefor or in substitution thereof, are referred to in this Indenture as the &#8220;<B>Initial Notes</B>.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Additional Notes</I>. Without notice to or the consent of any Holder, the Company may, subject to the provisions of this Indenture
(including <B>Section</B><B></B><B>&nbsp;2.02</B>), originally issue additional Notes with the same terms as the Initial Notes (except, to the extent applicable, with respect to the Last Original Issue Date of such additional Notes), which
additional Notes will, subject to the foregoing, be considered to be part of the same series of, and rank equally and ratably with all other, Notes issued under this Indenture; <I>provided</I>, <I>however</I>, that if any such additional Notes (and
any Notes that are resold after such Notes have been purchased or otherwise acquired by the Company or its Subsidiaries) are not fungible with other Notes issued under this Indenture for federal income tax or federal securities laws purposes, or if
applicable, the Depositary Procedures, then such additional Notes (or resold Notes) will be identified by a separate CUSIP number or by no CUSIP number. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.04. M<SMALL>ETHOD</SMALL> <SMALL>OF</SMALL> P<SMALL>AYMENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Global Notes</I>. The Company will pay, or cause the Paying Agent to pay, the principal (whether due upon maturity on the Maturity
Date, Redemption on a Redemption Date or repurchase on a Fundamental Change Repurchase Date or otherwise) of, Special Interest or Additional Interest, if any, on, and any cash Conversion Consideration for, any Global Note to the Depositary by wire
transfer of immediately available funds no later than the time the same is due as provided in this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Physical Notes</I>.
The Company will pay, or cause the Paying Agent to pay, the principal (whether due upon maturity on the Maturity Date, Redemption on a Redemption Date or repurchase on a Fundamental Change Repurchase Date or otherwise) of, Special Interest or
Additional Interest, if any, on, and any cash Conversion Consideration due upon conversion of, any Physical Note no later than the time the same is due as provided in this Indenture as follows: (i)&nbsp;if the principal amount of such Physical Note
is at least five million dollars ($5,000,000) (or such lower amount as the Company may choose in its sole and absolute discretion) and the Holder of such Physical Note entitled to such payment has delivered to the Paying Agent or the Trustee, no
later than the time set forth in the immediately following sentence, a written request that the Company make such payment by wire transfer to an account of such Holder within the United States, by wire transfer of immediately available funds to such
account; and (ii)&nbsp;in all other cases, by check mailed to the address of the Holder of such Physical Note entitled to such payment as set forth in the Register. To be timely, such written request must be so delivered no later than the Close of
Business on the following date: (x)&nbsp;with respect to the payment of Special Interest or Additional Interest, if any, due on an Interest Payment Date, the immediately preceding Interest Record Date; (y)&nbsp;with respect to any cash Conversion
Consideration due upon conversion, the applicable Conversion Date; and (z)&nbsp;with respect to any other payment, the date that is fifteen (15)&nbsp;calendar days immediately before the date such payment is due. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 16 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.05. N<SMALL>O</SMALL> R<SMALL>EGULAR</SMALL> I<SMALL>NTEREST</SMALL>;
A<SMALL>CCRUAL</SMALL> <SMALL>AND</SMALL> P<SMALL>AYMENT</SMALL> <SMALL>OF</SMALL> S<SMALL>PECIAL</SMALL> I<SMALL>NTEREST</SMALL> <SMALL>AND</SMALL> A<SMALL>DDITIONAL</SMALL> I<SMALL>NTEREST</SMALL>; D<SMALL>EFAULTED</SMALL> A<SMALL>MOUNTS</SMALL>;
W<SMALL>HEN</SMALL> P<SMALL>AYMENT</SMALL> D<SMALL>ATE</SMALL> <SMALL>IS</SMALL> N<SMALL>OT</SMALL> <SMALL>A</SMALL> B<SMALL>USINESS</SMALL> D<SMALL>AY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>No Regular Interest; Accrual and Payment of Special Interest and Additional Interest</I>. The Notes will not bear regular interest, and
the principal amount of the Notes will not accrete; <I>provided</I>, <I>however</I>, that Additional Interest and Special Interest will accrue on the Notes to the extent, and only to the extent, provided in <B>Sections</B> <B>3.04</B> and
<B>7.03</B>, respectively. The amount of any such Special Interest or Additional Interest that is payable on any applicable Interest Payment Date will be the amount of unpaid Special Interest or Additional Interest, as applicable, that has accrued
from, and including, the last date as of which such interest has been paid or duly provided for (or if later, the date as of which such interest has begun to accrue, as provided in <B>Section</B><B>&nbsp;3.04</B> or <B>7.03</B>, as applicable) to,
but excluding, such Interest Payment Date (or, if earlier, the date as of which such interest has ceased to accrue, as provided in <B>Section</B><B>&nbsp;3.04</B> or <B>7.03</B>, as applicable). If any Special Interest or Additional Interest has
accrued on any Note, then such interest will be payable in arrears on the next Interest Payment Date to the Holder of such Note as of the Close of Business on the immediately preceding Interest Record Date. Additional Interest and Special Interest,
if any, on the Notes will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year comprised of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Defaulted Amounts</I>. If the Company fails to pay any amount (a &#8220;<B>Defaulted Amount</B>&#8221;) payable on a Note on or before
the due date therefor as provided in this Indenture, then, regardless of whether such failure constitutes an Event of Default, (i)&nbsp;such Defaulted Amount will forthwith cease to be payable to the Holder of such Note otherwise entitled to such
payment; (ii)&nbsp;to the extent lawful, interest (&#8220;<B>Default Interest</B>&#8221;) will accrue on such Defaulted Amount for each day, if any, during the period from, and including, such due date to, but excluding, the date of payment of such
Defaulted Amount and Default Interest, which Default Interest will accrue on each such day at the combined rate at which Special Interest and Additional Interest accrues on such Note on such day (it being understood, for the avoidance of doubt, that
no Default Interest will accrue on such Note on any day on which no Special Interest or Additional Interest accrues on such Note); (iii) such Defaulted Amount and Default Interest will be paid on a payment date selected by the Company to the Holder
of such Note as of the Close of Business on a special record date selected by the Company, <I>provided</I> that such special record date must be no more than fifteen (15), nor less than ten (10), calendar days before such payment date; and
(iv)&nbsp;at least fifteen (15)&nbsp;calendar days before such special record date, the Company will send notice to the Trustee and the Holders that states such special record date, such payment date and the amount of such Defaulted Amount and
Default Interest to be paid on such payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Delay of Payment when Payment Date is Not a Business Day</I>. If the due date
for a payment on a Note as provided in this Indenture is not a Business Day, then, notwithstanding anything to the contrary in this Indenture or the Notes, such payment may be made on the immediately following Business Day and no interest will
accrue on such payment as a result of the related delay. Solely for purposes of the immediately preceding sentence, a day on which the applicable place of payment is authorized or required by law or executive order to close or be closed will be
deemed not to be a &#8220;Business Day.&#8221; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 17 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.06. R<SMALL>EGISTRAR</SMALL>, P<SMALL>AYING</SMALL> A<SMALL>GENT</SMALL>
<SMALL>AND</SMALL> C<SMALL>ONVERSION</SMALL> A<SMALL>GENT</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. The Company will maintain (i)&nbsp;an office
or agency in the continental United States where Notes may be presented for registration of transfer or for exchange (the &#8220;<B>Registrar</B>&#8221;); (ii) an office or agency in the continental United States where Notes may be presented for
payment (the &#8220;<B>Paying Agent</B>&#8221;); and (iii)&nbsp;an office or agency in the continental United States where Notes may be presented for conversion (the &#8220;<B>Conversion Agent</B>&#8221;). The Company hereby designates the corporate
trust office of the Trustee in the continental United States identified in <B>Section</B><B></B><B>&nbsp;11.01</B> as such office. If the Company fails to maintain a Registrar, Paying Agent or Conversion Agent, then the Trustee will act as such and
will receive compensation therefor in accordance with this Indenture and any other agreement between the Trustee and the Company. For the avoidance of doubt, the Company or any of its Subsidiaries may act as Registrar, Paying Agent or Conversion
Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Duties of the Registrar</I>. The Registrar will keep a record (the &#8220;<B>Register</B>&#8221;) of the names and
addresses of the Holders, the Notes held by each Holder and the transfer, exchange, repurchase, Redemption and conversion of Notes. Absent manifest error, the entries in the Register will be conclusive and the Company and the Trustee may treat each
Person whose name is recorded as a Holder in the Register as a Holder for all purposes. The Register will be in written form or in any form capable of being converted into written form reasonably promptly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I><FONT STYLE="white-space:nowrap">Co-Agents;</FONT> Company&#8217;s Right to Appoint Successor Registrars, Paying Agents and Conversion
Agents</I>. The Company may appoint one or more <FONT STYLE="white-space:nowrap">co-Registrars,</FONT> <FONT STYLE="white-space:nowrap">co-Paying</FONT> Agents and <FONT STYLE="white-space:nowrap">co-Conversion</FONT> Agents, each of whom will be
deemed to be a Registrar, Paying Agent or Conversion Agent, as applicable, under this Indenture. Subject to <B>Section</B><B></B><B>&nbsp;2.06(A)</B>, the Company may change any Registrar, Paying Agent or Conversion Agent (including appointing
itself or any of its Subsidiaries to act in such capacity) without notice to any Holder. The Company will notify the Trustee (and, upon request, any Holder) of the name and address of each Note Agent, if any, not a party to this Indenture and will
enter into an appropriate agency agreement with each such Note Agent, which agreement will implement the provisions of this Indenture that relate to such Note Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Initial Appointments</I>. The Company appoints the Trustee as the initial Paying Agent, the initial Registrar and the initial
Conversion Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.07. P<SMALL>AYING</SMALL> A<SMALL>GENT</SMALL> <SMALL>AND</SMALL> C<SMALL>ONVERSION</SMALL> A<SMALL>GENT</SMALL>
<SMALL>TO</SMALL> H<SMALL>OLD</SMALL> P<SMALL>ROPERTY</SMALL> <SMALL>IN</SMALL> T<SMALL>RUST</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will require each
Paying Agent or Conversion Agent that is not the Trustee to agree in writing that such Note Agent will (A)&nbsp;hold in trust for the benefit of Holders or the Trustee all money and other property held by such Note Agent for payment or delivery due
on the Notes; and (B)&nbsp;notify the Trustee of any default by the Company in making any such payment or delivery. The Company, at any time, may, and the Trustee, while any Default continues, may, require a Paying Agent or Conversion Agent to pay
or deliver, as applicable, all money and other property held by it to the Trustee, after which payment or delivery, as applicable, such Note Agent (if not the Company or any of its Subsidiaries) will have no further liability for such money or
property. If the Company or any of its Subsidiaries acts as Paying Agent or Conversion Agent, then (A)&nbsp;it will segregate and hold in a separate trust fund for the benefit of the Holders or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 18 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Trustee all money and other property held by it as Paying Agent or Conversion Agent; and (B)&nbsp;references in this Indenture or the Notes to the Paying Agent or Conversion Agent holding cash or
other property, or to the delivery of cash or other property to the Paying Agent or Conversion Agent, in each case for payment or delivery to any Holders or the Trustee or with respect to the Notes, will be deemed to refer to cash or other property
so segregated and held separately, or to the segregation and separate holding of such cash or other property, respectively. Upon the occurrence of any event pursuant to <B>clause</B> <B>(viii)</B>&nbsp;or <B>(ix)</B> of
<B>Section</B><B></B><B>&nbsp;7.01(A)</B> with respect to the Company (or with respect to any Subsidiary of the Company acting as Paying Agent or Conversion Agent), the Trustee will serve as the Paying Agent or Conversion Agent, as applicable, for
the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.08. H<SMALL>OLDER</SMALL> L<SMALL>ISTS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee is not the Registrar, then the Company will furnish to the Trustee, no later than seven (7)&nbsp;Business Days before each
Interest Payment Date on which any Special Interest or Additional Interest is payable, and at such other times as the Trustee may request, a list, in such form and as of such date or time as the Trustee may reasonably require, of the names and
addresses of the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.09. L<SMALL>EGENDS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Global Note Legend</I>. Each Global Note will bear the Global Note Legend (or any similar legend, not inconsistent with this Indenture,
required by the Depositary for such Global Note). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Affiliate Resale Legend</I>. Each Note will bear the Affiliate Resale Legend.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Restricted Note Legend</I>. Subject to <B>Section</B><B></B><B>&nbsp;2.12</B>, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) each Note that is a Transfer-Restricted Security will bear the Restricted Note Legend; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) if a Note is issued in exchange for, in substitution of, or to effect a partial conversion of, another Note (such other
Note being referred to as the &#8220;old Note&#8221; for purposes of this <B>Section</B><B></B><B>&nbsp;2.09(C)(ii)</B>), including pursuant to Section<B>&nbsp;2.10(B)</B>, <B>2.10(C)</B>, <B>2.11</B> or <B>2.13</B>, then such Note will bear the
Restricted Note Legend if such old Note bore the Restricted Note Legend at the time of such exchange or substitution, or on the related Conversion Date with respect to such conversion, as applicable; <I>provided</I>, <I>however</I>, that such Note
need not bear the Restricted Note Legend if such Note does not constitute a Transfer-Restricted Security immediately after such exchange or substitution, or as of such Conversion Date, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Other Legends</I>. A Note may bear any other legend or text, not inconsistent with this Indenture, as may be required by applicable law
or by any securities exchange or automated quotation system on which such Note is traded or quoted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Acknowledgment and Agreement
by the Holders</I>. A Holder&#8217;s acceptance of any Note bearing any legend required by this <B>Section</B><B></B><B>&nbsp;2.09</B> will constitute such Holder&#8217;s acknowledgment of, and agreement to comply with, the restrictions set forth in
such legend. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 19 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) <I>Restricted Stock Legend</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Conversion Share will bear the Restricted Stock Legend if the Note upon the conversion of which such Conversion Share
was issued was (or would have been had it not been converted) a Transfer-Restricted Security at the time such Conversion Share was issued; <I>provided</I>, <I>however</I>, that such Conversion Share need not bear the Restricted Stock Legend if the
Company determines, in its reasonable discretion, that such Conversion Share need not bear the Restricted Stock Legend. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything to the contrary in this <B>Section</B><B></B><B>&nbsp;2.09(F)</B>, a Conversion Share need not
bear a Restricted Stock Legend if such Conversion Share is issued in an uncertificated form that does not permit affixing legends thereto, <I>provided</I> the Company takes measures (including the assignment thereto of a &#8220;restricted&#8221;
CUSIP number) that it reasonably deems appropriate to enforce the transfer restrictions referred to in the Restricted Stock Legend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.10.
T<SMALL>RANSFERS</SMALL> <SMALL>AND</SMALL> E<SMALL>XCHANGES</SMALL>; C<SMALL>ERTAIN</SMALL> T<SMALL>RANSFER</SMALL> R<SMALL>ESTRICTIONS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Provisions Applicable to All Transfers and Exchanges</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Subject to this <B>Section</B><B></B><B>&nbsp;2.10</B>, Physical Notes and beneficial interests in Global Notes may be
transferred or exchanged from time to time. The Registrar will record each such transfer or exchange of Physical Notes in the Register. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each Note issued upon transfer or exchange of any other Note (such other Note being referred to as the &#8220;old
Note&#8221; for purposes of this <B>Section</B><B></B><B>&nbsp;2.10(A)(ii)</B>) or portion thereof in accordance with this Indenture will be the valid obligation of the Company, evidencing the same indebtedness, and entitled to the same benefits
under this Indenture, as such old Note or portion thereof, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The Company, the Trustee and the Note
Agents will not impose any service charge on any Holder for any transfer, exchange or conversion of Notes, but the Company, the Trustee, the Registrar and the Conversion Agent may require payment of a sum sufficient to cover any transfer tax or
similar governmental charge that may be imposed in connection with any transfer, exchange or, subject to <B>Section</B><B></B><B>&nbsp;5.02(E)</B>, conversion of Notes, other than exchanges pursuant to <B>Section</B><B>&nbsp;2.11</B>, <B>2.17</B> or
<B>8.05</B> not involving any transfer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Notwithstanding anything to the contrary in this Indenture or the Notes, a
Note may not be transferred or exchanged in part unless the portion to be so transferred or exchanged is in an Authorized Denomination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The Trustee will have no obligation or duty to monitor, determine or inquire as to compliance with any transfer
restrictions imposed under this Indenture or applicable law with respect to any Security, other than to require the delivery of such certificates or other documentation or evidence as expressly required by this Indenture and to examine the same to
determine substantial compliance as to form with the requirements of this Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 20 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Each Note issued upon transfer of, or in exchange for, another Note
will bear each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) Upon satisfaction of the
requirements of this Indenture to effect a transfer or exchange of any Note, the Company will cause such transfer or exchange to be effected as soon as reasonably practicable but in no event later than the second (2nd) Business Day after the date of
such satisfaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) For the avoidance of doubt, and subject to the terms of this Indenture, as used in this
<B>Section</B><B></B><B>&nbsp;2.10</B>, an &#8220;exchange&#8221; of a Global Note or a Physical Note includes (x)&nbsp;an exchange effected for the sole purpose of removing any Restricted Note Legend affixed to such Global Note or Physical Note;
and (y)&nbsp;if such Global Note or Physical Note is identified by a &#8220;restricted&#8221; CUSIP number, an exchange effected for the sole purpose of causing such Global Note or Physical Note to be identified by an &#8220;unrestricted&#8221;
CUSIP number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Transfers and Exchanges of Global Notes.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Subject to the immediately following sentence, no Global Note may be transferred or exchanged in whole except (x)&nbsp;by
the Depositary to a nominee of the Depositary; (y)&nbsp;by a nominee of the Depositary to the Depositary or to another nominee of the Depositary; or (z)&nbsp;by the Depositary or any such nominee to a successor Depositary or a nominee of such
successor Depositary. No Global Note (or any portion thereof) may be transferred to, or exchanged for, a Physical Note; <I>provided</I>, <I>however</I>, that a Global Note will be exchanged, pursuant to customary procedures, for one or more Physical
Notes if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) (x) the Depositary notifies the Company or the Trustee that the Depositary is unwilling or unable to
continue as depositary for such Global Note or (y)&nbsp;the Depositary ceases to be a &#8220;clearing agency&#8221; registered under Section&nbsp;17A of the Exchange Act and, in each case, the Company fails to appoint a successor Depositary within
ninety (90)&nbsp;days of such notice or cessation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) an Event of Default has occurred and is continuing and the Company,
the Trustee or the Registrar has received a written request from the Depositary, or from a holder of a beneficial interest in such Global Note, to exchange such Global Note or beneficial interest, as applicable, for one or more Physical Notes; or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the Company, in its sole discretion, permits the exchange of any beneficial interest in such Global Note for one or
more Physical Notes at the request of the owner of such beneficial interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 21 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Upon satisfaction of the requirements of this Indenture to effect a
transfer or exchange of any Global Note (or any portion thereof): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Trustee will reflect any resulting decrease of
the principal amount of such Global Note by notation on the &#8220;Schedule of Exchanges of Interests in the Global Note&#8221; forming part of such Global Note (and, if such notation results in such Global Note having a principal amount of zero,
then the Company may (but is not required to) instruct the Trustee to cancel such Global Note pursuant to <B>Section</B><B></B><B>&nbsp;2.15</B>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if required to effect such transfer or exchange, then the Trustee will reflect any resulting increase of the principal
amount of any other Global Note by notation on the &#8220;Schedule of Exchanges of Interests in the Global Note&#8221; forming part of such other Global Note; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if required to effect such transfer or exchange, then the Company will issue, execute and deliver, and the Trustee will
authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, a new Global Note bearing each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if such Global Note (or such portion thereof), or any beneficial interest therein, is to be exchanged for one or more
Physical Notes, then the Company will issue, execute and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Physical Notes that (x)&nbsp;are in Authorized Denominations and
have an aggregate principal amount equal to the principal amount of such Global Note to be so exchanged; (y)&nbsp;are registered in such name(s) as the Depositary specifies (or as otherwise determined pursuant to customary procedures); and
(z)&nbsp;bear each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Each transfer or exchange of
a beneficial interest in any Global Note will be made in accordance with the Depositary Procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Transfers and Exchanges of
Physical Notes.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Subject to this <B>Section</B><B></B><B>&nbsp;2.10</B>, a Holder of a Physical Note may
(x)&nbsp;transfer such Physical Note (or any portion thereof in an Authorized Denomination) to one or more other Person(s); (y) exchange such Physical Note (or any portion thereof in an Authorized Denomination) for one or more other Physical Notes
in Authorized Denominations having an aggregate principal amount equal to the aggregate principal amount of the Physical Note (or portion thereof) to be so exchanged; and (z)&nbsp;if then permitted by the Depositary Procedures, transfer such
Physical Note (or any portion thereof in an Authorized Denomination) in exchange for a beneficial interest in one or more Global Notes; <I>provided</I>, <I>however</I>, that, to effect any such transfer or exchange, such Holder must: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) surrender such Physical Note to be transferred or exchanged to the office of the Registrar, together with any endorsements
or transfer instruments reasonably required by the Company, the Trustee or the Registrar; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) deliver such
certificates, documentation or evidence as may be required pursuant to <B>Section</B><B></B><B>&nbsp;2.10(D)</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 22 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Upon the satisfaction of the requirements of this Indenture to effect a
transfer or exchange of any Physical Note (such Physical Note being referred to as the &#8220;old Physical Note&#8221; for purposes of this <B>Section</B><B></B><B>&nbsp;2.10(C)(ii)</B>) of a Holder (or any portion of such old Physical Note in an
Authorized Denomination): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) such old Physical Note will be promptly cancelled pursuant to
<B>Section</B><B></B><B>&nbsp;2.15</B>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if such old Physical Note is to be so transferred or exchanged only in part,
then the Company will issue, execute and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Physical Notes that (x)&nbsp;are in Authorized Denominations and have an
aggregate principal amount equal to the principal amount of such old Physical Note not to be so transferred or exchanged; (y)&nbsp;are registered in the name of such Holder; and (z)&nbsp;bear each legend, if any, required by
<B>Section</B><B></B><B>&nbsp;2.09</B>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) in the case of a transfer: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) to the Depositary or a nominee thereof that will hold its interest in such old Physical Note (or such portion thereof) to
be so transferred in the form of one or more Global Notes, the Trustee will reflect an increase of the principal amount of one or more existing Global Notes by notation on the &#8220;Schedule of Exchanges of Interests in the Global Note&#8221;
forming part of such Global Note(s), which increase(s) are in Authorized Denominations and aggregate to the principal amount to be so transferred, and which Global Note(s) bear each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>;
<I>provided</I>, <I>however</I>, that if such transfer cannot be so effected by notation on one or more existing Global Notes (whether because no Global Notes bearing each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B> then
exist, because any such increase will result in any Global Note having an aggregate principal amount exceeding the maximum aggregate principal amount permitted by the Depositary or otherwise), then the Company will issue, execute and deliver, and
the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Global Notes that (x)&nbsp;are in Authorized Denominations and have an aggregate principal amount equal to the principal amount that
is to be so transferred but that is not effected by notation as provided above; and (y)&nbsp;bear each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) to a transferee that will hold its interest in such old Physical Note (or such portion thereof) to be so transferred in
the form of one or more Physical Notes, the Company will issue, execute and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Physical Notes that (x)&nbsp;are in
Authorized Denominations and have an aggregate principal amount equal to the principal amount to be so transferred; (y)&nbsp;are registered in the name of such transferee; and (z)&nbsp;bear each legend, if any, required by
<B>Section</B><B></B><B>&nbsp;2.09</B>; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 23 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) in the case of an exchange, the Company will issue, execute and deliver,
and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Physical Notes that (x)&nbsp;are in Authorized Denominations and have an aggregate principal amount equal to the principal amount
to be so exchanged; (y)&nbsp;are registered in the name of the Person to whom such old Physical Note was registered; and (z)&nbsp;bear each legend, if any, required by <B>Section</B><B></B><B>&nbsp;2.09</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Requirement to Deliver Documentation and Other Evidence</I>. If a Holder of any Note that is identified by a &#8220;restricted&#8221;
CUSIP number or that bears a Restricted Note Legend or is a Transfer-Restricted Security requests to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) cause such Note
to be identified by an &#8220;unrestricted&#8221; CUSIP number; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) remove such Restricted Note Legend; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) register the transfer of such Note to the name of another Person, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then the Company, the Trustee and the Registrar may refuse to effect such identification, removal or transfer, as applicable, unless there is delivered to the
Company, the Trustee and the Registrar such certificates or other documentation or evidence as the Company, the Trustee and the Registrar may reasonably require to determine that such identification, removal or transfer, as applicable, complies with
the Securities Act and other applicable securities laws; <I>provided</I>, <I>however</I>, that no such certificates, documentation or evidence need be so delivered on and after the Free Trade Date with respect to such Note unless the Company
determines, in its reasonable discretion, that such Note is not eligible to be offered, sold or otherwise transferred pursuant to Rule 144 or otherwise without any requirements as to volume, manner of sale, availability of current public information
or notice under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Transfers of Notes Subject to Redemption, Repurchase or Conversion</I>. Notwithstanding
anything to the contrary in this Indenture or the Notes, the Company, the Trustee and the Registrar will not be required to register the transfer of or exchange any Note that (i)&nbsp;has been surrendered for conversion, except to the extent that
any portion of such Note is not subject to conversion; (ii)&nbsp;is subject to a Fundamental Change Repurchase Notice validly delivered, and not withdrawn, pursuant to <B>Section</B><B></B><B>&nbsp;4.02(F)</B>, except to the extent that any portion
of such Note is not subject to such notice or the Company fails to pay the applicable Fundamental Change Repurchase Price when due; or (iii)&nbsp;has been selected for Redemption pursuant to a Redemption Notice, except to the extent that any portion
of such Note is not subject to Redemption or the Company fails to pay the applicable Redemption Price when due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.11.
E<SMALL>XCHANGE</SMALL> <SMALL>AND</SMALL> C<SMALL>ANCELLATION</SMALL> <SMALL>OF</SMALL> N<SMALL>OTES</SMALL> <SMALL>TO</SMALL> B<SMALL>E</SMALL> C<SMALL>ONVERTED</SMALL> <SMALL>OR</SMALL> <SMALL>TO</SMALL> B<SMALL>E</SMALL>
R<SMALL>EPURCHASED</SMALL> P<SMALL>URSUANT</SMALL> <SMALL>TO</SMALL> <SMALL>A</SMALL> R<SMALL>EPURCHASE</SMALL> U<SMALL>PON</SMALL> F<SMALL>UNDAMENTAL</SMALL> C<SMALL>HANGE</SMALL> <SMALL>OR</SMALL> R<SMALL>EDEEMED</SMALL> P<SMALL>URSUANT</SMALL>
<SMALL>TO</SMALL> <SMALL>A</SMALL> R<SMALL>EDEMPTION</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Partial Conversions of Physical Notes and Partial Repurchases of
Physical Notes Pursuant to a Repurchase Upon Fundamental Change</I> <I>or Partial Redemptions of Physical Notes</I>. If only a portion of a Physical Note of a Holder is to be converted pursuant to <B>Article 5</B> or repurchased pursuant to a
Repurchase Upon Fundamental Change or redeemed pursuant to a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 24 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Redemption, then, as soon as reasonably practicable after such Physical Note is surrendered for such conversion, repurchase or Redemption, as applicable, the Company will cause such Physical Note
to be exchanged, pursuant and subject to <B>Section</B><B></B><B>&nbsp;2.10(C)</B>, for (i)&nbsp;one or more Physical Notes that are in Authorized Denominations and have an aggregate principal amount equal to the principal amount of such Physical
Note that is not to be so converted, repurchased or redeemed, as applicable, and deliver such Physical Note(s) to such Holder; and (ii)&nbsp;a Physical Note having a principal amount equal to the principal amount to be so converted, repurchased or
redeemed, as applicable, which Physical Note will be converted, repurchased or redeemed, as applicable, pursuant to the terms of this Indenture; <I>provided</I>, <I>however</I>, that the Physical Note referred to in this <B>clause (ii)</B>&nbsp;need
not be issued at any time after which such principal amount subject to such conversion, repurchase or Redemption, as applicable, is deemed to cease to be outstanding pursuant to <B>Section</B><B></B><B>&nbsp;2.18</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Cancellation of Notes that Are Converted, Notes that Are Repurchased Pursuant to a Repurchase Upon Fundamental Change and Notes that
Are Redeemed Pursuant to a Redemption</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Physical Notes</I>. If a Physical Note (or any portion thereof that has
not theretofore been exchanged pursuant to <B>Section</B><B></B><B>&nbsp;2.11(A)</B>) of a Holder is to be converted pursuant to <B>Article 5</B> or repurchased pursuant to a Repurchase Upon Fundamental Change or redeemed pursuant to a Redemption,
then, promptly after the later of the time such Physical Note (or such portion) is deemed to cease to be outstanding pursuant to <B>Section</B><B></B><B>&nbsp;2.18</B> and the time such Physical Note is surrendered for such conversion, repurchase or
Redemption, as applicable, (1)&nbsp;such Physical Note will be cancelled pursuant to <B>Section</B><B></B><B>&nbsp;2.15</B>; and (2)&nbsp;in the case of a partial conversion, repurchase or Redemption, as applicable, the Company will issue, execute
and deliver to such Holder, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, one or more Physical Notes that (x)&nbsp;are in Authorized Denominations and have an aggregate principal amount
equal to the principal amount of such Physical Note that is not to be so converted, repurchased or redeemed, as applicable; (y)&nbsp;are registered in the name of such Holder; and (z)&nbsp;bear each legend, if any, required by
<B>Section</B><B></B><B>&nbsp;2.09</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Global Notes</I>. If a Global Note (or any portion thereof) is to be
converted pursuant to <B>Article 5</B> or repurchased pursuant to a Repurchase Upon Fundamental Change or redeemed pursuant to a Redemption, then, promptly after the time such Note (or such portion) is deemed to cease to be outstanding pursuant to
<B>Section</B><B></B><B>&nbsp;2.18</B>, the Trustee will reflect a decrease of the principal amount of such Global Note in an amount equal to the principal amount of such Global Note to be so converted, repurchased or redeemed, as applicable, by
notation on the &#8220;Schedule of Exchanges of Interests in the Global Note&#8221; forming part of such Global Note (and, if the principal amount of such Global Note is zero following such notation, cancel such Global Note pursuant to
<B>Section</B><B></B><B>&nbsp;2.15</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 25 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.12. R<SMALL>EMOVAL</SMALL> <SMALL>OF</SMALL> T<SMALL>RANSFER</SMALL>
R<SMALL>ESTRICTIONS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of any other provision of this Indenture (including
<B>Section</B><B></B><B>&nbsp;3.04</B>), the Restricted Note Legend affixed to any Note will be deemed, pursuant to this <B>Section</B><B></B><B>&nbsp;2.12</B> and the footnote to such Restricted Note Legend, to be removed therefrom upon the
Company&#8217;s delivery to the Trustee of notice, signed on behalf of the Company by one (1)&nbsp;of its Officers, to such effect (and, for the avoidance of doubt, such notice need not be accompanied by an Officer&#8217;s Certificate or an Opinion
of Counsel in order to be effective to cause such Restricted Note Legend to be deemed to be removed from such Note). If such Note bears a &#8220;restricted&#8221; CUSIP or ISIN number at the time of such delivery, then, upon such delivery, such Note
will be deemed, pursuant to this <B>Section</B><B></B><B>&nbsp;2.12</B> and the footnotes to the CUSIP and ISIN numbers set forth on the face of the certificate representing such Note, to thereafter bear the &#8220;unrestricted&#8221; CUSIP and ISIN
numbers identified in such footnotes; <I>provided</I>, <I>however</I>, that if such Note is a Global Note and the Depositary thereof requires a mandatory exchange or other procedure to cause such Global Note to be identified by
&#8220;unrestricted&#8221; CUSIP and ISIN numbers in the facilities of such Depositary, then (i)&nbsp;the Company will effect such exchange or procedure as soon as reasonably practicable; and (ii)&nbsp;for purposes of
<B>Section</B><B></B><B>&nbsp;3.04</B> and the definition of Freely Tradable, such Global Note will not be deemed to be identified by &#8220;unrestricted&#8221; CUSIP and ISIN numbers until such time as such exchange or procedure is effected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.13. R<SMALL>EPLACEMENT</SMALL> N<SMALL>OTES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Holder of any Note claims that such Note has been mutilated, lost, destroyed or wrongfully taken, then the Company will issue, execute
and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, a replacement Note upon surrender to the Trustee of such mutilated Note, or upon delivery to the Trustee of evidence of such
loss, destruction or wrongful taking reasonably satisfactory to the Trustee and the Company. In the case of a lost, destroyed or wrongfully taken Note, the Company and the Trustee may require the Holder thereof to provide such security or indemnity
that is satisfactory to the Company and the Trustee to protect the Company and the Trustee from any loss that any of them may suffer if such Note is replaced. The Company may charge for its and the Trustee&#8217;s expenses in replacing a Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every replacement Note issued pursuant to this <B>Section</B><B></B><B>&nbsp;2.13</B> will be an additional obligation of the Company and will
be entitled to all of the benefits of this Indenture equally and ratably with all other Notes issued under this Indenture, whether or not the lost, destroyed or wrongfully taken Note will at any time be enforceable by anyone. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.14. R<SMALL>EGISTERED</SMALL> H<SMALL>OLDERS</SMALL>; C<SMALL>ERTAIN</SMALL> R<SMALL>IGHTS</SMALL> <SMALL>WITH</SMALL>
R<SMALL>ESPECT</SMALL> <SMALL>TO</SMALL> G<SMALL>LOBAL</SMALL> N<SMALL>OTES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only the Holder of a Note will have rights under
this Indenture as the owner of such Note. Without limiting the generality of the foregoing, Depositary Participants will have no rights as such under this Indenture with respect to any Global Note held on their behalf by the Depositary or its
nominee, or by the Trustee as its custodian, and the Company, the Trustee and the Note Agents, and their respective agents, may treat the Depositary as the absolute owner of such Global Note for all purposes whatsoever; <I>provided</I>,
<I>however</I>, that (A)&nbsp;the Holder of any Global Note may grant proxies and otherwise authorize any Person, including Depositary Participants and Persons that hold interests in Notes through Depositary Participants, to take any action that
such Holder is entitled to take with respect to such Global Note under this Indenture or the Notes; and (B)&nbsp;the Company and the Trustee, and their respective agents, may give effect to any written certification, proxy or other authorization
furnished by the Depositary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 26 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.15. C<SMALL>ANCELLATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may at any time deliver Notes to the Trustee for cancellation. The Registrar, the Paying Agent and the Conversion Agent will
forward to the Trustee each Note duly surrendered to them for transfer, exchange, payment or conversion. The Trustee will promptly cancel all Notes so surrendered to it in accordance with its customary procedures. Without limiting the generality of
<B>Section</B><B></B><B>&nbsp;2.03(B)</B>, the Company may not originally issue new Notes to replace Notes that it has paid or that have been cancelled upon transfer, exchange, payment or conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.16. N<SMALL>OTES</SMALL> H<SMALL>ELD</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> <SMALL>OR</SMALL>
<SMALL>ITS</SMALL> A<SMALL>FFILIATES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of <B>Section</B><B>&nbsp;2.18</B>, in determining
whether the Holders of the required aggregate principal amount of Notes have concurred in any direction, waiver or consent, Notes owned by the Company or any of its Affiliates will be deemed not to be outstanding; <I>provided</I>, <I>however</I>,
that, for purposes of determining whether the Trustee is protected in relying on any such direction, waiver or consent, only Notes that a Responsible Officer of the Trustee knows are so owned will be so disregarded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any Note or share of Common Stock issued upon the conversion or exchange of a Note that is repurchased or owned by the Company or any of its Affiliates may
not be resold by the Company or any such Affiliate unless registered under the Securities Act or resold pursuant to an exemption from the registration requirements of the Securities Act in a transaction that results in such Note or share of Common
Stock, as the case may be, no longer being a &#8220;restricted security&#8221; (as defined in Rule 144 under the Securities Act). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.17.
T<SMALL>EMPORARY</SMALL> N<SMALL>OTES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until definitive Notes are ready for delivery, the Company may issue, execute and
deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, temporary Notes. Temporary Notes will be substantially in the form of definitive Notes but may have variations that the Company
considers appropriate for temporary Notes. The Company will promptly prepare, issue, execute and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, definitive Notes in exchange for
temporary Notes. Until so exchanged, each temporary Note will in all respects be entitled to the same benefits under this Indenture as definitive Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.18. O<SMALL>UTSTANDING</SMALL> N<SMALL>OTES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. The Notes that are outstanding at any time will be deemed to be those Notes that, at such time, have been duly executed
and authenticated, excluding those Notes (or portions thereof) that have theretofore been (i)&nbsp;cancelled by the Trustee or delivered to the Trustee for cancellation in accordance with <B>Section</B><B></B><B>&nbsp;2.15</B>; (ii) assigned a
principal amount of zero by notation on the &#8220;Schedule of Exchanges of Interests in the Global Note&#8221; forming part of any a Global Note representing such Note; (iii)&nbsp;paid in full (including upon conversion) in accordance with this
Indenture; or (iv)&nbsp;deemed to cease to be outstanding to the extent provided in, and subject to, <B>clause (B)</B>, <B>(C)</B> or <B>(D)</B>&nbsp;of this <B>Section</B><B></B><B>&nbsp;2.18</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 27 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Replaced Notes</I>. If a Note is replaced pursuant to
<B>Section</B><B></B><B>&nbsp;2.13</B>, then such Note will cease to be outstanding at the time of its replacement, unless the Trustee and the Company receive proof reasonably satisfactory to them that such Note is held by a &#8220;<I>bona fide</I>
purchaser&#8221; under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Maturing Notes and Notes Called for Redemption or Subject to Repurchase</I>. If, on a
Redemption Date, a Fundamental Change Repurchase Date or the Maturity Date, the Paying Agent holds money sufficient to pay the aggregate Redemption Price, Fundamental Change Repurchase Price or principal amount, respectively, together, in each case,
with the aggregate interest (if any), in each case due on such date, then (unless there occurs a Default in the payment of any such amount)&nbsp;(i) the Notes (or portions thereof) to be redeemed or repurchased, or that mature, on such date will be
deemed, as of such date, to cease to be outstanding, except to the extent provided in <B>Section</B><B></B><B>&nbsp;4.02(D)</B>, <B>4.03(E)</B> or <B>5.02(D)</B>; and (ii)&nbsp;the rights of the Holders of such Notes (or such portions thereof), as
such, will terminate with respect to such Notes (or such portions thereof), other than the right to receive the Redemption Price, Fundamental Change Repurchase Price or principal amount, as applicable, of, and accrued and unpaid interest, if any,
on, such Notes (or such portions thereof), in each case as provided in this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Notes to Be Converted</I>. At the Close of
Business on the Conversion Date for any Note (or any portion thereof) to be converted, such Note (or such portion) will (unless there occurs a Default in the delivery of the Conversion Consideration or any interest due, pursuant to
<B>Section</B><B></B><B>&nbsp;5.03(B)</B> or <B>Section</B><B></B><B>&nbsp;5.02(D)</B>, upon such conversion) be deemed to cease to be outstanding, except to the extent provided in <B>Section</B><B></B><B>&nbsp;5.02(D)</B> or
<B>Section</B><B></B><B>&nbsp;5.08</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Cessation of Accrual of Interest</I>. Except as provided in
<B>Section</B><B></B><B>&nbsp;4.02(D)</B>, <B>4.03(E)</B> or <B>5.02(D)</B>, no Special Interest or Additional Interest will accrue on any Note from and including the date that such Note is deemed, pursuant to this
<B>Section</B><B></B><B>&nbsp;2.18</B>, to cease to be outstanding, unless there occurs a default in the payment or delivery of any cash or other property due on such Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.19. R<SMALL>EPURCHASES</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the generality of <B>Section</B><B></B><B>&nbsp;2.15</B>, subject to applicable law, the Company may, from time to time,
repurchase Notes in open market purchases or otherwise, whether through private or public tender or exchange offers, cash-settled swaps or other cash-settled derivatives, without delivering prior notice to Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.20. CUSIP <SMALL>AND</SMALL> ISIN N<SMALL>UMBERS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;2.12</B>, the Company may use one or more CUSIP or ISIN numbers to identify any of the Notes, and, if
so, the Company and the Trustee will use such CUSIP or ISIN number(s) in notices to Holders; <I>provided</I>, <I>however</I>, that (i)&nbsp;the Trustee makes no representation as to the correctness or accuracy of any such CUSIP or ISIN number; and
(ii)&nbsp;the effectiveness of any such notice will not be affected by any defect in, or omission of, any such CUSIP or ISIN number. The Company will promptly notify the Trustee of any change in the CUSIP or ISIN number(s) identifying any Notes.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 28 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 3. COVENANTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.01. P<SMALL>AYMENT</SMALL> <SMALL>ON</SMALL> N<SMALL>OTES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. The Company will pay or cause to be paid all the principal of, the Fundamental Change Repurchase Price and Redemption
Price for, interest, if any, on, and other amounts due with respect to, the Notes on the dates and in the manner set forth in this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Deposit of Funds</I>. Before 11:00 A.M., New York City time, on each Redemption Date, each Fundamental Change Repurchase Date, each
Interest Payment Date on which any Special Interest or Additional Interest is payable, the Maturity Date and each other date on which any cash amount is due on the Notes, the Company will deposit, or will cause there to be deposited, with the Paying
Agent cash, in funds immediately available on such date, sufficient to pay the cash amount due on the applicable Notes on such date. The Paying Agent will return to the Company, as soon as practicable, any money not required for such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.02. E<SMALL>XCHANGE</SMALL> A<SMALL>CT</SMALL> R<SMALL>EPORTS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. The Company will send to the Trustee copies of all reports that the Company is required to file with the SEC pursuant to
Section&nbsp;13(a) or 15(d) of the Exchange Act within fifteen (15)&nbsp;calendar days after the date that the Company is required to file the same (after giving effect to all applicable grace periods under the Exchange Act); <I>provided</I>,
<I>however</I>, that the Company need not send to the Trustee any material for which the Company has received, or is seeking in good faith and has not been denied, confidential treatment by the SEC. Any report that the Company files with the SEC
through the EDGAR system (or any successor thereto) will be deemed to be sent to the Trustee at the time such report is so filed via the EDGAR system (or such successor). Upon the request of any Holder, the Company will provide to such Holder a copy
of any report that the Company has sent the Trustee pursuant to this <B>Section</B><B></B><B>&nbsp;3.02(A)</B>, other than a report that is deemed to be sent to the Trustee pursuant to the preceding sentence. Delivery of reports, information and
documents to the Trustee under this Indenture is for informational purposes only and the information and the Trustee&#8217;s receipt of the foregoing will not constitute constructive notice of any information contained therein, or determinable from
information contained therein including the Company&#8217;s compliance with any of its covenants under this Indenture (as to which the Trustee is entitled to rely exclusively on an Officer&#8217;s Certificate). The Trustee will have no obligation
whatsoever to monitor or confirm, on a continuing basis or otherwise, the Company&#8217;s compliance with its covenants or with respect to any reports or other documents filed with the SEC via the EDGAR system (or any successor thereto) or any other
website, or to participate in any conference calls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Trustee&#8217;s Disclaimer</I>. The Trustee need not determine whether the
Company has filed any material via the EDGAR system (or such successor). The sending or filing of reports pursuant to <B>Section</B><B></B><B>&nbsp;3.02(A) </B>will not be deemed to constitute actual or constructive notice to the Trustee of any
information contained, or determinable from information contained, therein, including the Company&#8217;s compliance with any of its covenants under this Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 29 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.03. R<SMALL>ULE</SMALL> 144A I<SMALL>NFORMATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Company is not subject to Section&nbsp;13 or 15(d) of the Exchange Act at any time when any Notes or shares of Common Stock issuable
upon conversion of the Notes are outstanding and constitute &#8220;restricted securities&#8221; (as defined in Rule 144), then the Company (or its successor) will promptly provide, to the Trustee and, upon written request, to any Holder, beneficial
owner or prospective purchaser of such Notes or shares, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act to facilitate the resale of such Notes or shares pursuant to Rule 144A. The Company (or its
successor) will take such further action as any Holder or beneficial owner of such Notes or shares may reasonably request to enable such Holder or beneficial owner to sell such Notes or shares pursuant to Rule 144A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.04. A<SMALL>DDITIONAL</SMALL> I<SMALL>NTEREST</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Accrual of Additional Interest</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) If, at any time during the six (6)&nbsp;month period beginning on, and including, the date that is six (6)&nbsp;months
after the Last Original Issue Date of any Note, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Company fails to timely file any report (other than Form <FONT
STYLE="white-space:nowrap">8-K</FONT> reports) that the Company is required to file with the SEC pursuant to Section&nbsp;13 or 15(d) of the Exchange Act (after giving effect to all applicable grace periods thereunder); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) such Note is not otherwise Freely Tradable, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">then Additional Interest will accrue on such Note for each day during such period on which such failure is continuing or such Note is not
Freely Tradable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In addition, Additional Interest will accrue on a Note on each day on which such Note is not Freely
Tradable on or after the <FONT STYLE="white-space:nowrap">De-Legending</FONT> Deadline Date for such Note; <I>provided</I>, <I>however</I>, that no Additional Interest shall accrue or be owed pursuant to this
<B>Section</B><B></B><B>&nbsp;3.04(A)(ii)</B> until the fifteenth (15th) Business Day following written notification to the Company by the Trustee (at the direction of any Holder of such Note) or any Holder or beneficial owner of such Note
requesting that the Company comply with its obligations described in this <B>Section</B><B></B><B>&nbsp;3.04(A)(ii)</B> (which notice may be given at any time after the three hundred thirtieth (330th) day after the Last Original Issue Date of the
Notes or any additional Notes, as the case may be), it being understood and agreed that in no event shall Additional Interest accrue or be owed pursuant to this <B>Section</B><B></B><B>&nbsp;3.04(A)(ii) </B>for any period prior to the three hundred
eightieth (380th) day after the Last Original Issue Date of the Notes or any additional Notes, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Amount and
Payment of Additional Interest</I>. Any Additional Interest that accrues on a Note pursuant to <B>Section</B><B></B><B>&nbsp;3.04(A)</B> will accrue at a rate per annum equal to one half of one percent (0.50%) of the principal amount thereof;
<I>provided</I>, <I>however</I>, that in no event will Additional Interest that may accrue as a result of the Company&#8217;s failure to timely file any report (other than Form <FONT STYLE="white-space:nowrap">8-K</FONT> reports) that the Company is
required to file with the SEC pursuant to Section&nbsp;13 or 15(d) of the Exchange Act (after giving effect to all applicable grace periods thereunder), pursuant to this <B>Section</B><B></B><B>&nbsp;3.04</B>, together with any Special Interest that
is payable at the Company&#8217;s election pursuant to <B>Section</B><B></B><B>&nbsp;7.03</B> as the sole remedy for any Reporting Event of Default, accrue on any day on a Note at a combined rate per annum that exceeds one half of one percent
(0.50%). For the avoidance of doubt, any Additional Interest that accrues on a Note will, subject to the proviso of the immediately preceding sentence, be in addition to any Special Interest that accrues on such Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 30 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Notice of Accrual of Additional Interest; Trustee&#8217;s Disclaimer</I>. The Company
will send notice to the Holder of each Note, and to the Trustee, of the commencement and termination of any period in which Additional Interest accrues on such Note. In addition, if any Additional Interest accrues on any Note, then, no later than
five (5)&nbsp;Business Days before each date on which such Additional Interest is to be paid, the Company will deliver an Officer&#8217;s Certificate to the Trustee and the Paying Agent stating (i)&nbsp;that the Company is obligated to pay
Additional Interest pursuant to <B>Section</B><B></B><B>&nbsp;3.04</B> on such Note on such date of payment; and (ii)&nbsp;the amount of such Additional Interest that is payable on such date of payment. The Trustee will have no duty to determine
whether any Additional Interest is payable or the amount thereof and may assume without inquiry that no Additional Interest is payable until written notice of such Additional Interest has been provided to the Trustee by the Company in the form of
such Officer&#8217;s Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Exclusive Remedy</I>. The accrual of Additional Interest pursuant to
<B>Section</B><B></B><B>&nbsp;3.04</B> will be the exclusive remedy available to Holders for the failure of their Notes to become Freely Tradable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.05. C<SMALL>OMPLIANCE</SMALL> <SMALL>AND</SMALL> D<SMALL>EFAULT</SMALL> C<SMALL>ERTIFICATES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Annual Compliance Certificate</I>. Within one hundred and twenty (120)&nbsp;days after December&nbsp;31, 2025 and each fiscal year of
the Company ending thereafter, the Company will deliver an Officer&#8217;s Certificate to the Trustee stating (i)&nbsp;that the signatory thereto has supervised a review of the activities of the Company and its Subsidiaries during such fiscal year
with a view towards determining whether any Default or Event of Default has occurred; and (ii)&nbsp;whether, to such signatory&#8217;s knowledge, a Default or Event of Default has occurred and is continuing (and, if so, describing all such Defaults
or Events of Default and what action the Company is taking or proposes to take with respect thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Default Certificate</I>. If
a Default or Event of Default occurs, then the Company will, within thirty (30)&nbsp;days after its first occurrence, deliver an Officer&#8217;s Certificate to the Trustee describing the same and what action the Company is taking or proposes to take
with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.06. S<SMALL>TAY</SMALL>, E<SMALL>XTENSION</SMALL> <SMALL>AND</SMALL> U<SMALL>SURY</SMALL> L<SMALL>AWS</SMALL>.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that it may lawfully do so, the Company (A)&nbsp;agrees that it will not at any time insist upon, plead, or in any
manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever enacted or in force) that may affect the covenants or the performance of this Indenture; and (B)&nbsp;expressly waives all benefits
or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution of any power granted to the Trustee by this Indenture, but will suffer and permit the execution of every such power as though
no such law has been enacted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 31 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.07. A<SMALL>CQUISITION</SMALL> <SMALL>OF</SMALL> N<SMALL>OTES</SMALL> <SMALL>BY</SMALL>
<SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> <SMALL>AND</SMALL> <SMALL>ITS</SMALL> A<SMALL>FFILIATES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the
generality of <B>Section</B><B></B><B>&nbsp;2.18</B>, Notes that the Company or any of its Subsidiaries have purchased or otherwise acquired will be deemed to remain outstanding (except to the extent provided in
<B>Section</B><B></B><B>&nbsp;2.16</B>) until such time as such Notes are delivered to the Trustee for cancellation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 4.
REPURCHASE AND REDEMPTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4.01. N<SMALL>O</SMALL> S<SMALL>INKING</SMALL> F<SMALL>UND</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No sinking fund is required to be provided for the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4.02. R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL> H<SMALL>OLDERS</SMALL> <SMALL>TO</SMALL> R<SMALL>EQUIRE</SMALL> <SMALL>THE</SMALL>
C<SMALL>OMPANY</SMALL> <SMALL>TO</SMALL> R<SMALL>EPURCHASE</SMALL> N<SMALL>OTES</SMALL> <SMALL>UPON</SMALL> <SMALL>A</SMALL> F<SMALL>UNDAMENTAL</SMALL> C<SMALL>HANGE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Right of Holders to Require the Company to Repurchase Notes Upon a Fundamental Change</I>. Subject to the other terms of this
<B>Section</B><B></B><B>&nbsp;4.02</B>, if a Fundamental Change occurs, then each Holder will have the right (the &#8220;<B>Fundamental Change Repurchase Right</B>&#8221;) to require the Company to repurchase such Holder&#8217;s Notes (or any
portion thereof in an Authorized Denomination) on the Fundamental Change Repurchase Date for such Fundamental Change for a cash purchase price equal to the Fundamental Change Repurchase Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Repurchase Prohibited in Certain Circumstances</I>. If the principal amount of the Notes has been accelerated and such acceleration has
not been rescinded on or before the Fundamental Change Repurchase Date for a Repurchase Upon Fundamental Change (including as a result of the payment of the related Fundamental Change Repurchase Price, and any related interest pursuant to the
proviso to <B>Section</B><B></B><B>&nbsp;4.02(D)</B>, on such Fundamental Change Repurchase Date), then (i)&nbsp;the Company may not repurchase any Notes pursuant to this <B>Section</B><B></B><B>&nbsp;4.02</B>; and (ii)&nbsp;the Company will cause
any Notes theretofore surrendered for such Repurchase Upon Fundamental Change to be returned to the Holders thereof (or, if applicable with respect to Global Notes, cancel any instructions for book-entry transfer to the Company, the Trustee or the
Paying Agent of the applicable beneficial interest in such Notes in accordance with the Depositary Procedures). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Fundamental Change
Repurchase Date</I>. The Fundamental Change Repurchase Date for any Fundamental Change will be a Business Day of the Company&#8217;s choosing that is no more than thirty five (35), nor less than twenty (20), Business Days after the date the Company
sends the related Fundamental Change Notice pursuant to <B>Section</B><B></B><B>&nbsp;4.02(E)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Fundamental Change Repurchase
Price</I>. The Fundamental Change Repurchase Price for any Note to be repurchased upon a Repurchase Upon Fundamental Change following a Fundamental Change is an amount in cash equal to the principal amount of such Note plus accrued and unpaid
Special Interest and Additional Interest, if any, on such Note to, but excluding, the Fundamental Change Repurchase Date for such Fundamental Change; <I>provided</I>, <I>however</I>, that if any Special Interest or Additional Interest is payable on
an Interest Payment Date and such Fundamental Change Repurchase Date is after the related Interest Record Date and on or before </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 32 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Interest Payment Date, then (i)&nbsp;the Holder of such Note at the Close of Business on such Interest Record Date will be entitled, notwithstanding such Repurchase Upon Fundamental Change,
to receive, on or, at the Company&#8217;s election, before such Interest Payment Date, the unpaid Special Interest or Additional Interest, as applicable, that would have been paid on such Note on such Interest Payment Date (assuming, solely for
these purposes, that such Note remained outstanding through such Interest Payment Date, if such Fundamental Change Repurchase Date is before such Interest Payment Date); and (ii)&nbsp;the Fundamental Change Repurchase Price will not include accrued
and unpaid Special Interest or Additional Interest on such Note to, but excluding, such Fundamental Change Repurchase Date. For the avoidance of doubt, if such Interest Payment Date is not a Business Day within the meaning of
<B>Section</B><B></B><B>&nbsp;2.05(C)</B> and such Fundamental Change Repurchase Date occurs on the Business Day immediately after such Interest Payment Date, then (x)&nbsp;such accrued and unpaid Special Interest or Additional Interest, as
applicable, to, but excluding, such Interest Payment Date will be paid, in accordance with <B>Section</B><B></B><B>&nbsp;2.05(C)</B>, on the next Business Day to Holders as of the Close of Business on the immediately preceding Interest Record Date;
and (y)&nbsp;the Fundamental Change Repurchase Price will include Special Interest and Additional Interest, if any, on the Notes to be repurchased from, and including, such Interest Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Fundamental Change Notice</I>. On or before the twentieth (20th) calendar day after the effective date of a Fundamental Change, the
Company will send to each Holder, the Trustee, the Conversion Agent (if other than the Trustee) and the Paying Agent (if other than the Trustee) a notice of such Fundamental Change (a &#8220;<B>Fundamental Change Notice</B>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such Fundamental Change Notice must state: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) briefly, the events causing such Fundamental Change; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the effective date of such Fundamental Change; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the procedures that a Holder must follow to require the Company to repurchase its Notes pursuant to this
<B>Section</B><B></B><B>&nbsp;4.02</B>, including the deadline for exercising the Fundamental Change Repurchase Right and the procedures for submitting and withdrawing a Fundamental Change Repurchase Notice; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Fundamental Change Repurchase Date for such Fundamental Change; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Fundamental Change Repurchase Price per $1,000 principal amount of Notes for such Fundamental Change (and, if any
Special Interest or Additional Interest is payable on an Interest Payment Date and such Fundamental Change Repurchase Date is after the related Interest Record Date and on or before such Interest Payment Date, the amount, manner and timing of the
interest payment payable pursuant to the proviso to <B>Section</B><B></B><B>&nbsp;4.02(D)</B>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the name and address
of the Paying Agent and the Conversion Agent; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) the Conversion Rate in effect on the date of such Fundamental Change
Notice and a description and quantification of any adjustments to the Conversion Rate that may result from such Fundamental Change (including pursuant to <B>Section</B><B></B><B>&nbsp;5.07</B>); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 33 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) that Notes for which a Fundamental Change Repurchase Notice has been
duly tendered and not duly withdrawn must be delivered to the Paying Agent for the Holder thereof to be entitled to receive the Fundamental Change Repurchase Price; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) that Notes (or any portion thereof) that are subject to a Fundamental Change Repurchase Notice that has been duly tendered
may be converted only if such Fundamental Change Repurchase Notice is withdrawn in accordance with this Indenture; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)
the CUSIP and ISIN numbers, if any, of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the failure to deliver a Fundamental Change Notice nor any defect in a
Fundamental Change Notice will limit the Fundamental Change Repurchase Right of any Holder or otherwise affect the validity of any proceedings relating to any Repurchase Upon Fundamental Change. At the Company&#8217;s written request given at least
two (2)&nbsp;Business Days before such notice is to be sent (or such shorter period as will be acceptable to the Trustee), the Trustee will give such notice in the Company&#8217;s name and at the Company&#8217;s expense; <I>provided</I>,
<I>however</I>, that, in all cases, the text of such Fundamental Change Notice will be prepared by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) <I>Procedures to
Exercise the Fundamental Change Repurchase Right</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Delivery of Fundamental Change Repurchase Notice and Notes to
Be Repurchased</I>. To exercise its Fundamental Change Repurchase Right for a Note following a Fundamental Change, the Holder thereof must deliver to the Paying Agent: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) before the Close of Business on the Business Day immediately before the related Fundamental Change Repurchase Date (or such
later time as may be required by law), a duly completed, written Fundamental Change Repurchase Notice with respect to such Note; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) such Note, duly endorsed for transfer (if such Note is a Physical Note) or by book-entry transfer (if such Note is a Global
Note). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Paying Agent will promptly deliver to the Company a copy of each Fundamental Change Repurchase Notice that it receives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Contents of Fundamental Change Repurchase Notices</I>. Each Fundamental Change Repurchase Notice with respect to a Note
must state: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if such Note is a Physical Note, the certificate number of such Note; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the principal amount of such Note to be repurchased, which must be an Authorized Denomination; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) that such Holder is exercising its Fundamental Change Repurchase Right with respect to such principal amount of such Note;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if such Note is a Global Note, then such Fundamental Change Repurchase Notice must comply with the
Depositary Procedures (and any such Fundamental Change Repurchase Notice delivered in compliance with the Depositary Procedures will be deemed to satisfy the requirements of this <B>Section</B><B></B><B>&nbsp;4.02(F)</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 34 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <I>Withdrawal of Fundamental Change Repurchase Notice</I>. A Holder
that has delivered a Fundamental Change Repurchase Notice with respect to a Note may withdraw such Fundamental Change Repurchase Notice by delivering a written notice of withdrawal to the Paying Agent at any time before the Close of Business on the
Business Day immediately before the related Fundamental Change Repurchase Date. Such withdrawal notice must state: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if
such Note is a Physical Note, the certificate number of such Note; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the principal amount of such Note to be withdrawn,
which must be an Authorized Denomination; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the principal amount of such Note, if any, that remains subject to such
Fundamental Change Repurchase Notice, which must be an Authorized Denomination; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if such Note is a
Global Note, then such withdrawal notice must comply with the Depositary Procedures (and any such withdrawal notice delivered in compliance with the Depositary Procedures will be deemed to satisfy the requirements of this
<B>Section</B><B></B><B>&nbsp;4.02(F)</B>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon receipt of any such withdrawal notice with respect to a Note (or any portion thereof),
the Paying Agent will (x)&nbsp;promptly deliver a copy of such withdrawal notice to the Company; and (y)&nbsp;if such Note is surrendered to the Paying Agent, cause such Note (or such portion thereof in accordance with
<B>Section</B><B></B><B>&nbsp;2.11</B>, treating such Note as having been then surrendered for partial repurchase in the amount set forth in such withdrawal notice as remaining subject to repurchase) to be returned to the Holder thereof (or, if
applicable with respect to any Global Note, cancel any instructions for book-entry transfer to the Company, the Trustee or the Paying Agent of the applicable beneficial interest in such Note in accordance with the Depositary Procedures). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) <I>Payment of the Fundamental Change Repurchase Price</I>. Without limiting the Company&#8217;s obligation to deposit the Fundamental
Change Repurchase Price within the time prescribed by <B>Section</B><B></B><B>&nbsp;3.01(B)</B>, the Company will cause the Fundamental Change Repurchase Price for a Note (or portion thereof) to be repurchased pursuant to a Repurchase Upon
Fundamental Change to be paid to the Holder thereof on or before the later of (i)&nbsp;the applicable Fundamental Change Repurchase Date; and (ii)&nbsp;the date (x)&nbsp;such Note is delivered to the Paying Agent (in the case of a Physical Note) or
(y)&nbsp;the Depositary Procedures relating to the repurchase, and the delivery to the Paying Agent, of such Holder&#8217;s beneficial interest in such Note to be repurchased are complied with (in the case of a Global Note). For the avoidance of
doubt, interest payable pursuant to the proviso to <B>Section</B><B></B><B>&nbsp;4.02(D)</B> on any Note to be repurchased pursuant to a Repurchase Upon Fundamental Change must be paid pursuant to such proviso regardless of whether such Note is
delivered or such Depositary Procedures are complied with pursuant to the first sentence of this <B>Section</B><B></B><B>&nbsp;4.02(G)</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 35 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) <I>Third Party May Conduct Repurchase Offer In Lieu of the Company</I>. Notwithstanding
anything to the contrary in this <B>Section</B><B></B><B>&nbsp;4.02</B>, the Company will be deemed to satisfy its obligations under this <B>Section</B><B></B><B>&nbsp;4.02</B> if (i)&nbsp;one or more third parties conduct any Repurchase Upon
Fundamental Change and related offer to repurchase Notes otherwise required by this <B>Section</B><B></B><B>&nbsp;4.02</B> in a manner that would have satisfied the requirements of this <B>Section</B><B></B><B>&nbsp;4.02</B> if conducted directly by
the Company; and (ii)&nbsp;an owner of a beneficial interest in any Note repurchased by such third party or parties will not receive a lesser amount (as a result of taxes) than such owner would have received had the Company repurchased such Note.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) <I>No Requirement to Conduct an Offer to Repurchase Notes if the Fundamental Change Results in the Notes Becoming Convertible into an
Amount of Cash Exceeding the Fundamental Change Repurchase Price</I>. Notwithstanding anything to the contrary in this <B>Section</B><B></B><B>&nbsp;4.02</B>, the Company will not be required to send a Fundamental Change Notice pursuant to
<B>Section</B><B></B><B>&nbsp;4.02(E)</B>, or offer to repurchase or repurchase any Notes pursuant to this <B>Section</B><B></B><B>&nbsp;4.02</B>, in connection with a Fundamental Change occurring pursuant to <B>clause (B)(ii)</B> (or pursuant to
<B>clause (A)</B>&nbsp;that also constitutes a Fundamental Change occurring pursuant to <B>clause (B)(ii)</B>) of the definition thereof, if (i)&nbsp;such Fundamental Change constitutes a Common Stock Change Event whose Reference Property consists
entirely of cash in U.S. dollars; (ii)&nbsp;immediately after such Fundamental Change, the Notes become convertible, pursuant to <B>Section</B><B></B><B>&nbsp;5.09(A)</B> and, if applicable, <B>Section</B><B></B><B>&nbsp;5.07</B>, into consideration
that consists solely of U.S. dollars in an amount per $1,000 aggregate principal amount of Notes that equals or exceeds the Fundamental Change Repurchase Price per $1,000 aggregate principal amount of Notes (which Fundamental Change Repurchase Price
will, if any Special Interest or Additional Interest is accruing on the Notes as of the effective date of such Fundamental Change, be calculated (x)&nbsp;assuming that such Fundamental Change Repurchase Price includes accrued and unpaid Special
Interest or Additional Interest, as applicable, to, but excluding, the latest possible Fundamental Change Repurchase Date for such Fundamental Change and (y)&nbsp;without regard to the proviso in the first sentence of
<B>Section</B><B></B><B>&nbsp;4.02(D)</B>); and (iii)&nbsp;the Company timely sends the notice relating to such Fundamental Change required pursuant to <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(3)(b)</B> and includes, in such notice, a statement that
the Company is relying on this <B>Section</B><B></B><B>&nbsp;4.02(I)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) <I>Compliance with Applicable Securities Laws</I>. To the
extent applicable, the Company will comply, in all material respects, with all federal and state securities laws in connection with a Repurchase Upon Fundamental Change (including complying with Rules <FONT STYLE="white-space:nowrap">13e-4</FONT>
and <FONT STYLE="white-space:nowrap">14e-1</FONT> under the Exchange Act and filing any required Schedule TO, to the extent applicable) so as to permit effecting such Repurchase Upon Fundamental Change in the manner set forth in this Indenture;
<I>provided</I>, <I>however</I>, that, to the extent that the Company&#8217;s obligations pursuant to this <B>Section</B><B></B><B>&nbsp;4.02</B> conflict with any law or regulation that is applicable to the Company and enacted after the Issue Date,
the Company&#8217;s compliance with such law or regulation will not be considered to be a Default of such obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) <I>Repurchase
in Part</I>. Subject to the terms of this <B>Section</B><B></B><B>&nbsp;4.02</B>, Notes may be repurchased pursuant to a Repurchase Upon Fundamental Change in part, but only in Authorized Denominations. Provisions of this
<B>Section</B><B></B><B>&nbsp;4.02</B> applying to the repurchase of a Note in whole will equally apply to the repurchase of a permitted portion of a Note. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 36 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;4.03. R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>
<SMALL>TO</SMALL> R<SMALL>EDEEM</SMALL> <SMALL>THE</SMALL> N<SMALL>OTES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>No Right to Redeem Before
November</I><I></I><I>&nbsp;20, 2029</I>. The Company may not redeem the Notes at its option at any time before November&nbsp;20, 2029. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Right to Redeem the Notes on or After</I> <I>November</I><I></I><I>&nbsp;20, 2029</I>. Subject to the terms of this
<B>Section</B><B></B><B>&nbsp;4.03</B> (including, for the avoidance of doubt, <B>Section</B><B></B><B>&nbsp;4.03(J)</B>), the Company has the right, at its election, to redeem all, or any portion (subject to the Partial Redemption Limitation) in an
Authorized Denomination, of the Notes, at any time, and from time to time, on a Redemption Date on or after November&nbsp;20, 2029 and on or before the twenty fifth (25th) Scheduled Trading Day immediately before the Maturity Date, for a cash
purchase price equal to the Redemption Price, but only if the Last Reported Sale Price per share of Common Stock exceeds one hundred and thirty percent (130%) of the Conversion Price on (i)&nbsp;each of at least twenty (20)&nbsp;Trading Days
(whether or not consecutive) during the thirty (30)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before the Redemption Notice Date for such Redemption; and (ii)&nbsp;the Trading Day immediately before such
Redemption Notice Date. For the avoidance of doubt, the calling of any Notes for Redemption will constitute a Make-Whole Fundamental Change with respect to such Notes pursuant to <B>clause (B)</B>&nbsp;of the definition thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Redemption Prohibited in Certain Circumstances</I>. If the principal amount of the Notes has been accelerated and such acceleration has
not been rescinded on or before the Redemption Date (except as a result of a failure to make the payment of the related Redemption Price, and any related interest pursuant to the proviso to <B>Section</B><B></B><B>&nbsp;4.03(E)</B>, on such
Redemption Date), then (i)&nbsp;the Company may not call for Redemption or otherwise redeem any Notes pursuant to this <B>Section</B><B></B><B>&nbsp;4.03</B>; and (ii)&nbsp;the Company will cause any Notes theretofore surrendered for such Redemption
to be returned to the Holders thereof (or, if applicable with respect to Global Notes, cancel any instructions for book-entry transfer to the Company, the Trustee or the Paying Agent of the applicable beneficial interests in such Notes in accordance
with the Depositary Procedures). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Redemption Date</I>. The Redemption Date for any Redemption will be a Business Day of the
Company&#8217;s choosing that is no more than fifty (50), nor less than<I> </I>thirty (30), Scheduled Trading Days after the Redemption Notice Date for such Redemption; <I>provided</I>, <I>however</I>, that if, in accordance with
<B>Section</B><B></B><B>&nbsp;5.03(A)(i)(3)</B>, the Company is then otherwise permitted to settle conversions of Notes by Physical Settlement (and, for the avoidance of doubt, has not irrevocably elected another Settlement Method), and has elected
to settle all conversions of Notes with a Conversion Date that occurs on or after such Redemption Notice Date and on or before the second (2nd) Business Day immediately before the Redemption Date by Physical Settlement, then the Company may instead
elect to choose a Redemption Date that is a Business Day no more than sixty (60), nor less than thirty (30), calendar days after such Redemption Notice Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Redemption Price</I>. The Redemption Price for any Note called for Redemption is an amount in cash equal to the principal amount of
such Note plus accrued and unpaid interest on such Note to, but excluding, the Redemption Date for such Redemption; <I>provided</I>, <I>however</I>, that if any Special Interest or Additional Interest is payable on an Interest Payment Date and such
Redemption Date is after the related Interest Record Date and on or before such Interest Payment Date, then (i)&nbsp;the Holder of such Note at the Close of Business on such Interest Record Date will be entitled, notwithstanding such Redemption, to
receive, on or, at the Company&#8217;s election, before </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 37 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Interest Payment Date, the unpaid interest that would have accrued on such Note to, but excluding, such Interest Payment Date (assuming, solely for these purposes, that such Note remained
outstanding through such Interest Payment Date, if such Redemption Date is before such Interest Payment Date); and (ii)&nbsp;the Redemption Price will not include accrued and unpaid Special Interest or Additional Interest on such Note to, but
excluding, such Redemption Date. For the avoidance of doubt, if such Interest Payment Date is not a Business Day within the meaning of <B>Section</B><B></B><B>&nbsp;2.05(C)</B> and such Redemption Date occurs on the Business Day immediately after
such Interest Payment Date, then (x)&nbsp;such accrued and unpaid Special Interest or Additional Interest, as applicable, to, but excluding, such Interest Payment Date will be paid, in accordance with <B>Section</B><B></B><B>&nbsp;2.05(C)</B>, on
the next Business Day to Holders as of the Close of Business on the immediately preceding Interest Record Date; and (y)&nbsp;the Redemption Price will include Special Interest and Additional Interest, if any, on the Notes to be redeemed from, and
including, such Interest Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) <I>Redemption Notice</I>. To call any Notes for Redemption, the Company must send to each
Holder of such Notes, the Trustee, the Conversion Agent (if other than the Trustee) and the Paying Agent (if other than the Trustee) a written notice of such Redemption (a &#8220;<B>Redemption Notice</B>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such Redemption Notice must state: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) that such Notes have been called for Redemption, briefly describing the Company&#8217;s Redemption right under this
Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Redemption Date for such Redemption; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Redemption Price per $1,000 principal amount of Notes for such Redemption (and, if any Special Interest or Additional
Interest is payable on an Interest Payment Date and the Redemption Date is after the related Interest Record Date and on or before such Interest Payment Date, the amount, manner and timing of the interest payment payable pursuant to the proviso to
<B>Section</B><B></B><B>&nbsp;4.03(E)</B>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the name and address of the Paying Agent and the Conversion Agent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) that Notes called for Redemption may be converted at any time before the Close of Business on the second (2nd) Business Day
immediately before the Redemption Date (or, if the Company fails to pay the Redemption Price due on such Redemption Date in full, at any time until such time as the Company pays such Redemption Price in full); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the Conversion Rate in effect on the Redemption Notice Date for such Redemption and a description and quantification of
any adjustments to the Conversion Rate that may result from such Redemption (including pursuant to <B>Section</B><B></B><B>&nbsp;5.07</B>); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) the Settlement Method that will apply to all conversions of Notes with a Conversion Date that occurs on or after such
Redemption Notice Date and on or before the second (2nd) Business Day before such Redemption Date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) the CUSIP
and ISIN numbers, if any, of the Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 38 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or before the Redemption Notice Date, the Company will send a copy of such Redemption
Notice to the Trustee, the Conversion Agent (if other than the Trustee) and the Paying Agent (if other than the Trustee). At the Company&#8217;s written request given at least two (2)&nbsp;Business Days before such notice is to be sent to Holders
(or such shorter period as will be acceptable to the Trustee), the Trustee will give such notice in the Company&#8217;s name and at the Company&#8217;s expense; <I>provided</I>, <I>however</I>, that, in all cases, the text of such Redemption Notice
will be prepared by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) <I>Selection and Conversion of Notes to Be Redeemed in Part</I>. If less than all Notes then
outstanding are called for Redemption, then: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Notes to be redeemed will be selected as follows: (1)&nbsp;in the
case of Global Notes, in accordance with the Depositary Procedures; and (2)&nbsp;in the case of Physical Notes, pro rata, by lot or by such other method the Trustee considers fair and appropriate; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) if only a portion of a Note is subject to Redemption and such Note is converted in part, then the converted portion of
such Note will be deemed to be from the portion of such Note that was subject to Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) <I>Payment of the Redemption Price</I>.
Without limiting the Company&#8217;s obligation to deposit the Redemption Price by the time prescribed by <B>Section</B><B></B><B>&nbsp;3.01(B)</B>, the Company will cause the Redemption Price for a Note (or portion thereof) subject to Redemption to
be paid to the Holder thereof on or before the applicable Redemption Date. For the avoidance of doubt, interest payable pursuant to the proviso to <B>Section</B><B></B><B>&nbsp;4.03(E)</B> on any Note (or portion thereof) subject to Redemption must
be paid pursuant to such proviso. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) <I>Special Provisions for Partial Calls</I>. If the Company elects to redeem less than all of the
outstanding Notes pursuant to this <B>Section</B><B></B><B>&nbsp;4.03</B>, and the Holder of any Note, or any owner of a beneficial interest in any Global Note, is reasonably not able to determine, before the Close of Business on the twenty seventh
(27th) Scheduled Trading Day (or, if, in accordance with <B>Section</B><B></B><B>&nbsp;5.03(A)(i)(3)</B>, the Company has elected to settle all conversions of Notes with a Conversion Date that occurs on or after the Redemption Notice Date for such
Redemption and on or before the second (2nd) Business Day immediately before the Redemption Date by Physical Settlement, the tenth (10th) calendar day) immediately before the Redemption Date for such Redemption, whether such Note or beneficial
interest, as applicable, is to be redeemed pursuant to such Redemption, then such Holder or owner, as applicable, will be entitled to convert such Note or beneficial interest, as applicable, at any time before the Close of Business on the second
(2nd) Business Day immediately before such Redemption Date, and each such conversion will be deemed to be of a Note called for Redemption for purposes of this <B>Section</B><B></B><B>&nbsp;4.03</B> and <B>Sections</B> <B>5.01(C)(i)(4)</B> and
<B>5.07</B>. The Trustee will have no obligation to make any determination in connection with the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) <I>Partial Redemption
Limitation</I>. If the Company elects to redeem less than all of the outstanding Notes pursuant to this <B>Section</B><B></B><B>&nbsp;4.03</B>, then the excess of the principal amount of Notes outstanding as of the time the Company sends the related
Redemption Notice over the aggregate principal amount of Notes set forth in such Redemption Notice as being subject to Redemption must be at least seventy-five million dollars ($75,000,000) (such requirement, the &#8220;<B>Partial Redemption
Limitation</B>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 39 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 5. CONVERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.01. R<SMALL>IGHT</SMALL> <SMALL>TO</SMALL> C<SMALL>ONVERT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. Subject to the provisions of this <B>Article 5</B>, each Holder may, at its option, convert such Holder&#8217;s Notes
into Conversion Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Conversions in Part</I>. Subject to the terms of this Indenture, Notes may be converted in part,
but only in Authorized Denominations. Provisions of this <B>Article 5</B> applying to the conversion of a Note in whole will equally apply to conversions of a permitted portion of a Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>When Notes May Be Converted</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Generally</I>. Subject to <B>Section</B><B></B><B>&nbsp;5.01(C)(ii)</B>, a Note may be converted only in the following
circumstances: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) <I>Conversion upon Satisfaction of Common Stock Sale Price Condition</I>. A Holder may convert its
Notes during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March&nbsp;31, 2026, if the Last Reported Sale Price per share of Common Stock exceeds one hundred and thirty percent (130%) of
the Conversion Price for each of at least twenty (20)&nbsp;Trading Days (whether or not consecutive) during the thirty (30)&nbsp;consecutive Trading Days ending on, and including, the last Trading Day of the immediately preceding calendar quarter.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) <I>Conversion upon Satisfaction of Note Trading Price Condition</I>. A Holder may convert its Notes during the five
(5)&nbsp;consecutive Business Days immediately after any ten (10)&nbsp;consecutive Trading Day period (such ten (10)&nbsp;consecutive Trading Day period, the &#8220;<B>Measurement Period</B>&#8221;) if the Trading Price per $1,000 principal amount
of Notes, as determined following a request by a Holder in accordance with the procedures set forth below, for each Trading Day of the Measurement Period was less than ninety eight percent (98%) of the product of the Last Reported Sale Price per
share of Common Stock on such Trading Day and the Conversion Rate on such Trading Day. The condition set forth in the preceding sentence is referred to in this Indenture as the &#8220;<B>Trading Price Condition</B>.&#8221; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Trading Price will be determined by the Bid Solicitation Agent pursuant to this <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(2)</B> and the
definition of &#8220;Trading Price.&#8221; The Bid Solicitation Agent (if not the Company) will have no obligation to determine the Trading Price of the Notes unless the Company has requested such determination in writing, and the Company will have
no obligation to make such request (or seek bids itself) unless a Holder holding not less than two million dollars ($2,000,000)&nbsp;in aggregate principal amount of Notes (or such lesser principal amount as may be then outstanding) provides the
Company with reasonable evidence that the Trading Price per $1,000 principal amount of Notes would be less than ninety eight percent (98%) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 40 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
of the product of the Last Reported Sale Price per share of Common Stock and the Conversion Rate. If a Holder provides such evidence, then the Company will (if acting as Bid Solicitation Agent),
or will instruct the Bid Solicitation Agent to, determine the Trading Price of the Notes beginning on the next Trading Day and on each successive Trading Day until the Trading Price per $1,000 principal amount of Notes is greater than or equal to
ninety eight percent (98%) of the product of the Last Reported Sale Price per share of Common Stock on such Trading Day and the Conversion Rate on such Trading Day. If the Trading Price Condition has been met as set forth above, then the Company
will notify the Holders, the Trustee and the Conversion Agent (if other than the Trustee) of the same. If, on any Trading Day after the Trading Price Condition has been met as set forth above, the Trading Price per $1,000 principal amount of Notes
is greater than or equal to ninety eight percent (98%) of the product of the Last Reported Sale Price per share of Common Stock on such Trading Day and the Conversion Rate on such Trading Day, then the Company will notify the Holders, the Trustee
and the Conversion Agent (if other than the Trustee) of the same. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) <I>Conversion upon Specified Corporate Events</I>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Certain Distributions</I>. If, before February&nbsp;15, 2033, the Company elects to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) distribute, to all or substantially all holders of Common Stock, any rights, options or warrants (other than rights issued
pursuant to a stockholder rights plan, so long as such rights have not separated from the Common Stock and are not exercisable until the occurrence of a triggering event, except that such rights will be deemed to be distributed under this <B>clause
(I)</B>&nbsp;upon their separation from the Common Stock or upon the occurrence of such triggering event) entitling them, for a period of not more than sixty (60)&nbsp;calendar days after the record date of such distribution, to subscribe for or
purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten (10)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before
the date such distribution is announced (determined in the manner set forth in the third paragraph of <B>Section</B><B></B><B>&nbsp;5.05(A)(ii)</B>); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(II) distribute, to all or substantially all holders of Common Stock, assets or securities of the Company or rights to
purchase the Company&#8217;s securities, which distribution per share of Common Stock has a value, as reasonably determined by the Board of Directors, exceeding ten percent (10%) of the Last Reported Sale Price per share of Common Stock on the
Trading Day immediately before the date such distribution is announced, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 41 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">then, in either case, (x)&nbsp;the Company will send notice of such distribution, and of
the related right to convert Notes, to Holders, the Trustee and the Conversion Agent (if other than the Trustee) at least thirty (30)&nbsp;Scheduled Trading Days before the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such
distribution (or, if later in the case of any such separation of rights issued pursuant to a stockholder rights plan or the occurrence of any such triggering event under a stockholder rights plan, as soon as reasonably practicable after the Company
becomes aware that such separation or triggering event has occurred or will occur); and (y)&nbsp;once the Company has sent such notice, Holders may convert their Notes at any time until the earlier of the Close of Business on the Business Day
immediately before such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and the Company&#8217;s announcement that such distribution will not take place; <I>provided</I>, <I>however</I>, that the Notes will not become convertible pursuant to
clause (y)&nbsp;above (but the Company will be required to send notice of such distribution pursuant to clause (x)&nbsp;above) on account of such distribution if each Holder participates, at the same time and on the same terms as holders of Common
Stock, and solely by virtue of being a Holder, in such distribution without having to convert such Holder&#8217;s Notes and as if such Holder held a number of shares of Common Stock equal to the product of (i)&nbsp;the Conversion Rate in effect on
the record date for such distribution; and (ii)&nbsp;the aggregate principal amount (expressed in thousands) of Notes held by such Holder on such record date; <I>provided</I>, <I>further</I>, that if the Company is then otherwise permitted to settle
conversions of Notes by Physical Settlement (and, for the avoidance of doubt, the Company has not elected (or been deemed to have elected) another Settlement Method to apply, including pursuant to <B>Section</B><B></B><B>&nbsp;5.03(A)(i)(1)</B>),
then the Company may instead elect to provide such notice at least ten (10)&nbsp;Scheduled Trading Days before such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, in which case (x)&nbsp;the Company must settle all conversions of Notes
with a Conversion Date occurring on or after the date the Company provides such notice and on or before the Business Day immediately before the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution (or any earlier
announcement by the Company that such distribution will not take place) by Physical Settlement; and (y)&nbsp;such notice must state that all such conversions will be settled by Physical Settlement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Certain Corporate Events</I>. If a Fundamental Change, Make-Whole Fundamental Change (other than a Make-Whole
Fundamental Change pursuant to <B>clause (B)</B>&nbsp;of the definition thereof) or Common Stock Change Event occurs (other than a merger or other business combination transaction that is effected solely to change the Company&#8217;s jurisdiction of
incorporation and that does not constitute a Fundamental Change or a Make-Whole Fundamental Change), then, in each case, Holders may convert their Notes at any time from, and including, the effective date of such transaction or event to, and
including, the thirty fifth (35th) Trading Day after such effective date (or, if such transaction or event also constitutes a Fundamental Change (other than an Exempted Fundamental Change), to, but excluding, the related Fundamental Change
Repurchase Date); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 42 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">
<I>provided</I>, <I>however</I>, that if the Company does not provide the notice referred to in the immediately following sentence by the Business Day after such effective date, then the last day
on which the Notes are convertible pursuant to this sentence will be extended by the number of Business Days from, and including, the Business Day after such effective date to, but excluding, the date the Company provides such notice. No later than
the Business Day after such effective date, the Company will send notice to the Holders, the Trustee and the Conversion Agent (if other than the Trustee) of such transaction or event, such effective date and the related right to convert Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) <I>Conversion upon Redemption</I>. If the Company calls any Note for Redemption, then the Holder of such Note may convert
such Note at any time before the Close of Business on the second (2nd) Business Day immediately before the related Redemption Date (or, if the Company fails to pay the Redemption Price due on such Redemption Date in full, at any time until such time
as the Company pays such Redemption Price in full). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) <I>Conversions During Free Convertibility Period</I>. A Holder may
convert its Notes at any time from, and including, February&nbsp;15, 2033 until the Close of Business on the second (2nd) Scheduled Trading Day immediately before the Maturity Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the Notes may become convertible pursuant to any one or more of the preceding
<FONT STYLE="white-space:nowrap">sub-paragraphs</FONT> of this <B>Section</B><B></B><B>&nbsp;5.01(C)(i)</B> and the Notes ceasing to be convertible pursuant to a particular <FONT STYLE="white-space:nowrap">sub-paragraph</FONT> of this
<B>Section</B><B></B><B>&nbsp;5.01(C)(i)</B> will not preclude the Notes from being convertible pursuant to any other <FONT STYLE="white-space:nowrap">sub-paragraph</FONT> of this <B>Section</B><B></B><B>&nbsp;5.01(C)(i)</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Limitations and Closed Periods</I>. Notwithstanding anything to the contrary in this Indenture or the Notes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Notes may be surrendered for conversion only after the Open of Business and before the Close of Business on a day that is a
Business Day; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in no event may any Note be converted after the Close of Business on the second (2nd) Scheduled Trading
Day immediately before the Maturity Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if the Company calls any Note for Redemption pursuant to
<B>Section</B><B></B><B>&nbsp;4.03</B>, then the Holder of such Note may not convert such Note after the Close of Business on the second (2nd) Business Day immediately before the applicable Redemption Date, except to the extent the Company fails to
pay the Redemption Price for such Note in accordance with this Indenture; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 43 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) if a Fundamental Change Repurchase Notice is validly delivered pursuant
to <B>Section</B><B></B><B>&nbsp;4.02(F)</B> with respect to any Note, then such Note may not be converted, except to the extent (a)&nbsp;such Note is not subject to such notice; (b)&nbsp;such notice is withdrawn in accordance with
<B>Section</B><B></B><B>&nbsp;4.02(F)</B>; or (c)&nbsp;the Company fails to pay the Fundamental Change Repurchase Price for such Note in accordance with this Indenture when required (or, if applicable, a third party fails to make such payment in
lieu of the Company in accordance with <B>Section</B><B></B><B>&nbsp;4.02(H)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.02. C<SMALL>ONVERSION</SMALL>
P<SMALL>ROCEDURES</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Global Notes</I>. To convert a beneficial interest in a Global Note that is convertible pursuant to
<B>Section</B><B></B><B>&nbsp;5.01(C)</B>, the owner of such beneficial interest must (1)&nbsp;comply with the Depositary Procedures for converting such beneficial interest (at which time such conversion will become irrevocable); and (2)&nbsp;pay
any amounts due pursuant to <B>Section</B><B></B><B>&nbsp;5.02(D)</B> or <B>Section</B><B></B><B>&nbsp;5.02(E)</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
<I>Physical Notes</I>. To convert all or a portion of a Physical Note that is convertible pursuant to <B>Section</B><B></B><B>&nbsp;5.01(C)</B>, the Holder of such Note must (1)&nbsp;complete, manually sign and deliver to the Conversion Agent the
conversion notice attached to such Physical Note or a facsimile of such conversion notice; (2)&nbsp;deliver such Physical Note to the Conversion Agent (at which time such conversion will become irrevocable); (3) furnish any endorsements and transfer
documents that the Company or the Conversion Agent may require; and (4)&nbsp;pay any amounts due pursuant to <B>Section</B><B></B><B>&nbsp;5.02(D)</B> or <B>Section</B><B></B><B>&nbsp;5.02(E)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Effect of Converting a Note</I>. At the Close of Business on the Conversion Date for a Note (or any portion thereof) to be converted,
such Note (or such portion) will (unless there occurs a Default in the delivery of the Conversion Consideration or interest, if any, due, pursuant to <B>Section</B><B>&nbsp;5.03(B)</B> or <B>5.02(D)</B>, upon such conversion) be deemed to cease to
be outstanding (and, for the avoidance of doubt, no Person will be deemed to be a Holder of such Note (or such portion thereof) as of the Close of Business on such Conversion Date), except to the extent provided in
<B>Section</B><B></B><B>&nbsp;5.02(D)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Holder of Record of Conversion Shares</I>. The Person in whose name any share of Common
Stock is issuable upon conversion of any Note will be deemed to become the holder of record of such share as of the Close of Business on (i)&nbsp;the Conversion Date for such conversion, in the case of Physical Settlement; or (ii)&nbsp;the last VWAP
Trading Day of the Observation Period for such conversion, in the case of Combination Settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Interest Payable upon Conversion
in Certain Circumstances</I>. If any Special Interest or Additional Interest is payable on an Interest Payment Date and the Conversion Date of a Note is after the related Interest Record Date and before such Interest Payment Date, then (i)&nbsp;the
Holder of such Note at the Close of Business on such Interest Record Date will be entitled, notwithstanding such conversion (and, for the avoidance of doubt, notwithstanding anything set forth in the proviso to this sentence), to receive, on or, at
the Company&#8217;s election, before such Interest Payment Date, the unpaid Special Interest or Additional Interest, as applicable, that would have been paid on such Note on such Interest Payment Date (assuming, solely for these purposes, that such
Note remained outstanding through such Interest Payment Date); and (ii)&nbsp;the Holder surrendering such Note for conversion must deliver to the Conversion Agent, at the time of such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 44 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
surrender, an amount of cash equal to the amount of such interest referred to in clause (i)&nbsp;above; <I>provided</I>, <I>however</I>, that the Holder surrendering such Note for conversion need
not deliver such cash (I)&nbsp;with respect to any Note called for Redemption, if the Company has specified a Redemption Date that is after such Interest Record Date and on or before the second (2nd) Business Day immediately after such Interest
Payment Date; (II)&nbsp;if such Conversion Date occurs after the Interest Record Date immediately before the Maturity Date; (III)&nbsp;if the Company has specified a Fundamental Change Repurchase Date that is after such Interest Record Date and on
or before the Business Day immediately after such Interest Payment Date; or (IV)&nbsp;to the extent of any (x)&nbsp;overdue Special Interest or Additional Interest or (y)&nbsp;interest that has accrued on any overdue interest. For the avoidance of
doubt, as a result of, and without limiting the generality of, the foregoing, if a Note is converted with a Conversion Date that is after the Interest Record Date immediately before the Maturity Date, then the Company will pay, as provided above,
Special Interest and Additional Interest, if any, that would have been due on such Note on the Maturity Date had such Note not been converted. For the avoidance of doubt, if the Conversion Date of a Note to be converted is on an Interest Payment
Date on which any Special Interest or Additional Interest is payable, then the Holder of such Note at the Close of Business on the Interest Record Date immediately before such Interest Payment Date will be entitled to receive, on such Interest
Payment Date, such Special Interest or Additional Interest, as applicable, and such Note, when surrendered for conversion, need not be accompanied by any cash amount pursuant to the first sentence of this <B>Section</B><B></B><B>&nbsp;5.02(D)</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Taxes and Duties</I>. If a Holder converts a Note, the Company will pay any documentary, stamp or similar issue or transfer tax or
duty due on the issue or delivery of any shares of Common Stock upon such conversion; <I>provided</I>, <I>however</I>, that if any tax or duty is due because such Holder requested such shares to be registered in a name other than such Holder&#8217;s
name, then such Holder will pay such tax or duty and, until having received a sum sufficient to pay such tax or duty, the Conversion Agent may refuse to deliver any such shares to be issued in a name other than that of such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) <I>Conversion Agent to Notify Company of Conversions</I>. If any Note is submitted for conversion to the Conversion Agent or the
Conversion Agent receives any notice of conversion with respect to a Note, then the Conversion Agent will promptly (and, in any event, no later than the Business Day following the date the Conversion Agent receives such Note or notice) notify the
Company and the Trustee of such occurrence, together with any other information reasonably requested by the Company, and will cooperate with the Company to determine the Conversion Date for such Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.03. S<SMALL>ETTLEMENT</SMALL> <SMALL>UPON</SMALL> C<SMALL>ONVERSION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Settlement Method</I>. Upon the conversion of any Note, the Company will settle such conversion by paying or delivering, as applicable
and as provided in this <B>Article 5</B>, either (x)&nbsp;shares of Common Stock, together, if applicable, with cash in lieu of fractional shares as provided in <B>Section</B><B></B><B>&nbsp;5.03(B)(i)(1)</B> (a &#8220;<B>Physical
Settlement</B>&#8221;); (y) solely cash as provided in <B>Section</B><B></B><B>&nbsp;5.03(B)(i)(2)</B> (a &#8220;<B>Cash Settlement</B>&#8221;); or (z)&nbsp;a combination of cash and shares of Common Stock, together, if applicable, with cash in lieu
of fractional shares as provided in <B>Section</B><B></B><B>&nbsp;5.03(B)(i)(3)</B> (a &#8220;<B>Combination Settlement</B>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 45 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>The Company&#8217;s Right to Elect Settlement Method</I>. The Company
will have the right to elect the Settlement Method applicable to any conversion of a Note; <I>provided</I>, <I>however</I>, that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) subject to <B>clause (3)</B>&nbsp;below, all conversions of Notes with a Conversion Date that occurs on or after
February&nbsp;15, 2033 will be settled using the same Settlement Method, and the Company will send notice of such Settlement Method to Holders, the Trustee and the Conversion Agent (if other than the Trustee) no later than the Open of Business on
February&nbsp;15, 2033; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) subject to <B>clause (3)</B>&nbsp;below, if the Company elects a Settlement Method with
respect to the conversion of any Note whose Conversion Date occurs before February&nbsp;15, 2033, then the Company will send notice of such Settlement Method to the Holder of such Note, the Trustee and the Conversion Agent (if other than the
Trustee) no later than the Close of Business on the Business Day immediately after such Conversion Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) if any Notes
are called for Redemption, then (a)&nbsp;the Company will specify, in the related Redemption Notice (and, in the case of a Redemption of less than all outstanding Notes, in a notice simultaneously sent to all Holders of Notes not called for
Redemption) sent pursuant to <B>Section</B><B></B><B>&nbsp;4.03(F)</B>, the Settlement Method that will apply to all conversions of Notes called (or deemed called) for Redemption, and not with respect to the Notes not called (or deemed called) for
Redemption, with a Conversion Date that occurs on or after the related Redemption Notice Date and on or before the second (2nd) Business Day before the related Redemption Date; and (b)&nbsp;if such Redemption Date occurs on or after
February&nbsp;15, 2033, then such Settlement Method must be the same Settlement Method that, pursuant to <B>clause (1)</B>&nbsp;above, applies to all conversions of Notes with a Conversion Date that occurs on or after February&nbsp;15, 2033; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the Company will use the same Settlement Method for all conversions of Notes with the same Conversion Date (and, for the
avoidance of doubt, the Company will not be obligated to use the same Settlement Method with respect to conversions of Notes with different Conversion Dates, except as provided in <B>clause (1)</B>&nbsp;or <B>(3)</B> above); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) if the Company does not timely elect a Settlement Method with respect to the conversion of a Note, then the Company will be
deemed to have elected the Default Settlement Method (and, for the avoidance of doubt, the failure to timely make such election will not constitute a Default or Event of Default); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) if the Company timely elects Combination Settlement with respect to the conversion of a Note but does not timely notify the
Holder of such Note (with a copy to the Trustee and the Conversion Agent (if other than the Trustee)) of the applicable Specified Dollar Amount, then the Specified Dollar Amount for such conversion will be deemed to be $1,000 per $1,000 principal
amount of Notes (and, for the avoidance of doubt, the failure to timely send such notification will not constitute a Default or Event of Default); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 46 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) the Settlement Method will be subject to <B>Sections</B> <B>4.03(D)</B>,
<B>5.09(A)(2)</B> and <B>5.01(C)(i)(3)(a)</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>The Company</I><I>&#8217;</I><I>s Right to Irrevocably Fix the
Settlement Method</I>. The Company will have the right, exercisable at its election by sending notice of such exercise to the Holders (with a copy to the Trustee and the Conversion Agent (if other than the Trustee)), to (1)&nbsp;irrevocably fix the
Settlement Method that will apply to all conversions of Notes with a Conversion Date that occurs on or after the date such notice is sent to Holders; or (2)&nbsp;irrevocably elect Combination Settlement to apply to all conversions of Notes with a
Conversion Date that occurs on or after the date such notice is sent to Holders, and eliminate a Specified Dollar Amount or range of Specified Dollar Amounts that will apply to such conversions, <I>provided</I>, in each case, that (w)&nbsp;the
Settlement Method(s) so elected pursuant to <B>clause (1)</B>&nbsp;or <B>(2)</B> above must be a Settlement Method or Settlement Method(s), as applicable, that the Company is then permitted to elect (for the avoidance of doubt, including pursuant
to, and subject to, the other provisions of this <B>Section</B><B></B><B>&nbsp;5.03(A)</B>); (x) no such irrevocable election or Default Settlement Method change will affect any Settlement Method theretofore elected (or deemed to be elected) with
respect to any Note pursuant to this Indenture (including pursuant to <B>Section</B><B></B><B>&nbsp;8.01(G)</B> or this <B>Section</B><B></B><B>&nbsp;5.03(A)</B>); (y) upon any such irrevocable election pursuant to <B>clause (1)</B>&nbsp;above, the
Default Settlement Method will automatically be deemed to be set to the Settlement Method so fixed; and (z)&nbsp;upon any such irrevocable election pursuant to <B>clause (2)</B>&nbsp;above, the Company will, if needed, simultaneously change the
Default Settlement Method to Combination Settlement with a Specified Dollar Amount that is consistent with such irrevocable election. Such notice, if sent, must set forth the applicable Settlement Method and expressly state that the election is
irrevocable and applicable to all conversions of Notes with a Conversion Date that occurs on or after the date such notice is sent to Holders. For the avoidance of doubt, such an irrevocable election, if made, will be effective without the need to
amend this Indenture or the Notes, including pursuant to <B>Section</B><B></B><B>&nbsp;8.01(G)</B> (it being understood, however, that the Company may nonetheless choose to execute such an amendment at its option). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <I>Requirement to Publicly Disclose the Fixed or Default Settlement Method.</I> If the Company changes the Default
Settlement Method pursuant to <B>clause (x)</B>&nbsp;of the proviso to the definition of such term or irrevocably fixes the Settlement Method(s) pursuant <B>Section</B><B></B><B>&nbsp;5.03(A)(ii)</B>, then the Company will either post the Default
Settlement Method or fixed Settlement Method(s), as applicable, on its website or disclose the same in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (or any successor form) that is filed with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Conversion Consideration</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Generally</I>. Subject to <B>Section</B><B></B><B>&nbsp;5.03(B)(ii)</B>, <B>Section</B><B></B><B>&nbsp;5.03(B)(iii)
</B>and<B> Section</B><B></B><B>&nbsp;5.09(A)(2)</B>, the type and amount of consideration (the &#8220;<B>Conversion Consideration</B>&#8221;) due in respect of each $1,000 principal amount of a Note to be converted will be as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if Physical Settlement applies to such conversion, a number of shares of Common Stock equal to the Conversion Rate in
effect on the Conversion Date for such conversion; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 47 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if Cash Settlement applies to such conversion, cash in an amount equal
to the sum of the Daily Conversion Values for each VWAP Trading Day in the Observation Period for such conversion; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)
if Combination Settlement applies to such conversion, consideration consisting of (a)&nbsp;a number of shares of Common Stock equal to the sum of the Daily Share Amounts for each VWAP Trading Day in the Observation Period for such conversion; and
(b)&nbsp;an amount of cash equal to the sum of the Daily Cash Amounts for each VWAP Trading Day in such Observation Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Cash in Lieu of Fractional Shares</I>. If Physical Settlement or Combination Settlement applies to the conversion of
any Note and the number of shares of Common Stock deliverable pursuant to <B>Section</B><B></B><B>&nbsp;5.03(B)(i)</B> upon such conversion is not a whole number, then such number will be rounded down to the nearest whole number and the Company will
deliver, in addition to the other consideration due upon such conversion, cash in lieu of the related fractional share in an amount equal to the product of (1)&nbsp;such fraction and (2) (x) the Daily VWAP on the Conversion Date for such conversion
(or, if such Conversion Date is not a VWAP Trading Day, the immediately preceding VWAP Trading Day), in the case of Physical Settlement; or (y)&nbsp;the Daily VWAP on the last VWAP Trading Day of the Observation Period for such conversion, in the
case of Combination Settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <I>Conversion of Multiple Notes by a Single Holder</I>. If a Holder converts more
than one (1)&nbsp;Note on a single Conversion Date, then the Conversion Consideration due in respect of such conversion will (in the case of any Global Note, to the extent permitted by, and practicable under, the Depositary Procedures) be computed
based on the total principal amount of Notes converted on such Conversion Date by such Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <I>Notice of
Calculation of Conversion Consideration</I>. If Cash Settlement or Combination Settlement applies to the conversion of any Note, then the Company will determine the Conversion Consideration due thereupon promptly following the last VWAP Trading Day
of the applicable Observation Period and will promptly thereafter send notice to the Trustee and the Conversion Agent (if other than the Trustee) of the same and the calculation thereof in reasonable detail. Neither the Trustee nor the Conversion
Agent will have any duty to make any such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Delivery of the Conversion Consideration</I>. Except as set forth in
<B>Sections</B> <B>5.05(D)</B> and <B>5.09</B>, the Company will pay or deliver, as applicable, the Conversion Consideration due upon the conversion of any Note to the Holder as follows: (i)&nbsp;if Cash Settlement or Combination Settlement applies
to such conversion, on the second (2nd) Business Day immediately after the last VWAP Trading Day of the Observation Period for such conversion; and (ii)&nbsp;if Physical Settlement applies to such conversion, on the second (2nd) Business Day
immediately after the Conversion Date for such conversion; <I>provided</I>, <I>however</I>, that if Physical Settlement applies to the conversion of any Note with a Conversion Date that is after the Interest Record Date immediately before the
Maturity Date, then, solely for purposes of such conversion, (x)&nbsp;the Company will pay </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 48 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or deliver, as applicable, the Conversion Consideration due upon such conversion on the Maturity Date (or, if the Maturity Date is not a Business Day, the next Business Day); and (y)&nbsp;the
Conversion Date will instead be deemed to be the second (2nd) Scheduled Trading Day immediately before the Maturity Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Deemed
Payment of Principal and Interest; Settlement of Accrued Interest Notwithstanding Conversion</I>. If a Holder converts a Note, then the Company will not adjust the Conversion Rate to account for any accrued and unpaid interest on such Note, and,
except as provided in <B>Section</B><B></B><B>&nbsp;5.02(D)</B>, the Company&#8217;s delivery of the Conversion Consideration due in respect of such conversion will be deemed to fully satisfy and discharge the Company&#8217;s obligation to pay the
principal of, and accrued and unpaid interest, if any, on, such Note to, but excluding the Conversion Date. As a result, except as provided in <B>Section</B><B></B><B>&nbsp;5.02(D)</B>, any accrued and unpaid interest on a converted Note will be
deemed to be paid in full rather than cancelled, extinguished or forfeited. In addition, subject to <B>Section</B><B></B><B>&nbsp;5.02(D)</B>, if the Conversion Consideration for a Note consists of both cash and shares of Common Stock, then accrued
and unpaid interest that is deemed to be paid therewith will be deemed to be paid first out of such cash. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.04. R<SMALL>ESERVE</SMALL>
<SMALL>AND</SMALL> S<SMALL>TATUS</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> I<SMALL>SSUED</SMALL> <SMALL>UPON</SMALL> C<SMALL>ONVERSION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Stock Reserve</I>. At all times when any Notes are outstanding, the Company will reserve (out of its authorized and not outstanding but
unissued shares of Common Stock that are not reserved for other purposes) a number of shares of Common Stock sufficient to permit the conversion of all then-outstanding Notes, assuming (x)&nbsp;Physical Settlement will apply to such conversion; and
(y)&nbsp;the Conversion Rate is increased by the maximum amount pursuant to which the Conversion Rate may be increased pursuant to <B>Section</B><B></B><B>&nbsp;5.07</B>. To the extent the Company delivers shares of Common Stock held in its treasury
in settlement of the conversion of any Notes, each reference in this Indenture or the Notes to the issuance of shares of Common Stock in connection therewith will be deemed to include such delivery, <I>mutatis mutandis</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Status of Conversion Shares; Listing</I>. Each Conversion Share, if any, delivered upon conversion of any Note will be a newly issued
or treasury share (except that any Conversion Share delivered by a designated financial institution pursuant to <B>Section</B><B></B><B>&nbsp;5.08</B> need not be a newly issued or treasury share) and will be duly authorized and validly issued,
fully paid, <FONT STYLE="white-space:nowrap">non-assessable,</FONT> free from preemptive rights and free of any lien or adverse claim (except to the extent of any lien or adverse claim created by the action or inaction of the Holder of such Note or
the Person to whom such Conversion Share will be delivered). If the Common Stock is then listed on any securities exchange, or quoted on any inter-dealer quotation system, then the Company will use its reasonable best efforts to cause each
Conversion Share, when delivered upon conversion of any Note, to be admitted for listing on such exchange or quotation on such system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 49 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.05. A<SMALL>DJUSTMENTS</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL>
C<SMALL>ONVERSION</SMALL> R<SMALL>ATE</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Events Requiring an Adjustment to the Conversion Rate</I>. The Conversion Rate
will be adjusted from time to time as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Stock Dividends, Splits and Combinations</I>. If the Company issues
solely shares of Common Stock as a dividend or distribution on all or substantially all shares of the Common Stock, or if the Company effects a stock split or a stock combination of the Common Stock (in each case excluding an issuance solely
pursuant to a Common Stock Change Event, as to which <B>Section</B><B></B><B>&nbsp;5.09</B> will apply), then the Conversion Rate will be adjusted based on the following formula: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200226628.jpg" ALT="LOGO" STYLE="width:1.23681in;height:0.509028in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Open of Business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution, or immediately before the Open of Business on the effective
date of such stock split or stock combination, as applicable;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date or effective date, as applicable;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately before the Open of Business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date or effective date, as applicable, without giving effect to such dividend,
distribution, stock split or stock combination; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>OS<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after giving effect to such dividend, distribution, stock split or stock combination.</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If any dividend, distribution, stock split or stock combination of the type described in this
<B>Section</B><B></B><B>&nbsp;5.05(A)(i)</B> is declared or announced, but not so paid or made, then the Conversion Rate will be readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution or to
effect such stock split or stock combination, to the Conversion Rate that would then be in effect had such dividend, distribution, stock split or stock combination not been declared or announced. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Rights, Options and Warrants</I>. If the Company distributes, to all or substantially all holders of Common Stock,
rights, options or warrants (other than rights issued or otherwise distributed pursuant to a stockholder rights plan, as to which <B>Sections 5.05(A)(iii)(1)</B> and <B>5.05(F)</B> will apply) entitling such holders, for a period of not more than
sixty (60)&nbsp;calendar days after the record date of such distribution, to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten
(10)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before the date such distribution is announced, then the Conversion Rate will be increased based on the following formula: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200226853.jpg" ALT="LOGO" STYLE="width:1.4375in;height:0.434028in;">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 50 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Open of Business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Open of Business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>OS</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately before the Open of Business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>X</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Y</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">a number of shares of Common Stock obtained by dividing (x)&nbsp;the aggregate price payable to exercise such rights, options or warrants by (y)&nbsp;the average of the Last Reported Sale Prices per share of Common Stock for the ten
(10)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before the date such distribution is announced.</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent such rights, options or warrants are not so distributed, the Conversion Rate will be readjusted
to the Conversion Rate that would then be in effect had the increase to the Conversion Rate for such distribution been made on the basis of only the rights, options or warrants, if any, actually distributed. In addition, to the extent that shares of
Common Stock are not delivered after the expiration of such rights, options or warrants (including as a result of such rights, options or warrants not being exercised), the Conversion Rate will be readjusted to the Conversion Rate that would then be
in effect had the increase to the Conversion Rate for such distribution been made on the basis of delivery of only the number of shares of Common Stock actually delivered upon exercise of such rights, options or warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">For purposes of this <B>Section</B><B></B><B>&nbsp;5.05(A)(ii)</B> and <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(3)(a)(I)</B>, in determining
whether any rights, options or warrants entitle holders of Common Stock to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten
(10)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before the date the distribution of such rights, options or warrants is announced, and in determining the aggregate price payable to exercise such rights,
options or warrants, there will be taken into account any consideration the Company receives for such rights, options or warrants and any amount payable on exercise thereof, with the value of such consideration, if not cash, to be determined by the
Company in good faith and in a commercially reasonable manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 51 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <I>Spin-Offs and Other Distributed Property</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) <I>Distributions Other than Spin-Offs</I>. If the Company distributes shares of its Capital Stock, evidences of its
indebtedness or other assets or property of the Company, or rights, options or warrants to acquire Capital Stock of the Company or other securities, to all or substantially all holders of the Common Stock, excluding: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) dividends, distributions, rights, options or warrants for which an adjustment to the Conversion Rate is required (or would
be required without regard to <B>Section</B><B></B><B>&nbsp;5.05(C)</B>) pursuant to <B>Section</B><B>&nbsp;5.05(A)(i)</B> or <B>5.05(A)(ii)</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) dividends or distributions paid exclusively in cash for which an adjustment to the Conversion Rate is required (or would
be required without regard to <B>Section</B><B></B><B>&nbsp;5.05(C)</B>) pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)(iv)</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) rights issued or otherwise distributed pursuant to a stockholder rights plan, except to the extent provided in
<B>Section</B><B></B><B>&nbsp;5.05(F)</B>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) Spin-Offs for which an adjustment to the Conversion Rate is required (or
would be required without regard to <B>Section</B><B></B><B>&nbsp;5.05(C)</B>) pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(2)</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) a distribution solely pursuant to a tender offer or exchange offer for shares of Common Stock, as to which
<B>Section</B><B></B><B>&nbsp;5.05(A)(v)</B> will apply; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) a distribution solely pursuant to a Common Stock Change
Event, as to which <B>Section</B><B></B><B>&nbsp;5.09</B> will apply, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">then the Conversion Rate will be increased based on the following
formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200226984.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Open of Business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Open of Business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>SP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices per share of Common Stock for the ten (10)&nbsp;consecutive Trading Days ending on, and including, the Trading Day immediately before such
<FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>FMV</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the fair market value (as determined by the Company in good faith and in a commercially reasonable manner), as of such Ex-Dividend Date, of the shares of Capital Stock, evidences of indebtedness, assets, property, rights, options or
warrants distributed per share of Common Stock pursuant to such distribution;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 52 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if <I>FMV</I> is equal to or greater than <I>SP</I>,
then, in lieu of the foregoing adjustment to the Conversion Rate, each Holder will receive, for each $1,000 principal amount of Notes held by such Holder on the record date for such distribution, at the same time and on the same terms as holders of
Common Stock, and without having to convert its Notes, the amount and kind of shares of Capital Stock, evidences of indebtedness, assets, property, rights, options or warrants that such Holder would have received in such distribution if such Holder
had owned, on such record date, a number of shares of Common Stock equal to the Conversion Rate in effect on such record date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">To the
extent such distribution is not so paid or made, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the distribution, if any, actually made or paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) <I>Spin-Offs</I>. If the Company distributes or dividends shares of Capital Stock of any class or series, or similar equity
interests, of or relating to an Affiliate, a Subsidiary or other business unit of the Company to all or substantially all holders of the Common Stock (other than solely pursuant to (x)&nbsp;a Common Stock Change Event, as to which
<B>Section</B><B></B><B>&nbsp;5.09</B> will apply; or (y)&nbsp;a tender offer or exchange offer for shares of Common Stock, as to which <B>Section</B><B></B><B>&nbsp;5.05(A)(v)</B> will apply), and such Capital Stock or equity interests are listed
or quoted (or will be listed or quoted upon the consummation of the transaction) on a U.S. national securities exchange (a &#8220;<B><FONT STYLE="white-space:nowrap">Spin-Off</FONT></B>&#8221;), then the Conversion Rate will be increased based on
the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200227117.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Close of Business on the last Trading Day of the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period for such
<FONT STYLE="white-space:nowrap">Spin-Off;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>FMV</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the product of (x)&nbsp;the average of the Last Reported Sale Prices per share or unit of the Capital Stock or equity interests distributed in such <FONT STYLE="white-space:nowrap">Spin-Off</FONT> over the ten (10)&nbsp;consecutive
Trading Day period (the <FONT STYLE="white-space:nowrap">&#8220;Spin-Off</FONT> Valuation Period&#8221;) beginning on, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such
<FONT STYLE="white-space:nowrap">Spin-Off</FONT> (such average to be determined as if references to Common Stock in the definitions of Last Reported Sale Price, Trading Day and Market Disruption Event were instead references to such Capital Stock or
equity interests); and (y)&nbsp;the number of shares or units of such Capital Stock or equity interests distributed per share of Common Stock in such <FONT STYLE="white-space:nowrap">Spin-Off;</FONT> and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><I>SP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices per share of Common Stock for each Trading Day in the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 53 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this
<B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(2)</B>, (i) if any VWAP Trading Day of the Observation Period for a Note whose conversion will be settled pursuant to Cash Settlement or Combination Settlement occurs during the <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period for such <FONT STYLE="white-space:nowrap">Spin-Off,</FONT> then, solely for purposes of determining the Conversion Rate for such VWAP Trading Day for such conversion, such <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period will be deemed to consist of the Trading Days occurring in the period from, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> to, and including, such VWAP Trading Day; and (ii)&nbsp;if the Conversion Date for a Note whose conversion will be settled pursuant to Physical Settlement occurs during the
<FONT STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period for such <FONT STYLE="white-space:nowrap">Spin-Off,</FONT> then, solely for purposes of determining the Conversion Consideration for such conversion, such <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Valuation Period will be deemed to consist of the Trading Days occurring in the period from, and including, the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> to, and including, such Conversion Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">To the extent any dividend or distribution of the type
set forth in this <B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(2)</B> is declared but not made or paid, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the
dividend or distribution, if any, actually made or paid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <I>Cash Dividends or Distributions</I>. If any cash dividend
or distribution is made to all or substantially all holders of Common Stock, then the Conversion Rate will be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200227251.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Open of Business on the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date for such dividend or distribution;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Open of Business on such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>SP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Last Reported Sale Price per share of Common Stock on the Trading Day immediately before such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>D</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the cash amount distributed per share of Common Stock in such dividend or distribution;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 54 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if <I>D</I> is equal to or greater than <I>SP</I>,
then, in lieu of the foregoing adjustment to the Conversion Rate, each Holder will receive, for each $1,000 principal amount of Notes held by such Holder on the record date for such dividend or distribution, at the same time and on the same terms as
holders of Common Stock, and without having to convert its Notes, the amount of cash that such Holder would have received in such dividend or distribution if such Holder had owned, on such record date, a number of shares of Common Stock equal to the
Conversion Rate in effect on such record date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent such dividend or distribution is declared but not made or paid, the
Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the dividend or distribution, if any, actually made or paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>Tender Offers or Exchange Offers</I>. If the Company or any of its Subsidiaries makes a payment in respect of a tender
offer or exchange offer for shares of Common Stock (other than solely pursuant to an <FONT STYLE="white-space:nowrap">odd-lot</FONT> tender offer pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(h)(5)</FONT> under the Exchange Act), and the
value (determined as of the Expiration Time by the Company in good faith and in a commercially reasonable manner) of the cash and other consideration paid or payable per share of Common Stock in such tender or exchange offer exceeds the Last
Reported Sale Price per share of Common Stock on the Trading Day immediately after the last date (the &#8220;<B>Expiration Date</B>&#8221;) on which tenders or exchanges may be made pursuant to such tender or exchange offer (as it may be amended),
then the Conversion Rate will be increased based on the following formula: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107200227383.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">where: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately before the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period for such tender or exchange offer;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>CR<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>AC</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the aggregate value (determined as of the time (the &#8220;Expiration Time&#8221;) such tender or exchange offer expires by the Company in good faith and in a commercially reasonable manner) of all cash and other consideration paid
or payable for shares of Common Stock purchased or exchanged in such tender or exchange offer;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 55 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>OS<SUB STYLE="font-size:75%; vertical-align:bottom">0</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately before the Expiration Time (including all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>OS<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the number of shares of Common Stock outstanding immediately after the Expiration Time (excluding all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer); and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>SP</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">=</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the average of the Last Reported Sale Prices per share of Common Stock over the ten (10)&nbsp;consecutive Trading Day period (the &#8220;Tender/Exchange Offer Valuation Period&#8221;) beginning on, and including, the Trading Day
immediately after the Expiration Date;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that the Conversion Rate will in no event be adjusted down pursuant to this
<B>Section</B><B></B><B>&nbsp;5.05(A)(v)</B>, except to the extent provided in the immediately following paragraph. Notwithstanding anything to the contrary in this <B>Section</B><B></B><B>&nbsp;5.05(A)(v)</B>, (i) if any VWAP Trading Day of the
Observation Period for a Note whose conversion will be settled pursuant to Cash Settlement or Combination Settlement occurs during the Tender/Exchange Offer Valuation Period for such tender or exchange offer, then, solely for purposes of determining
the Conversion Rate for such VWAP Trading Day for such conversion, such Tender/Exchange Offer Valuation Period will be deemed to consist of the Trading Days occurring in the period from, and including, the Trading Day immediately after the
Expiration Date for such tender or exchange offer to, and including, such VWAP Trading Day; and (ii)&nbsp;if the Conversion Date for a Note whose conversion will be settled pursuant to Physical Settlement occurs during the Tender/Exchange Offer
Valuation Period for such tender or exchange offer, then, solely for purposes of determining the Conversion Consideration for such conversion, such Tender/Exchange Offer Valuation Period will be deemed to consist of the Trading Days occurring in the
period from, and including, the Trading Day immediately after the Expiration Date to, and including, such Conversion Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the extent
such tender or exchange offer is announced but not consummated (including as a result of the Company being precluded from consummating such tender or exchange offer under applicable law), or any purchases or exchanges of shares of Common Stock in
such tender or exchange offer are rescinded, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the purchases or exchanges of shares of Common Stock, if any,
actually made, and not rescinded, in such tender or exchange offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>No Adjustments in Certain Cases</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Where Holders Participate in the Transaction or Event Without Conversion</I>. Notwithstanding anything to the contrary
in <B>Section</B><B></B><B>&nbsp;5.05(A)</B>, the Company will not be obligated to adjust the Conversion Rate on account of a transaction or other event otherwise requiring an adjustment pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B> (other
than a stock split or combination of the type set forth in <B>Section</B><B></B><B>&nbsp;5.05(A)(i)</B> or a tender or exchange offer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 56 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
of the type set forth in <B>Section</B><B></B><B>&nbsp;5.05(A)(v)</B>) if each Holder participates, at the same time and on the same terms as holders of Common Stock, and solely by virtue of
being a Holder of Notes, in such transaction or event without having to convert such Holder&#8217;s Notes and as if such Holder held a number of shares of Common Stock equal to the product of (i)&nbsp;the Conversion Rate in effect on the related
record date; and (ii)&nbsp;the aggregate principal amount (expressed in thousands) of Notes held by such Holder on such date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Certain Events</I>. The Company will not be required to adjust the Conversion Rate except as provided in
<B>Section</B><B></B><B>&nbsp;5.05</B> or <B>Section</B><B></B><B>&nbsp;5.07</B>. Without limiting the foregoing, the Company will not be obligated to adjust the Conversion Rate on account of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) except as otherwise provided in <B>Section</B><B></B><B>&nbsp;5.05</B>, the sale of shares of Common Stock for a purchase
price that is less than the market price per share of Common Stock or less than the Conversion Price; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the issuance of
any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Company&#8217;s securities and the investment of additional optional amounts in shares of Common Stock under any
such plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the issuance of any shares of Common Stock or options or rights to purchase shares of Common Stock pursuant
to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Company or any of its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or exchangeable security
of the Company outstanding as of the Issue Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) solely a change in the par value of the Common Stock; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) accrued and unpaid interest on the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Adjustment Deferral</I>. If an adjustment to the Conversion Rate otherwise required by this <B>Article 5</B> would result in a change
of less than one percent (1%) to the Conversion Rate, then, notwithstanding anything to the contrary in this <B>Article 5</B>, the Company may, at its election, defer such adjustment, except that all such deferred adjustments must be given effect
immediately upon the earliest of the following: (i)&nbsp;when all such deferred adjustments would result in a change of at least one percent (1%) to the Conversion Rate; (ii)&nbsp;the Conversion Date of, or any VWAP Trading Day of an Observation
Period for, any Note; (iii)&nbsp;the date a Fundamental Change or Make-Whole Fundamental Change occurs; (iv)&nbsp;the date the Company calls any Notes for Redemption; and (v)&nbsp;February&nbsp;15, 2033. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Adjustments Not Yet Effective</I>. Notwithstanding anything to the contrary in this Indenture or the Notes, if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a Note is to be converted and Physical Settlement or Combination Settlement applies to such conversion; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 57 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the record date, effective date or Expiration Time for any event that
requires an adjustment to the Conversion Rate pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B> has occurred on or before the Conversion Date for such conversion (in the case of Physical Settlement) or on or before any VWAP Trading Day in the
Observation Period for such conversion (in the case of Combination Settlement), but an adjustment to the Conversion Rate for such event has not yet become effective as of such Conversion Date or VWAP Trading Day, as applicable; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Conversion Consideration due upon such conversion includes any whole shares of Common Stock (in the case of Physical
Settlement) or due in respect of such VWAP Trading Day includes any whole or fractional shares of Common Stock (in the case of Combination Settlement); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) such shares are not entitled to participate in such event (because they were not held on the related record date or
otherwise), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, solely for purposes of such conversion, the Company will, without duplication, give effect to such adjustment on such Conversion Date
(in the case of Physical Settlement) or such VWAP Trading Day (in the case of Combination Settlement). In such case, if the date on which the Company is otherwise required to deliver the consideration due upon such conversion is before the first
date on which the amount of such adjustment can be determined, then the Company will delay the settlement of such conversion until the second (2nd) Business Day after such first date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>Conversion Rate Adjustments where Converting Holders Participate in the Relevant Transaction or Event</I>. Notwithstanding anything to
the contrary in this Indenture or the Notes, if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a Conversion Rate adjustment for any dividend or distribution becomes
effective on any <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a Note is to be converted pursuant to Physical Settlement or Combination Settlement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Conversion Date for such conversion (in the case of Physical Settlement) or any VWAP Trading Day in the Observation
Period for such conversion (in the case of Combination Settlement) occurs on or after such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date and on or before the related record date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Conversion Consideration due upon such conversion includes any whole shares of Common Stock (in the case of Physical
Settlement) or due in respect of such VWAP Trading Day includes any whole or fractional shares of Common Stock (in the case of Combination Settlement), in each case based on a Conversion Rate that is adjusted for such dividend or distribution; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) such shares would be entitled to participate in such dividend or distribution (including pursuant to
<B>Section</B><B></B><B>&nbsp;5.02(C)</B>), </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 58 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then (x)&nbsp;in the case of Physical Settlement, such Conversion Rate adjustment will not be given effect
for such conversion and the shares of Common Stock issuable upon such conversion based on such unadjusted Conversion Rate will not be entitled to participate in such dividend or distribution, but there will be added, to the Conversion Consideration
otherwise due upon such conversion, the same kind and amount of consideration that would have been delivered in such dividend or distribution with respect to such shares of Common Stock had such shares been entitled to participate in such dividend
or distribution; and (y)&nbsp;in the case of Combination Settlement, the Conversion Rate adjustment relating to such <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date will be made for such conversion in respect of such VWAP Trading Day, but
the shares of Common Stock issuable with respect to such VWAP Trading Day based on such adjusted Conversion Rate will not be entitled to participate in such dividend or distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) <I>Stockholder Rights Plans</I>. If the Company has a stockholder rights plan in effect upon conversion of any Notes into Common Stock,
the Holder converting such Notes will receive, in addition to any shares of Common Stock such Holder receives in connection with such conversion, the rights under such stockholder rights plan. However, if, prior to any conversion of Notes, the
rights have separated from the shares of Common Stock in accordance with the provisions of the applicable stockholder rights plan, then the Conversion Rate will be adjusted pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(1)</B> at the time of
such separation as if the Company distributed, to all or substantially all holders of Common Stock, shares of its capital stock, evidences of indebtedness, assets, property, rights, options or warrants as described above in
<B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(1)</B>, subject to readjustment in accordance with the final paragraph of <B>Section</B><B></B><B>&nbsp;5.05(A)(iii)(1)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) <I>Limitation on Effecting Transactions Resulting in Certain Adjustments</I>. The Company will not engage in or be a party to any
transaction or event that would require the Conversion Rate to be adjusted pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B> or <B>Section</B><B></B><B>&nbsp;5.07</B> to an amount that would result in the Conversion Price per share of Common
Stock being less than the par value per share of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) <I>Equitable Adjustments to Prices</I>. Whenever any provision of this
Indenture requires the Company to calculate the average of the Last Reported Sale Prices, or any function thereof, over a period of multiple days (including to calculate the Stock Price or an adjustment to the Conversion Rate), or to calculate Daily
VWAPs, Daily Conversion Values, Daily Cash Amounts or Daily Share Amounts over an Observation Period, the Company will make proportionate adjustments to such calculations to account for any adjustment to the Conversion Rate that becomes effective,
or any event requiring an adjustment to the Conversion Rate where the <FONT STYLE="white-space:nowrap">Ex-Dividend</FONT> Date, effective date or Expiration Date, as applicable, of such event occurs, at any time during such period or Observation
Period, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) <I>Calculation of Number of Outstanding Shares of Common Stock</I>. For purposes of
<B>Section</B><B></B><B>&nbsp;5.05(A)</B>, the number of shares of Common Stock outstanding at any time will (i)&nbsp;include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock; and
(ii)&nbsp;exclude shares of Common Stock held in the Company&#8217;s treasury (unless the Company pays any dividend or makes any distribution on shares of Common Stock held in its treasury). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 59 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) <I>Calculations</I>. All calculations with respect to the Conversion Rate and
adjustments thereto will be made to the nearest 1/10,000th of a share of Common Stock (with 5/100,000ths rounded upward). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) <I>Notice
of Conversion Rate Adjustments</I>. Upon the effectiveness of any adjustment to the Conversion Rate pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B>, the Company will promptly send notice to the Holders, the Trustee and the Conversion Agent (if
other than the Trustee) containing (i)&nbsp;a brief description of the transaction or other event on account of which such adjustment was made; (ii)&nbsp;the Conversion Rate in effect immediately after such adjustment; and (iii)&nbsp;the effective
time of such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.06. V<SMALL>OLUNTARY</SMALL> A<SMALL>DJUSTMENTS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. To the extent permitted by law and applicable stock exchange rules, the Company, from time to time, may (but is not
required to) increase the Conversion Rate by any amount if (i)&nbsp;the Board of Directors determines that such increase is either (x)&nbsp;in the best interest of the Company; or (y)&nbsp;advisable to avoid or diminish any income tax imposed on
holders of Common Stock or rights to purchase Common Stock as a result of any dividend or distribution of shares (or rights to acquire shares) of Common Stock or any similar event; (ii)&nbsp;such increase is in effect for a period of at least twenty
(20)&nbsp;Business Days; and (iii)&nbsp;such increase is irrevocable during such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Notice of Voluntary Increases</I>. If the
Board of Directors determines to increase the Conversion Rate pursuant to <B>Section</B><B></B><B>&nbsp;5.06(A)</B>, then, no later than the first Business Day of the related twenty (20)&nbsp;Business Day period referred to in
<B>Section</B><B></B><B>&nbsp;5.06(A)</B>, the Company will send notice to each Holder, the Trustee and the Conversion Agent (if other than the Trustee) of such increase, the amount thereof and the period during which such increase will be in
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.07. A<SMALL>DJUSTMENTS</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> C<SMALL>ONVERSION</SMALL> R<SMALL>ATE</SMALL>
<SMALL>IN</SMALL> C<SMALL>ONNECTION</SMALL> <SMALL>WITH</SMALL> <SMALL>A</SMALL> M<SMALL>AKE</SMALL>-W<SMALL>HOLE</SMALL> F<SMALL>UNDAMENTAL</SMALL> C<SMALL>HANGE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. If a Make-Whole Fundamental Change occurs and the Conversion Date for the conversion of a Note occurs during the related
Make-Whole Fundamental Change Conversion Period, then, subject to this <B>Section</B><B></B><B>&nbsp;5.07</B>, the Conversion Rate applicable to such conversion will be increased by a number of shares (the &#8220;<B>Additional Shares</B>&#8221;) set
forth in the table below corresponding (after interpolation as provided in, and subject to, the provisions below) to the Make-Whole Fundamental Change Effective Date and the Stock Price of such Make-Whole Fundamental Change: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="46" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Make-Whole<BR>Fundamental Change<BR>Effective Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$90.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$105.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$121.50</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$140.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$157.95</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$200.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$250.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$300.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$400.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$500.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$600.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$750.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">November&nbsp;7, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2846</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2027</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1087</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2028</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.6809</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.3947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2029</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4053</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.0824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.6211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.3426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2030</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.7917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.3044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.9761</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.5242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.2674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2031</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.2699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.6304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.1244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.8006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.3831</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2032</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.0247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.7805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.4940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.1814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">May&nbsp;15, 2033</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.8806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.2933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.0000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 60 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If such Make-Whole Fundamental Change Effective Date or Stock Price is not set forth in the
table above, then: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) if such Stock Price is between two Stock Prices in the table above or the Make-Whole Fundamental
Change Effective Date is between two dates in the table above, then the number of Additional Shares will be determined by straight-line interpolation between the numbers of Additional Shares set forth for the higher and lower Stock Prices in the
table above or the earlier and later dates in the table above, based on a <FONT STYLE="white-space:nowrap">365-</FONT> or <FONT STYLE="white-space:nowrap">366-day</FONT> year, as applicable; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) if the Stock Price is greater than $750.00 (subject to adjustment in the same manner as the Stock Prices set forth in the
column headings of the table above are adjusted pursuant to <B>Section</B><B></B><B>&nbsp;5.07(B)</B>), or less than $90.00 (subject to adjustment in the same manner), per share, then no Additional Shares will be added to the Conversion Rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Indenture or the Notes, in no event will the Conversion Rate be increased to an amount that
exceeds 11.1111 shares of Common Stock per $1,000 principal amount of Notes, which amount is subject to adjustment in the same manner as, and at the same time and for the same events for which, the Conversion Rate is required to be adjusted pursuant
to <B>Section</B><B></B><B>&nbsp;5.05(A)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, but subject to <B>Section</B><B></B><B>&nbsp;4.03(I)</B>, (x)
the sending of a Redemption Notice will constitute a Make-Whole Fundamental Change only with respect to the Notes called (or deemed called) for Redemption pursuant to such Redemption Notice, and not with respect to any other Notes; and (y)&nbsp;the
Conversion Rate applicable to the Notes not so called for Redemption will not be subject to increase pursuant to this <B>Section</B><B></B><B>&nbsp;5.07</B> on account of such Redemption Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Adjustment of Stock Prices and Number of Additional Shares</I>. The Stock Prices in the first row (<I>i.e.</I>, the column headers) of
the table set forth in <B>Section</B><B></B><B>&nbsp;5.07(A)</B> will be adjusted in the same manner as, and at the same time and for the same events for which, the Conversion Price is adjusted as a result of the operation of
<B>Section</B><B></B><B>&nbsp;5.05(A)</B>. The numbers of Additional Shares in the table set forth in <B>Section</B><B></B><B>&nbsp;5.07(A)</B> will be adjusted in the same manner as, and at the same time and for the same events for which, the
Conversion Rate is adjusted pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Notice of the Occurrence of a Make-Whole
Fundamental Change</I>. The Company will notify the Holders, the Trustee and the Conversion Agent (if other than the Trustee) of each Make-Whole Fundamental Change (i)&nbsp;occurring pursuant to <B>clause (A)</B>&nbsp;of the definition thereof in
accordance with <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(3)(b)</B>; and (ii)&nbsp;occurring pursuant to <B>clause (B)</B>&nbsp;of the definition thereof in accordance with <B>Section</B><B></B><B>&nbsp;4.03(F)</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.08. E<SMALL>XCHANGE</SMALL> <SMALL>IN</SMALL> L<SMALL>IEU</SMALL> <SMALL>OF</SMALL> C<SMALL>ONVERSION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this <B>Article 5</B>, and subject to the terms of this <B>Section</B><B></B><B>&nbsp;5.08</B>, if
a Note is submitted for conversion, the Company may elect to arrange to have such Note exchanged in lieu of conversion by a financial institution designated by the Company. To make such election, the Company must send notice of such election to the
Holder of such Note, the Trustee and the Conversion Agent (if other than the Trustee) before the Close of Business on the Business Day immediately following the Conversion Date for such Note. If the Company has made such election, then: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) no later than the Business Day immediately following such Conversion Date, the Company must deliver (or cause the Conversion Agent to
deliver) such Note, together with delivery instructions for the Conversion Consideration due upon such conversion (including wire instructions, if applicable), to a financial institution designated by the Company that has agreed to deliver such
Conversion Consideration in the manner and at the time the Company would have had to deliver the same pursuant to this <B>Article 5</B>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 61 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) if such Note is a Global Note, then (i)&nbsp;such designated institution will send
written confirmation to the Conversion Agent promptly after wiring the cash Conversion Consideration, if any, and delivering any other Conversion Consideration, due upon such conversion to the Holder of such Note; and (ii)&nbsp;the Conversion Agent
will as soon as reasonably practicable thereafter contact such Holder&#8217;s custodian with the Depositary to confirm receipt of the same; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) such Note will not cease to be outstanding by reason of such exchange in lieu of conversion; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that if such financial institution does not accept such Note or fails to timely deliver such Conversion Consideration, then
the Company will be responsible for delivering such Conversion Consideration in the manner and at the time provided in this <B>Article 5</B> as if the Company had not elected to make an exchange in lieu of conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.09. E<SMALL>FFECT</SMALL> <SMALL>OF</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL> C<SMALL>HANGE</SMALL> E<SMALL>VENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. If there occurs any: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) recapitalization, reclassification or change of the Common Stock (other than (x)&nbsp;changes solely resulting from a
subdivision or combination of the Common Stock, (y)&nbsp;a change only in par value or from par value to no par value or no par value to par value and (z)&nbsp;stock splits and stock combinations that do not involve the issuance of any other series
or class of securities); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) consolidation, merger, combination or binding or statutory share exchange involving the
Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) sale, lease or other transfer of all or substantially all of the assets of the Company and its
Subsidiaries, taken as a whole, to any Person; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) other similar event, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and, as a result of which, the Common Stock is converted into, or is exchanged for, or represents solely the right to receive, other securities, cash or other
property, or any combination of the foregoing (such an event, a &#8220;<B>Common Stock Change Event</B>,&#8221; and such other securities, cash or property, the &#8220;<B>Reference Property</B>,&#8221; and the amount and kind of Reference Property
that a holder of one (1)&nbsp;share of Common Stock would be entitled to receive on account of such Common Stock Change Event (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property),
a &#8220;<B>Reference Property Unit</B>&#8221;), then, notwithstanding anything to the contrary in this Indenture or the Notes, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 62 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) from and after the effective time of such Common Stock Change Event,
(I)&nbsp;the Conversion Consideration due upon conversion of any Note, and the conditions to any such conversion, will be determined in the same manner as if each reference to any number of shares of Common Stock in this <B>Article 5</B> (or in any
related definitions) were instead a reference to the same number of Reference Property Units; (II)&nbsp;for purposes of <B>Section</B><B></B><B>&nbsp;4.03</B>, each reference to any number of shares of Common Stock in such Section (or in any related
definitions) will instead be deemed to be a reference to the same number of Reference Property Units; and (III)&nbsp;for purposes of the definitions of &#8220;Fundamental Change&#8221; and &#8220;Make-Whole Fundamental Change,&#8221; references to
&#8220;Common Stock&#8221; and the Company&#8217;s &#8220;common equity&#8221; will be deemed to mean the common equity (including depositary receipts representing common equity), if any, forming part of such Reference Property; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if such Reference Property Unit consists entirely of cash, then (I)&nbsp;each conversion of any Note with a Conversion Date
that occurs on or after the effective date of such Common Stock Change Event will be settled entirely in cash in an amount, per $1,000 principal amount of such Note being converted, equal to the product of (x)&nbsp;the Conversion Rate in effect on
such Conversion Date (including, for the avoidance of doubt, any increase to such Conversion Rate pursuant to <B>Section</B><B></B><B>&nbsp;5.07</B>, if applicable); and (y)&nbsp;the amount of cash constituting such Reference Property Unit; and
(II)&nbsp;the Company will settle each such conversion no later than the fifth (5th) Business Day after the relevant Conversion Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) for these purposes, (I)&nbsp;the Daily VWAP of any Reference Property Unit or portion thereof that consists of a class of
common equity securities will be determined by reference to the definition of &#8220;Daily VWAP,&#8221; substituting, if applicable, the Bloomberg page for such class of securities in such definition; and (II)&nbsp;the Daily VWAP of any Reference
Property Unit or portion thereof that does not consist of a class of common equity securities, and the Last Reported Sale Price of any Reference Property Unit or portion thereof that does not consist of a class of securities, will be the fair value
of such Reference Property Unit or portion thereof, as applicable, determined in good faith and in a commercially reasonable manner by the Company (or, in the case of cash denominated in U.S. dollars, the face amount thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Reference Property consists of more than a single type of consideration to be determined based in part upon any form of stockholder
election, then the composition of the Reference Property Unit will be deemed to be the weighted average of the types and amounts of consideration actually received, per share of Common Stock, by the holders of Common Stock. The Company will notify
Holders, the Trustee and the Conversion Agent (if other than the Trustee) of such weighted average as soon as practicable after such determination is made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 63 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or before the effective time of such Common Stock Change Event, the Company and the
resulting, surviving or transferee Person (if not the Company) of such Common Stock Change Event (the &#8220;<B>Successor Person</B>&#8221;) will execute and deliver to the Trustee a supplemental indenture pursuant to
<B>Section</B><B></B><B>&nbsp;8.01(F)</B>, which supplemental indenture will (x)&nbsp;provide for subsequent conversions of Notes in the manner set forth in this <B>Section</B><B></B><B>&nbsp;5.09</B>; (y) provide for subsequent adjustments to the
Conversion Rate pursuant to <B>Section</B><B></B><B>&nbsp;5.05(A)</B> in a manner consistent with this <B>Section</B><B></B><B>&nbsp;5.09</B>; and (z)&nbsp;contain such other provisions, if any, that the Company reasonably determines are appropriate
to preserve the economic interests of the Holders and to give effect to the provisions of this <B>Section</B><B></B><B>&nbsp;5.09(A)</B>. If the Reference Property includes shares of stock or other securities or assets (other than cash) of a Person
other than the Successor Person, then such other Person will also execute such supplemental indenture and such supplemental indenture will contain such additional provisions, if any, that the Company reasonably determines are appropriate to preserve
the economic interests of the Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Notice of Common Stock Change Events</I>. The Company will provide notice of each Common
Stock Change Event to Holders, the Trustee and the Conversion Agent (if other than the Trustee) no later than the Business Day after the effective date of such Common Stock Change Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Compliance Covenant</I>. The Company will not become a party to any Common Stock Change Event unless its terms are consistent with this
<B>Section</B><B></B><B>&nbsp;5.09</B>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 6. SUCCESSORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.01. W<SMALL>HEN</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL> M<SMALL>AY</SMALL> M<SMALL>ERGE</SMALL>, E<SMALL>TC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. The Company will not consolidate with or merge with or into, or (directly, or indirectly through one or more of its
Subsidiaries) sell, lease or otherwise transfer, in one transaction or a series of transactions, all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to another Person (a &#8220;<B>Business Combination
Event</B>&#8221;), unless: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the resulting, surviving or transferee Person either (x)&nbsp;is the Company or (y)&nbsp;if
not the Company, is a Qualified Successor Entity (such Qualified Successor Entity, the &#8220;<B>Successor Entity</B>&#8221;) duly organized and existing under the laws of the United States of America, any State thereof or the District of Columbia
that expressly assumes (by executing and delivering to the Trustee, at or before the effective time of such Business Combination Event, a supplemental indenture pursuant to <B>Section</B><B></B><B>&nbsp;8.01(E)</B>) all of the Company&#8217;s
obligations under this Indenture and the Notes; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) immediately after giving effect to such Business Combination
Event, no Default or Event of Default will have occurred and be continuing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Delivery of Officer&#8217;s Certificate and Opinion of
Counsel to the Trustee</I>. Before the effective time of any Business Combination Event, the Company will deliver to the Trustee an Officer&#8217;s Certificate and Opinion of Counsel, each stating that (i)&nbsp;such Business Combination Event (and,
if applicable, the related supplemental indenture) complies with <B>Section</B><B></B><B>&nbsp;6.01(A)</B>; and (ii)&nbsp;all conditions precedent to such Business Combination Event provided in this Indenture have been satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 64 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.02. S<SMALL>UCCESSOR</SMALL> E<SMALL>NTITY</SMALL> S<SMALL>UBSTITUTED</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the effective time of any Business Combination Event that complies with <B>Section</B><B></B><B>&nbsp;6.01</B>, the Successor Entity (if
not the Company) will succeed to, and may exercise every right and power of, the Company under this Indenture and the Notes with the same effect as if such Successor Entity had been named as the Company in this Indenture and the Notes, and, except
in the case of a lease, the predecessor Company will be discharged from its obligations under this Indenture and the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.03.
E<SMALL>XCLUSION</SMALL> <SMALL>FOR</SMALL> A<SMALL>SSET</SMALL> T<SMALL>RANSFERS</SMALL> <SMALL>WITH</SMALL> W<SMALL>HOLLY</SMALL> O<SMALL>WNED</SMALL> S<SMALL>UBSIDIARIES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this <B>Article 6</B>, this <B>Article 6</B> will not apply to any transfer of assets between or
among the Company and any one or more of its Wholly Owned Subsidiaries not effected by merger or consolidation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 7. DEFAULTS AND
REMEDIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.01. E<SMALL>VENTS</SMALL> <SMALL>OF</SMALL> D<SMALL>EFAULT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Definition of Events of Default</I>. &#8220;<B>Event of Default</B>&#8221; means the occurrence of any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a default in the payment when due (whether at maturity, upon Redemption, upon Repurchase Upon Fundamental Change or
otherwise) of the principal of, or the Redemption Price or Fundamental Change Repurchase Price for, any Note; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a
default for thirty (30)&nbsp;consecutive days in the payment when due of any Special Interest or Additional Interest that has accrued on any Note; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Company&#8217;s failure to deliver, when required by this Indenture, a Fundamental Change Notice, or a notice
pursuant to <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(3)</B>, if, in the case of any notice other than a notice pursuant to <B>Section</B><B></B><B>&nbsp;5.01(C)(i)(3)</B>, such failure is not cured within three (3)&nbsp;Business Days after its
occurrence; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a default in the Company&#8217;s obligation to convert a Note in accordance with <B>Article 5</B> upon
the exercise of the conversion right with respect thereto, if such default is not cured within two (2)&nbsp;Business Days after its occurrence; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) a default in the Company&#8217;s obligations under <B>Article 6</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) a default in any of the Company&#8217;s obligations or agreements under this Indenture or the Notes (other than a default
set forth in <B>clause</B> <B>(i)</B>, <B>(ii)</B>, <B>(iii)</B>, <B>(iv)</B> or <B>(v)</B>&nbsp;of this <B>Section</B><B></B><B>&nbsp;7.01(A)</B>) where such default is not cured or waived within sixty (60)&nbsp;days after notice to the Company by
the Trustee, or to the Company and the Trustee by Holders of at least twenty five percent (25%) of the aggregate principal amount of Notes then outstanding, which notice must specify such default, demand that it be remedied and state that such
notice is a &#8220;Notice of Default&#8221;; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 65 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) a default by the Company or any of the Company&#8217;s Significant
Subsidiaries with respect to any one or more mortgages, agreements or other instruments under which there is outstanding, or by which there is secured or evidenced, any indebtedness for money borrowed of at least one hundred million dollars
($100,000,000) (or its foreign currency equivalent) in the aggregate of the Company or any of the Company&#8217;s Subsidiaries, whether such indebtedness exists as of the Issue Date or is thereafter created, where such default: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) constitutes a failure to pay the principal of such indebtedness when due and payable at its stated maturity, upon required
repurchase, upon declaration of acceleration or otherwise, in each case after the expiration of any applicable grace period; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) results in such indebtedness becoming or being declared due and payable before its stated maturity, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in each case where such default is not cured or waived within thirty (30)&nbsp;days after notice to the Company by the Trustee or to the
Company and the Trustee by Holders of at least twenty five percent (25%) of the aggregate principal amount of Notes then outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) the Company or any of its Significant Subsidiaries, pursuant to or within the meaning of any Bankruptcy Law, either:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) commences a voluntary case or proceeding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) consents to the entry of an order for relief against it in an involuntary case or proceeding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) consents to the appointment of a custodian of it or for any substantial part of its property; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) makes a general assignment for the benefit of its creditors; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) takes any comparable action under any foreign Bankruptcy Law; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) generally is not paying its debts as they become due; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that either: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) is for relief against the Company or any of its Significant Subsidiaries in an involuntary case or proceeding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) appoints a custodian of the Company or any of its Significant Subsidiaries, or for any substantial part of the property of
the Company or any of its Significant Subsidiaries; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 66 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) orders the winding up or liquidation of the Company or any of its
Significant Subsidiaries; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) grants any similar relief under any foreign Bankruptcy Law, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">and, in each case under this <B>Section</B><B></B><B>&nbsp;7.01(A)(ix)</B>, such order or decree remains unstayed and in effect for at least
sixty (60)&nbsp;days. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Cause Irrelevant</I>. Each of the events set forth in <B>Section</B><B></B><B>&nbsp;7.01(A)</B> will
constitute an Event of Default regardless of the cause thereof or whether voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or
governmental body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.02. A<SMALL>CCELERATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Automatic Acceleration in Certain Circumstances</I>. If an Event of Default set forth in
<B>Section</B><B></B><B>&nbsp;7.01(A)(viii)</B> or <B>7.01(A)(ix)</B> occurs with respect to the Company (and not solely with respect to a Significant Subsidiary of the Company), then the principal amount of, and all accrued and unpaid interest, if
any, on, all of the Notes then outstanding will immediately become due and payable without any further action or notice by any Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Optional Acceleration</I>. Subject to <B>Section</B><B></B><B>&nbsp;7.03</B>, if an Event of Default (other than an Event of Default
set forth in <B>Section</B><B></B><B>&nbsp;7.01(A)(viii)</B> or <B>7.01(A)(ix)</B> with respect to the Company and not solely with respect to a Significant Subsidiary of the Company) occurs and is continuing, then the Trustee, by notice to the
Company, or Holders of at least twenty five percent (25%) of the aggregate principal amount of Notes then outstanding, by notice to the Company and the Trustee, may declare the principal amount of, and all accrued and unpaid interest, if any, on,
all of the Notes then outstanding to become due and payable immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Rescission of Acceleration</I>. Notwithstanding anything
to the contrary in this Indenture or the Notes, the Holders of a majority in aggregate principal amount of the Notes then outstanding, by notice to the Company and the Trustee, may, on behalf of all Holders, rescind any acceleration of the Notes and
its consequences if (i)&nbsp;such rescission would not conflict with any judgment or decree of a court of competent jurisdiction; and (ii)&nbsp;all existing Events of Default (except the <FONT STYLE="white-space:nowrap">non-payment</FONT> of
principal of, or interest, if any, on, the Notes that has become due solely because of such acceleration) have been cured or waived. No such rescission will affect any subsequent Default or impair any right consequent thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.03. S<SMALL>OLE</SMALL> R<SMALL>EMEDY</SMALL> <SMALL>FOR</SMALL> <SMALL>A</SMALL> F<SMALL>AILURE</SMALL> <SMALL>TO</SMALL>
R<SMALL>EPORT</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. Notwithstanding anything to the contrary in this Indenture or the Notes, the Company may
elect that the sole remedy for any Event of Default (a &#8220;<B>Reporting Event of Default</B>&#8221;) pursuant to <B>Section</B><B></B><B>&nbsp;7.01(A)(vi)</B> arising from the Company&#8217;s failure to comply with
<B>Section</B><B></B><B>&nbsp;3.02</B> will, for each of the first three hundred and sixty (360)&nbsp;calendar days on which a Reporting Event of Default has occurred and is continuing, consist exclusively of the accrual of Special Interest on the
Notes. If the Company has made such an election, then (i)&nbsp;the Notes will be subject to acceleration pursuant to <B>Section</B><B></B><B>&nbsp;7.02</B> on account of the relevant Reporting Event of Default from, and including, the three hundred
and sixty first (361st) calendar day on which a Reporting Event of Default has occurred and is continuing or if the Company fails to pay any accrued and unpaid Special Interest when due; and (ii)&nbsp;Special Interest will cease to accrue on any
Notes from, and including, such three hundred and sixty first (361st) calendar day (it being understood that interest on any defaulted Special Interest will nonetheless accrue pursuant to <B>Section</B><B></B><B>&nbsp;2.05(B)</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 67 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Amount and Payment of Special Interest</I>. Any Special Interest that accrues on a
Note pursuant to <B>Section</B><B></B><B>&nbsp;7.03(A)</B> will accrue at a rate per annum equal to one quarter of one percent (0.25%) of the principal amount thereof for the first one hundred and eighty (180)&nbsp;days on which Special Interest
accrues and, thereafter, at a rate per annum equal to one half of one percent (0.50%) of the principal amount thereof; <I>provided</I>, <I>however</I>, that in no event will Special Interest that is payable at the Company&#8217;s election pursuant
to <B>Section</B><B></B><B>&nbsp;7.03(A)</B> as the sole remedy for any Reporting Event of Default, together with any Additional Interest that may accrue as a result of the Company&#8217;s failure to timely file any report (other than Form <FONT
STYLE="white-space:nowrap">8-K</FONT> reports) that the Company is required to file with the SEC pursuant to Section&nbsp;13 or 15(d) of the Exchange Act (after giving effect to all applicable grace periods thereunder), pursuant to
<B>Section</B><B></B><B>&nbsp;3.04</B>, accrue on any day on a Note at a combined rate per annum that exceeds one half of one percent (0.50%). For the avoidance of doubt, any Special Interest that accrues on a Note will, subject to the proviso of
the immediately preceding sentence, be in addition to any Additional Interest that accrues on such Note. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Notice of Election</I>.
To make the election set forth in <B>Section</B><B></B><B>&nbsp;7.03(A)</B>, the Company must send to the Holders, the Trustee and the Paying Agent, before the date on which each Reporting Event of Default first occurs, a notice that
(i)&nbsp;briefly describes the report(s) that the Company failed to file with the SEC; (ii)&nbsp;states that the Company is electing that the sole remedy for such Reporting Event of Default consist of the accrual of Special Interest; and
(iii)&nbsp;briefly describes the periods during which and rate at which Special Interest will accrue and the circumstances under which the Notes will be subject to acceleration on account of such Reporting Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Notice to Trustee and Paying Agent; Trustee&#8217;s Disclaimer</I>. If Special Interest accrues on any Note, then, no later than five
(5)&nbsp;Business Days before each date on which such Special Interest is to be paid, the Company will deliver an Officer&#8217;s Certificate to the Trustee and the Paying Agent stating (i)&nbsp;that the Company is obligated to pay Special Interest
on such Note on such date of payment; and (ii)&nbsp;the amount of such Special Interest that is payable on such date of payment. The Trustee will have no duty to determine whether any Special Interest is payable or the amount thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) <I>No Effect on Other Events of Default</I>. No election pursuant to this <B>Section</B><B></B><B>&nbsp;7.03</B> with respect to a
Reporting Event of Default will affect the rights of any Holder with respect to any other Event of Default, including with respect to any other Reporting Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.04. O<SMALL>THER</SMALL> R<SMALL>EMEDIES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Trustee May Pursue All Remedies</I>. If an Event of Default occurs and is continuing, then the Trustee may pursue any available remedy
to collect the payment of any amounts due with respect to the Notes or to enforce the performance of any provision of this Indenture or the Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 68 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Procedural Matters</I>. The Trustee may maintain a proceeding even if it does not
possess any of the Notes or does not produce any of them in such proceeding. A delay or omission by the Trustee or any Holder in exercising any right or remedy following an Event of Default will not impair the right or remedy or constitute a waiver
of, or acquiescence in, such Event of Default. All remedies will be cumulative to the extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.05.
W<SMALL>AIVER</SMALL> <SMALL>OF</SMALL> P<SMALL>AST</SMALL> D<SMALL>EFAULTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Event of Default pursuant to <B>clause</B>
<B>(i)</B>, <B>(ii)</B>, <B>(iv)</B> or <B>(vi)</B>&nbsp;of <B>Section</B><B></B><B>&nbsp;7.01(A)</B> (that, in the case of <B>clause (vi)</B>&nbsp;only, results from a Default under any covenant that cannot be amended without the consent of each
affected Holder), and a Default that would, after notice, passage of time or both, be such an Event of Default, can be waived only with the consent of each affected Holder. Each other Default or Event of Default may be waived, on behalf of all
Holders, by the Holders of a majority in aggregate principal amount of the Notes then outstanding. If an Event of Default is so waived, then it will cease to exist. If a Default is so waived, then it will be deemed to be cured and any Event of
Default arising therefrom will be deemed not to occur. However, no such waiver will extend to any subsequent or other Default or Event of Default or impair any right arising therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.06. C<SMALL>ONTROL</SMALL> <SMALL>BY</SMALL> M<SMALL>AJORITY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of a majority in aggregate principal amount of the Notes then outstanding may direct the time, method and place of conducting any
proceeding for exercising any remedy available to the Trustee or exercising any trust or power conferred on it. However, the Trustee may refuse to follow any direction that conflicts with law, this Indenture or the Notes, or that, subject to
<B>Section</B><B></B><B>&nbsp;10.01</B>, the Trustee determines may be unduly prejudicial to the rights of other Holders or may involve the Trustee in liability, unless the Trustee is offered (and, if requested, provided with) security and indemnity
satisfactory to the Trustee against any loss, liability or expense to the Trustee that may result from the Trustee&#8217;s following such direction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.07. L<SMALL>IMITATION</SMALL> <SMALL>ON</SMALL> S<SMALL>UITS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Holder may pursue any remedy with respect to this Indenture or the Notes (except to enforce (x)&nbsp;its rights to receive the principal
of, or the Redemption Price or Fundamental Change Repurchase Price for, or interest, if any, on, any Notes; or (y)&nbsp;the Company&#8217;s obligations to convert any Notes pursuant to <B>Article 5</B>), unless: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) such Holder has previously delivered to the Trustee notice that an Event of Default is continuing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) Holders of at least twenty five percent (25%) in aggregate principal amount of the Notes then outstanding deliver a request to the Trustee
to pursue such remedy; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) such Holder or Holders offer and, if requested, provide to the Trustee security and indemnity satisfactory to
the Trustee against any loss, liability or expense to the Trustee that may result from the Trustee&#8217;s following such request; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 69 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) the Trustee does not comply with such request within sixty (60)&nbsp;calendar days after
its receipt of such request and such offer of security or indemnity; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) during such sixty (60)&nbsp;calendar day period, Holders of
a majority in aggregate principal amount of the Notes then outstanding do not deliver to the Trustee a direction that is inconsistent with such request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Holder of a Note may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another
Holder. The Trustee will have no duty to determine whether any Holder&#8217;s use of this Indenture complies with the preceding sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.08. A<SMALL>BSOLUTE</SMALL> R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL> H<SMALL>OLDERS</SMALL> <SMALL>TO</SMALL> I<SMALL>NSTITUTE</SMALL>
S<SMALL>UIT</SMALL> <SMALL>FOR</SMALL> <SMALL>THE</SMALL> E<SMALL>NFORCEMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> R<SMALL>IGHT</SMALL> <SMALL>TO</SMALL> R<SMALL>ECEIVE</SMALL> P<SMALL>AYMENT</SMALL> <SMALL>AND</SMALL>
C<SMALL>ONVERSION</SMALL> C<SMALL>ONSIDERATION</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Indenture or the Notes (but
without limiting <B>Section</B><B></B><B>&nbsp;8.01</B>), the right of each Holder of a Note to bring suit for the enforcement of any payment or delivery, as applicable, of the principal of, or the Redemption Price or Fundamental Change Repurchase
Price for, or any interest on, or the Conversion Consideration due pursuant to <B>Article 5</B> upon conversion of, such Note on or after the respective due dates therefor provided in this Indenture and the Notes, will not be impaired or affected
without the consent of such Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.09. C<SMALL>OLLECTION</SMALL> S<SMALL>UIT</SMALL> <SMALL>BY</SMALL> T<SMALL>RUSTEE</SMALL>.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee will have the right, upon the occurrence and continuance of an Event of Default pursuant to <B>clause</B> <B>(i)</B>,
<B>(ii)</B> or <B>(iv)</B>&nbsp;of <B>Section</B><B></B><B>&nbsp;7.01(A)</B>, to recover judgment in its own name and as trustee of an express trust against the Company for the total unpaid or undelivered principal of, or Redemption Price or
Fundamental Change Repurchase Price for, or interest, if any, on, or Conversion Consideration due pursuant to <B>Article 5</B> upon conversion of, the Notes, as applicable, and, to the extent lawful, any Default Interest on any Defaulted Amounts,
and such further amounts sufficient to cover the costs and expenses of collection, including compensation provided for in <B>Section</B><B></B><B>&nbsp;10.06</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.10. T<SMALL>RUSTEE</SMALL> M<SMALL>AY</SMALL> F<SMALL>ILE</SMALL> P<SMALL>ROOFS</SMALL> <SMALL>OF</SMALL> C<SMALL>LAIM</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee has the right to (A)&nbsp;file such proofs of claim and other papers or documents as may be necessary or advisable in order to
have the claims of the Trustee and the Holders allowed in any judicial proceedings relative to the Company (or any other obligor upon the Notes) or its creditors or property and (B)&nbsp;collect, receive and distribute any money or other property
payable or deliverable on any such claims. Each Holder authorizes any custodian in such proceeding to make such payments to the Trustee, and, if the Trustee consents to the making of such payments directly to the Holders, to pay to the Trustee any
amount due to the Trustee for the reasonable compensation, expenses, disbursements and advances of the Trustee, and its agents and counsel, and any other amounts payable to the Trustee pursuant to <B>Section</B><B></B><B>&nbsp;10.06</B>. To the
extent that the payment of any such compensation, expenses, disbursements, advances and other amounts out of the estate in such proceeding, is denied for any reason, payment of the same will be secured by a lien (senior to the rights of Holders) on,
and will be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be entitled to receive in such proceeding (whether in liquidation or under any plan of reorganization or arrangement or
otherwise). Nothing in this Indenture will be deemed to authorize the Trustee to authorize, consent to, accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of
any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 70 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.11. P<SMALL>RIORITIES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee will pay or deliver in the following order any money or other property that it collects pursuant to this <B>Article 7</B>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>First</I>: to the Trustee (in each of its capacities under this Indenture) and its agents and attorneys for amounts due
under <B>Section</B><B></B><B>&nbsp;10.06</B>, including payment of all fees, compensation, expenses and liabilities incurred, and all advances made, by the Trustee and the costs and expenses of collection; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Second</I>: to Holders for unpaid amounts or other property due on the Notes, including the principal of, or the Redemption
Price or Fundamental Change Repurchase Price for, or any interest on, or any Conversion Consideration due upon conversion of, the Notes, ratably, and without preference or priority of any kind, according to such amounts or other property due and
payable on all of the Notes; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Third</I>: to the Company or such other Person as a court of competent jurisdiction
directs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee may fix a record date and payment date for any payment or delivery to the Holders pursuant to this
<B>Section</B><B></B><B>&nbsp;7.11</B>, in which case the Trustee will instruct the Company to, and the Company will, deliver, at least fifteen (15)&nbsp;calendar days before such record date, to each Holder and the Trustee a notice stating such
record date, such payment date and the amount of such payment or nature of such delivery, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.12. U<SMALL>NDERTAKING</SMALL>
<SMALL>FOR</SMALL> C<SMALL>OSTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In any suit for the enforcement of any right or remedy under this Indenture or the Notes or
in any suit against the Trustee for any action taken or omitted by it as Trustee, a court, in its discretion, may (A)&nbsp;require the filing by any litigant party in such suit of an undertaking to pay the costs of such suit, and (B)&nbsp;assess
reasonable costs (including reasonable attorneys&#8217; fees) against any litigant party in such suit, having due regard to the merits and good faith of the claims or defenses made by such litigant party; <I>provided</I>, <I>however</I>, that this
<B>Section</B><B></B><B>&nbsp;7.12</B> does not apply to any suit by the Trustee, any suit by a Holder pursuant to <B>Section</B><B></B><B>&nbsp;7.08</B> or any suit by one or more Holders of more than ten percent (10%) in aggregate principal amount
of the Notes then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.13. C<SMALL>URE</SMALL> <SMALL>OF</SMALL> D<SMALL>EFAULTS</SMALL>; A<SMALL>BILITY</SMALL>
<SMALL>TO</SMALL> C<SMALL>URE</SMALL> <SMALL>OR</SMALL> W<SMALL>AIVE</SMALL> B<SMALL>EFORE</SMALL> E<SMALL>VENT</SMALL> <SMALL>OF</SMALL> D<SMALL>EFAULT</SMALL> O<SMALL>CCURS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, and without limiting the manner in which any Default or Event of Default can be cured, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a Default or Event of Default consisting of a failure to send a notice in accordance with this Indenture will be cured upon the sending of
such notice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 71 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) a Default or Event of Default in making any payment on (or delivering any other
consideration in respect of) any Note will be cured upon the delivery, in accordance with this Indenture, of such payment (or other consideration) together, if applicable, with Default Interest thereon; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) a Default that is (or, after notice, passage of time or both, would be) a Reporting Event of Default will be cured upon the filing of the
relevant report(s) giving rise to such Default; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>&nbsp;that (x)&nbsp;the cure of any Event of Default shall not invalidate any acceleration
of the Notes on account of such Event of Default that was properly effected prior to such time as such Event of Default was cured and (y)&nbsp;the cure of any Reporting Event of Default shall not affect the Company&#8217;s obligation to pay any
Special Interest that accrues prior to the time of such cure. In addition, for the avoidance of doubt, if a Default that is not an Event of Default is cured or waived before such Default would have constituted an Event of Default, then no Event of
Default will result from such Default. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 8. AMENDMENTS, SUPPLEMENTS AND WAIVERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.01. W<SMALL>ITHOUT</SMALL> <SMALL>THE</SMALL> C<SMALL>ONSENT</SMALL> <SMALL>OF</SMALL> H<SMALL>OLDERS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in <B>Section</B><B></B><B>&nbsp;8.02</B>, the Company and the Trustee may amend or supplement this
Indenture or the Notes without the consent of any Holder to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) cure any ambiguity or correct any omission, defect or inconsistency in
this Indenture or the Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) add guarantees with respect to the Company&#8217;s obligations under this Indenture or the Notes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) secure the Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) add
to the Company&#8217;s covenants or Events of Default for the benefit of the Holders or surrender any right or power conferred on the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) provide for the assumption of the Company&#8217;s obligations under this Indenture and the Notes pursuant to, and in compliance with,
<B>Article 6</B>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) enter into supplemental indentures pursuant to, and in accordance with, <B>Section</B><B></B><B>&nbsp;5.09</B> in
connection with a Common Stock Change Event; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) irrevocably elect or eliminate any Settlement Method or Specified Dollar Amount;
<I>provided</I>, <I>however</I>, that no such election or elimination will affect any Settlement Method theretofore elected (or deemed to be elected) with respect to any Note pursuant to <B>Section</B><B></B><B>&nbsp;5.03(A)</B>; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 72 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) evidence or provide for the acceptance of the appointment, under this Indenture, of a
successor Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) conform the provisions of this Indenture and the Notes to the &#8220;Description of Notes&#8221; section of the
Company&#8217;s preliminary offering memorandum, dated November&nbsp;4, 2025, as supplemented by the related pricing term sheet, dated November&nbsp;4, 2025; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) provide for or confirm the issuance of additional Notes pursuant to <B>Section</B><B></B><B>&nbsp;2.03(B)</B>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) comply with any requirement of the SEC in connection with any qualification of this Indenture or any supplemental indenture under the
Trust Indenture Act, as then in effect; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(L) make any other change to this Indenture or the Notes that does not, individually or in the
aggregate with all other such changes, adversely affect the rights of the Holders, as such, in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the written
request of any Holder of a Note or owner of a beneficial interest in a Global Note, the Company will provide a copy of the &#8220;Description of Notes&#8221; section and pricing term sheet referred to in <B>Section</B><B></B><B>&nbsp;8.01(I)</B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.02. W<SMALL>ITH</SMALL> <SMALL>THE</SMALL> C<SMALL>ONSENT</SMALL> <SMALL>OF</SMALL> H<SMALL>OLDERS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Generally</I>. Subject to <B>Sections 8.01</B>, <B>7.05</B> and <B>7.08</B> and the immediately following sentence, the Company and the
Trustee may, with the consent of the Holders of a majority in aggregate principal amount of the Notes then outstanding, amend or supplement this Indenture or the Notes or waive compliance with any provision of this Indenture or the Notes.
Notwithstanding anything to the contrary in the foregoing sentence, but subject to <B>Section</B><B></B><B>&nbsp;8.01</B>, without the consent of each affected Holder, no amendment or supplement to this Indenture or the Notes, or waiver of any
provision of this Indenture or the Notes, may: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) reduce the principal, or change the stated maturity, of any Note; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) reduce the Redemption Price or Fundamental Change Repurchase Price for any Note or change the times at which, or the
circumstances under which, the Notes may or will be redeemed or repurchased by the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) reduce the rate, or
extend the time for the payment, of Special Interest or Additional Interest on any Note; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) make any change that
adversely affects the conversion rights of any Note; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) impair the rights of any Holder set forth in
<B>Section</B><B></B><B>&nbsp;7.08</B> (as such section is in effect on the Issue Date); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) change the ranking of the
Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) make any Note payable in money, or at a place of payment, other than that stated in this Indenture or the
Note; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 73 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) reduce the amount of Notes whose Holders must consent to any
amendment, supplement, waiver or other modification; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) make any direct or indirect change to any amendment,
supplement, waiver or modification provision of this Indenture or the Notes that requires the consent of each affected Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
avoidance of doubt, pursuant to <B>clauses</B> <B>(i)</B>, <B>(ii)</B>, <B>(iii)</B> and <B>(iv)</B>&nbsp;of this <B>Section</B><B></B><B>&nbsp;8.02(A)</B>, no amendment or supplement to this Indenture or the Notes, or waiver of any provision of
this Indenture or the Notes, may change the amount or type of consideration due on any Note (whether on an Interest Payment Date, Redemption Date, Fundamental Change Repurchase Date or the Maturity Date or upon conversion, or otherwise), or the
date(s) or time(s) such consideration is payable or deliverable, as applicable, without the consent of each affected Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)
<I>Holders Need Not Approve the Particular Form of any Amendment</I>. A consent of any Holder pursuant to this <B>Section</B><B></B><B>&nbsp;8.02</B> need approve only the substance, and not necessarily the particular form, of the proposed
amendment, supplement or waiver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.03. N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> A<SMALL>MENDMENTS</SMALL>, S<SMALL>UPPLEMENTS</SMALL>
<SMALL>AND</SMALL> W<SMALL>AIVERS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as reasonably practicable after any amendment, supplement or waiver pursuant to
<B>Section</B><B>&nbsp;8.01</B> or <B>8.02</B> becomes effective, the Company will send to the Holders and the Trustee notice that (A)&nbsp;describes the substance of such amendment, supplement or waiver in reasonable detail and (B)&nbsp;states the
effective date thereof; <I>provided</I>, <I>however</I>, that the Company will not be required to provide such notice to the Holders if such amendment, supplement or waiver is included in a periodic report filed by the Company with the SEC within
four (4)&nbsp;Business Days of its effectiveness. The failure to send, or the existence of any defect in, such notice will not impair or affect the validity of such amendment, supplement or waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.04. R<SMALL>EVOCATION</SMALL>, E<SMALL>FFECT</SMALL> <SMALL>AND</SMALL> S<SMALL>OLICITATION</SMALL> <SMALL>OF</SMALL>
C<SMALL>ONSENTS</SMALL>; S<SMALL>PECIAL</SMALL> R<SMALL>ECORD</SMALL> D<SMALL>ATES</SMALL>; E<SMALL>TC</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) <I>Revocation and
Effect of Consents</I>. The consent of a Holder of a Note to an amendment, supplement or waiver will bind (and constitute the consent of) each subsequent Holder of any Note to the extent the same evidences any portion of the same indebtedness as the
consenting Holder&#8217;s Note, subject to the right of any Holder of a Note to revoke (if not prohibited pursuant to <B>Section</B><B></B><B>&nbsp;8.04(B)</B>) any such consent with respect to such Note by delivering notice of revocation to the
Trustee before the time such amendment, supplement or waiver becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) <I>Special Record Dates</I>. The Company may, but is
not required to, fix a record date for the purpose of determining the Holders entitled to consent or take any other action in connection with any amendment, supplement or waiver pursuant to this <B>Article 8</B>. If a record date is fixed, then,
notwithstanding anything to the contrary in <B>Section</B><B></B><B>&nbsp;8.04(A)</B>, only Persons who are Holders as of such record date (or their duly designated proxies) will be entitled to give such consent, to revoke any consent previously
given or to take any such action, regardless of whether such Persons continue to be Holders after such record date; <I>provided</I>, <I>however</I>, that no such consent will be valid or effective for more than one hundred and twenty
(120)&nbsp;calendar days after such record date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 74 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) <I>Solicitation of Consents</I>. For the avoidance of doubt, each reference in this
Indenture or the Notes to the consent of a Holder will be deemed to include any such consent obtained in connection with a repurchase of, or tender or exchange offer for, any Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) <I>Effectiveness and Binding Effect</I>. Each amendment, supplement or waiver pursuant to this <B>Article 8</B> will become effective in
accordance with its terms and, when it becomes effective with respect to any Note (or any portion thereof), will thereafter bind every Holder of such Note (or such portion). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.05. N<SMALL>OTATIONS</SMALL> <SMALL>AND</SMALL> E<SMALL>XCHANGES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any amendment, supplement or waiver changes the terms of a Note, then the Trustee or the Company may, in its discretion, require the Holder
of such Note to deliver such Note to the Trustee so that the Trustee may place an appropriate notation prepared by the Company on such Note and return such Note to such Holder. Alternatively, at its discretion, the Company may, in exchange for such
Note, issue, execute and deliver, and the Trustee will authenticate, in each case in accordance with <B>Section</B><B></B><B>&nbsp;2.02</B>, a new Note that reflects the changed terms. The failure to make any appropriate notation or issue a new Note
pursuant to this <B>Section</B><B></B><B>&nbsp;8.05</B> will not impair or affect the validity of such amendment, supplement or waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;8.06. T<SMALL>RUSTEE</SMALL> <SMALL>TO</SMALL> E<SMALL>XECUTE</SMALL> S<SMALL>UPPLEMENTAL</SMALL> I<SMALL>NDENTURES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee will execute and deliver any amendment or supplemental indenture authorized pursuant to this <B>Article 8</B>; <I>provided</I>,
<I>however</I>, that the Trustee need not (but may, in its sole and absolute discretion) execute or deliver any such amendment or supplemental indenture that the Trustee concludes adversely affects the Trustee&#8217;s rights, duties, liabilities or
immunities. In executing any amendment or supplemental indenture, the Trustee will be entitled to receive, and (subject to <B>Sections</B> <B>10.01</B> and <B>10.02</B>) will be fully protected in relying on, an Officer&#8217;s Certificate and an
Opinion of Counsel stating that (A)&nbsp;the execution and delivery of such amendment or supplemental indenture is authorized or permitted by this Indenture; and (B)&nbsp;in the case of the Opinion of Counsel, such amendment or supplemental
indenture is valid, binding and enforceable against the Company in accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 9. SATISFACTION AND DISCHARGE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.01. T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> C<SMALL>OMPANY</SMALL>&#8217;<SMALL>S</SMALL> O<SMALL>BLIGATIONS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indenture will be discharged, and will cease to be of further effect as to all Notes issued under this Indenture, when: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) all Notes then outstanding (other than Notes replaced pursuant to <B>Section</B><B></B><B>&nbsp;2.13</B>) have (i)&nbsp;been delivered to
the Trustee for cancellation; or (ii)&nbsp;become due and payable (whether on a Redemption Date, a Fundamental Change Repurchase Date, the Maturity Date, upon conversion or otherwise) for an amount of cash or Conversion Consideration, as applicable,
that has been fixed; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 75 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) the Company has caused there to be irrevocably deposited with the Trustee, or with the
Paying Agent (or, with respect to Conversion Consideration, the Conversion Agent), in each case for the benefit of the Holders, or has otherwise caused there to be delivered to the Holders, cash (or, with respect to Notes to be converted, Conversion
Consideration) sufficient to satisfy all amounts or other property due on all Notes then outstanding (other than Notes replaced pursuant to <B>Section</B><B></B><B>&nbsp;2.13</B>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) the Company has paid all other amounts payable by it under this Indenture; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) the Company has delivered to the Trustee an Officer&#8217;s Certificate and an Opinion of Counsel, each stating that the conditions
precedent to the discharge of this Indenture have been satisfied; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I>, <I>however</I>, that <B>Article 10</B> and
<B>Section</B><B></B><B>&nbsp;11.01</B> will survive such discharge and, until no Notes remain outstanding, <B>Section</B><B></B><B>&nbsp;2.15</B> and the obligations of the Trustee, the Paying Agent and the Conversion Agent with respect to money or
other property deposited with them will survive such discharge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Company&#8217;s request, the Trustee will acknowledge the
satisfaction and discharge of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.02. R<SMALL>EPAYMENT</SMALL> <SMALL>TO</SMALL> C<SMALL>OMPANY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to applicable unclaimed property law, the Trustee, the Paying Agent and the Conversion Agent will promptly notify the Company if there
exists (and, at the Company&#8217;s request, promptly deliver to the Company) any cash, Conversion Consideration or other property held by any of them for payment or delivery on the Notes that remain unclaimed two (2)&nbsp;years after the date on
which such payment or delivery was due. After such delivery to the Company, the Trustee, the Paying Agent and the Conversion Agent will have no further liability to any Holder with respect to such cash, Conversion Consideration or other property,
and Holders entitled to the payment or delivery of such cash, Conversion Consideration or other property must look to the Company for payment as a general creditor of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.03. R<SMALL>EINSTATEMENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee, the Paying Agent or the Conversion Agent is unable to apply any cash or other property deposited with it pursuant to
<B>Section</B><B></B><B>&nbsp;9.01</B> because of any legal proceeding or any order or judgment of any court or other governmental authority that enjoins, restrains or otherwise prohibits such application, then the discharge of this Indenture
pursuant to <B>Section</B><B></B><B>&nbsp;9.01</B> will be rescinded; <I>provided</I>, <I>however</I>, that if the Company thereafter pays or delivers any cash or other property due on the Notes to the Holders thereof, then the Company will be
subrogated to the rights of such Holders to receive such cash or other property from the cash or other property, if any, held by the Trustee, the Paying Agent or the Conversion Agent, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 76 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 10. TRUSTEE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.01. D<SMALL>UTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> T<SMALL>RUSTEE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) If an Event of Default has occurred and is continuing, of which a Responsible Officer of the Trustee has actual or written knowledge, the
Trustee will exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person&#8217;s
own affairs; <I>provided</I> that the Trustee will be under no obligation to exercise any of the rights or powers under this Indenture at the request or direction of any of the Holders unless such Holders have offered, and if requested, provided, to
the Trustee indemnity or security satisfactory to Trustee against any loss, liability or expense that might be incurred by it in compliance with such request or direction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) Except during the continuance of an Event of Default: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the duties of the Trustee will be determined solely by the express provisions of this Indenture, and the Trustee need
perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations will be read into this Indenture against the Trustee; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) in the absence of bad faith or willful misconduct on its part, the Trustee may conclusively rely, as to the truth of the
statements and the correctness of the opinions expressed therein, upon Officer&#8217;s Certificates or Opinions of Counsel that are provided to the Trustee and conform to the requirements of this Indenture. However, the Trustee will examine the
certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) The Trustee may not be relieved from liabilities for its negligence or willful misconduct, except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this paragraph will not limit the effect of <B>Section</B><B></B><B>&nbsp;10.01(B)</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Trustee will not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved
that the Trustee was negligent in ascertaining the pertinent facts; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Trustee will not be liable with respect
to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to <B>Section</B><B></B><B>&nbsp;7.06</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) Each provision of this Indenture that in any way relates to the Trustee is subject to paragraphs <B>(A)</B>, <B>(B)</B> and
<B>(C)</B>&nbsp;of this <B>Section</B><B></B><B>&nbsp;10.01</B>, regardless of whether such provision so expressly provides. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) No
provision of this Indenture will require the Trustee to expend or risk its own funds or incur any liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 77 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) The Trustee will not be liable for interest on any money received by it, except as the
Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds, except to the extent required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) Whether or not therein provided, every provision of this Indenture relating to the conduct or affecting the liability of, or affording
protection to, the Trustee will be subject to this <B>Section</B><B></B><B>&nbsp;10.01</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) If any party fails to deliver a notice
relating to an event the fact of which, pursuant to this Indenture, requires notice to be sent to the Trustee, the Trustee may conclusively rely on its failure to receive such notice as reason to act as if no such event occurred, unless a
Responsible Officer of the Trustee had actual knowledge of such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.02. R<SMALL>IGHTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL>
T<SMALL>RUSTEE</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) The Trustee may conclusively rely on any document that it believes to be genuine and signed or presented
by the proper Person, and the Trustee need not investigate any fact or matter stated in such document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) Before the Trustee acts or
refrains from acting, it may require an Officer&#8217;s Certificate, an Opinion of Counsel or both. The Trustee will not be liable for any action it takes or omits to take in good faith in reliance on such Officer&#8217;s Certificate or Opinion of
Counsel. The Trustee may consult with counsel; and the written advice of such counsel, or any Opinion of Counsel, will constitute full and complete authorization of the Trustee to take or omit to take any action in good faith in reliance thereon
without liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) The Trustee may act through its attorneys and agents and will not be responsible for the misconduct or negligence
of any such agent appointed with due care. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) The Trustee will not be liable for any action it takes or omits to take in good faith and
that it believes to be authorized or within the rights or powers vested in it by this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) Unless otherwise specifically
provided in this Indenture, any demand, request, direction or notice from the Company will be sufficient if signed by an Officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) The Trustee need not exercise any rights or powers vested in it by this Indenture at the request or direction of any Holder unless such
Holder has offered (and, if requested, provided) the Trustee security or indemnity satisfactory to the Trustee against any loss, liability or expense that it may incur in complying with such request or direction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(G) The Trustee will not be responsible or liable for any punitive, special, indirect or consequential loss or damage (including lost
profits), even if the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(H) The
permissive rights of the Trustee enumerated herein will not be construed as duties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(I) The Trustee will not be required to give any bond
or surety in respect of the execution of this Indenture or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 78 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(J) Unless a Responsible Officer of the Trustee has received notice from the Company that
Additional Interest is owing on the Notes or that the Company has elected to pay Special Interest on the Notes, the Trustee may assume no Additional Interest or Special Interest, as applicable, is payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(K) The rights, privileges, protections, immunities and benefits given to the Trustee, including its right to be indemnified, are extended to,
and will be enforceable by, the Trustee in each of its capacities under this Indenture, including as Note Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(L) The Trustee will not
be charged with knowledge of any document or agreement other than this Indenture and the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(M) The Trustee may request that the
Company deliver a certificate setting forth the names of individuals or titles of officers authorized at such time to take specified actions pursuant to this Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(N) Neither the Trustee nor any Note Agent will have any responsibility or liability to any person for any action taken or not taken by, or
any records or any other aspect of the operations of, the Depositary (including the delivery of notices, or the making of payments, through the facilities of the Depositary) and may conclusively rely, without investigation, on any information
provided by the Depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.03. I<SMALL>NDIVIDUAL</SMALL> R<SMALL>IGHTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL>
T<SMALL>RUSTEE</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee, in its individual or any other capacity, may become the owner or pledgee of any Note and may
otherwise deal with the Company or any of its Affiliates with the same rights that it would have if it were not Trustee; <I>provided</I>, <I>however</I>, that if the Trustee acquires a &#8220;conflicting interest&#8221; (within the meaning of
Section&nbsp;310(b) of the Trust Indenture Act), then it must eliminate such conflict within ninety (90)&nbsp;days or resign as Trustee. Each Note Agent will have the same rights and duties as the Trustee under this
<B>Section</B><B></B><B>&nbsp;10.03</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.04. T<SMALL>RUSTEE</SMALL>&#8217;<SMALL>S</SMALL> D<SMALL>ISCLAIMER</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee will not be (A)&nbsp;responsible for, and makes no representation as to, the validity or adequacy of this Indenture or the Notes;
(B)&nbsp;accountable for the Company&#8217;s use of the proceeds from the Notes or any money paid to the Company or upon the Company&#8217;s direction under any provision of this Indenture; (C)&nbsp;responsible for the use or application of any
money received by any Paying Agent other than the Trustee; and (D)&nbsp;responsible for any statement or recital in this Indenture, the Notes or any other document relating to the sale of the Notes or this Indenture, other than the Trustee&#8217;s
certificate of authentication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 79 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.05. N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> D<SMALL>EFAULTS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Default or Event of Default occurs and is continuing and is actually known to a Responsible Officer of the Trustee, then the Trustee will
send Holders a notice of such Default or Event of Default within ninety (90)&nbsp;days after it occurs or, if it is not actually known to a Responsible Officer of the Trustee at such time, promptly (and in any event within ten (10)&nbsp;Business
Days) after it becomes actually known to a Responsible Officer; <I>provided</I>, <I>however</I>, that, except in the case of a Default or Event of Default in the payment of the principal of, or interest, if any, on, any Note, or a Default in the
payment or delivery of any Conversion Consideration upon conversion of any Note, the Trustee may withhold such notice if and for so long as it in good faith determines that withholding such notice is in the interests of the Holders. The Trustee will
not be deemed to have notice or be charged with knowledge of any Default or Event of Default unless written notice thereof has been received by a Responsible Officer, and such notice references the Notes and this Indenture and states on its face
that a Default or Event of Default has occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.06. C<SMALL>OMPENSATION</SMALL> <SMALL>AND</SMALL> I<SMALL>NDEMNITY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) The Company will, from time to time, pay the Trustee and the Note Agents reasonable compensation for its acceptance of this Indenture and
services under this Indenture, as separately agreed by the Company and the Trustee. The Trustee&#8217;s compensation will not be limited by any law on compensation of a trustee of an express trust. In addition to the compensation for the
Trustee&#8217;s services, the Company will reimburse the Trustee promptly upon request for all reasonable disbursements, advances and expenses incurred or made by it under this Indenture, including the reasonable compensation, disbursements and
expenses of the Trustee&#8217;s agents and counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) The Company will indemnify the Trustee (in each of its capacities under this
Indenture) and its directors, officers, employees and agents, in their capacities as such, against any and all losses, liabilities or expenses incurred by it arising out of or in connection with the acceptance or administration of its duties under
this Indenture, including the costs and expenses of enforcing this Indenture against the Company (including this <B>Section</B><B></B><B>&nbsp;10.06</B>) and defending itself against any claim (whether asserted by the Company, any Holder or any
other Person) or liability in connection with the exercise or performance of any of its powers or duties under this Indenture, except to the extent any such loss, liability or expense is attributable to its negligence or willful misconduct, as
determined by a final decision of a court of competent jurisdiction. The Trustee will promptly notify the Company of any claim for which it may seek indemnity, but the Trustee&#8217;s failure to so notify the Company will not relieve the Company of
its obligations under this <B>Section</B><B></B><B>&nbsp;10.06(B)</B>, except to the extent the Company is materially prejudiced by such failure. The Company will defend such claim, and the Trustee will cooperate in such defense. If the Trustee is
advised by counsel that it may have defenses available to it that are in conflict with the defenses available to the Company, or that there is an actual or potential conflict of interest, then the Trustee may retain separate counsel, and the Company
will pay the reasonable fees and expenses of such counsel (including the reasonable fees and expenses of counsel to the Trustee incurred in evaluating whether such a conflict exists). The Company need not pay for any settlement of any such claim
made without its consent, which consent will not be unreasonably withheld. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) The obligations of the Company under this
<B>Section</B><B></B><B>&nbsp;10.06</B> will survive the resignation or removal of the Trustee and the discharge of this Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)
To secure the Company&#8217;s payment obligations in this <B>Section</B><B></B><B>&nbsp;10.06</B>, the Trustee will have a lien prior to the Notes on all money or property held or collected by the Trustee, except that held in trust to pay principal
of, or interest, if any, on, particular Notes, which lien will survive the discharge of this Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 80 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) If the Trustee incurs expenses or renders services after an Event of Default pursuant to
<B>clause</B> <B>(viii)</B>&nbsp;or <B>(ix)</B> of <B>Section</B><B></B><B>&nbsp;7.01(A)</B> occurs, then such expenses and the compensation for such services (including the fees and expenses of its agents and counsel) are intended to constitute
expenses of administration under any Bankruptcy Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.07. R<SMALL>EPLACEMENT</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL>
T<SMALL>RUSTEE</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) Notwithstanding anything to the contrary in this <B>Section</B><B></B><B>&nbsp;10.07</B>, a resignation
or removal of the Trustee, and the appointment of a successor Trustee, will become effective only upon such successor Trustee&#8217;s acceptance of appointment as provided in this <B>Section</B><B></B><B>&nbsp;10.07</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) The Trustee may resign at any time and be discharged from the trust created by this Indenture by so notifying the Company. The Holders of
a majority in aggregate principal amount of the Notes then outstanding may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Trustee fails to comply with <B>Section</B><B></B><B>&nbsp;10.09</B>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Trustee is adjudged to be bankrupt or insolvent or an order for relief is entered with respect to the Trustee under
any Bankruptcy Law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a custodian or public officer takes charge of the Trustee or its property; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the Trustee becomes incapable of acting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) If the Trustee resigns or is removed, or if a vacancy exists in the office of the Trustee for any reason, then (i)&nbsp;the Company will
promptly appoint a successor Trustee; and (ii)&nbsp;at any time within one (1)&nbsp;year after the successor Trustee takes office, the Holders of a majority in aggregate principal amount of the Notes then outstanding may appoint a successor Trustee
to replace such successor Trustee appointed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) If a successor Trustee does not take office within sixty (60)&nbsp;days
after the retiring Trustee resigns or is removed, then the retiring Trustee, the Company or the Holders of at least ten percent (10%) in aggregate principal amount of the Notes then outstanding may petition any court of competent jurisdiction for
the appointment of a successor Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E) If the Trustee, after written request by a Holder of at least six (6)&nbsp;months, fails to
comply with <B>Section</B><B></B><B>&nbsp;10.09</B>, then such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F) A successor Trustee will deliver a written acceptance of its appointment to the retiring Trustee and to the Company, upon which notice the
resignation or removal of the retiring Trustee will become effective and the successor Trustee will have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee will send notice of its succession to Holders. The
retiring Trustee will, upon payment of all amounts due to it under this Indenture, promptly transfer all property held by it as Trustee to the successor Trustee, which property will, for the avoidance of doubt, be subject to the lien provided for in
<B>Section</B><B></B><B>&nbsp;10.06(D)</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 81 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.08. S<SMALL>UCCESSOR</SMALL> T<SMALL>RUSTEE</SMALL> <SMALL>BY</SMALL>
M<SMALL>ERGER</SMALL>, E<SMALL>TC</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee consolidates, merges or converts into, or transfers all or substantially
all of its corporate trust business to, another entity, then such entity will become the successor Trustee without any further act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;10.09. E<SMALL>LIGIBILITY</SMALL>; D<SMALL>ISQUALIFICATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There will at all times be a Trustee under this Indenture that is a corporation organized and doing business under the laws of the United
States of America or of any state thereof, that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined capital and surplus of at least
$100.0&nbsp;million as set forth in its most recent published annual report of condition. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article 11. MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.01. N<SMALL>OTICES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice or communication by the Company or the Trustee to the other will be deemed to have been duly given if in writing and delivered in
person or by first class mail (registered or certified, return receipt requested), facsimile transmission, electronic transmission or other similar means of unsecured electronic communication or overnight air courier guaranteeing next day delivery,
or to the other&#8217;s address, which initially is as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Guardant Health, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3100
Hanover Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Palo Alto, CA 94304 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Chief Financial Officer </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One Bush Plaza, Suite 1200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San
Francisco, CA 94104 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Andrew Thorpe </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If to the Trustee: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">U.S. Bank
Trust Company, National Association </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Global Corporate Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1 California Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite 1000
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">415-677-3769</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Guardant Health, Inc. Administrator </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 82 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in the preceding paragraph, notices to the Trustee
(other than a notice pursuant to <B>Section</B><B></B><B>&nbsp;2.12</B>) or any Note Agent must be in writing and will be deemed to have been given upon actual receipt by the Trustee or such Note Agent, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company or the Trustee, by notice to the other, may designate additional or different addresses (including facsimile numbers and
electronic addresses) for subsequent notices or communications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any communication sent to Trustee under this Indenture that requires a
signature must be in the form of a document that is signed manually or by way of a digital signature provided by DocuSign (or such other digital signature provider as specified in writing to Trustee by an authorized representative of the Company).
The Company agrees to assume all risks arising out of its use of digital signatures and electronic methods to submit communications to Trustee, including the risk of the Trustee acting on unauthorized instructions and the risk of interception and
misuse by third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices and communications (other than those sent to Holders) will be deemed to have been duly given:
(A)&nbsp;at the time delivered by hand, if personally delivered; (B)&nbsp;five (5) Business Days after being deposited in the mail, postage prepaid, if mailed; (C)&nbsp;when receipt acknowledged, if transmitted by facsimile, electronic transmission
or other similar means of unsecured electronic communication; and (D)&nbsp;the next Business Day after timely delivery to the courier, if sent by overnight air courier guaranteeing next day delivery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices or communications required to be made to a Holder pursuant to this Indenture must be made in writing and will be deemed to be duly
sent or given in writing if mailed by first class mail, certified or registered, return receipt requested, or by overnight air courier guaranteeing next day delivery, to its address shown on the Register; <I>provided</I>, <I>however</I>, that a
notice or communication to a Holder of a Global Note may, but need not, instead be sent pursuant to the Depositary Procedures (in which case, such notice will be deemed to be duly sent or given in writing). The failure to send a notice or
communication to a Holder, or any defect in such notice or communication, will not affect its sufficiency with respect to any other Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Trustee is then acting as the Depositary&#8217;s custodian for the Notes, then, at the reasonable request of the Company to the
Trustee, the Trustee will cause any notice prepared by the Company to be sent to any Holder(s) pursuant to the Depositary Procedures, <I>provided</I> such request is evidenced in a Company Order delivered, together with the text of such notice, to
the Trustee at least two (2)&nbsp;Business Days before the date such notice is to be so sent. For the avoidance of doubt, such Company Order need not be accompanied by an Officer&#8217;s Certificate or Opinion of Counsel. The Trustee will not have
any liability relating to the contents of any notice that it sends to any Holder pursuant to any such Company Order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a notice or
communication is mailed or sent in the manner provided above within the time prescribed, it will be deemed to have been duly given, whether or not the addressee receives it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 83 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Indenture or the Notes, (A)&nbsp;whenever
any provision of this Indenture requires a party to send notice to another party, no such notice need be sent if the sending party and the recipient are the same Person acting in different capacities; and (B)&nbsp;whenever any provision of this
Indenture requires a party to send notice to more than one receiving party, and each receiving party is the same Person acting in different capacities, then only one such notice need be sent to such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.02. D<SMALL>ELIVERY</SMALL> <SMALL>OF</SMALL> O<SMALL>FFICER</SMALL>&#8217;<SMALL>S</SMALL> C<SMALL>ERTIFICATE</SMALL> <SMALL>AND</SMALL>
O<SMALL>PINION</SMALL> <SMALL>OF</SMALL> C<SMALL>OUNSEL</SMALL> <SMALL>AS</SMALL> <SMALL>TO</SMALL> C<SMALL>ONDITIONS</SMALL> P<SMALL>RECEDENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon any request or application by the Company to the Trustee to take any action under this Indenture (other than the initial authentication
of Notes under this Indenture), the Company will furnish to the Trustee: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) an Officer&#8217;s Certificate that complies with
<B>Section</B><B></B><B>&nbsp;11.03</B> and states that, in the opinion of the signatory thereto, all conditions precedent and covenants, if any, provided for in this Indenture relating to such action have been satisfied; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) an Opinion of Counsel that complies with <B>Section</B><B></B><B>&nbsp;11.03</B> and states that, in the opinion of such counsel, all such
conditions precedent and covenants, if any, have been satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.03. S<SMALL>TATEMENTS</SMALL> R<SMALL>EQUIRED</SMALL>
<SMALL>IN</SMALL> O<SMALL>FFICER</SMALL>&#8217;<SMALL>S</SMALL> C<SMALL>ERTIFICATE</SMALL> <SMALL>AND</SMALL> O<SMALL>PINION</SMALL> <SMALL>OF</SMALL> C<SMALL>OUNSEL</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Officer&#8217;s Certificate (other than an Officer&#8217;s Certificate pursuant to <B>Section</B><B></B><B>&nbsp;3.05</B>) or Opinion of
Counsel with respect to compliance with a covenant or condition provided for in this Indenture will include: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) a statement that the
signatory thereto has read such covenant or condition; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) a brief statement as to the nature and scope of the examination or
investigation upon which the statements or opinions contained therein are based; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C) a statement that, in the opinion of such signatory,
he, she or it has made such examination or investigation as is necessary to enable him, her or it to express an informed opinion as to whether or not such covenant or condition has been satisfied; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) a statement as to whether, in the opinion of such signatory, such covenant or condition has been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.04. R<SMALL>ULES</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> T<SMALL>RUSTEE</SMALL>, <SMALL>THE</SMALL> R<SMALL>EGISTRAR</SMALL>,
<SMALL>THE</SMALL> P<SMALL>AYING</SMALL> A<SMALL>GENT</SMALL> <SMALL>AND</SMALL> <SMALL>THE</SMALL> C<SMALL>ONVERSION</SMALL> A<SMALL>GENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar, the Paying Agent and the Conversion Agent may
make reasonable rules and set reasonable requirements for its functions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 84 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.05. N<SMALL>O</SMALL> P<SMALL>ERSONAL</SMALL> L<SMALL>IABILITY</SMALL> <SMALL>OF</SMALL>
D<SMALL>IRECTORS</SMALL>, O<SMALL>FFICERS</SMALL>, E<SMALL>MPLOYEES</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCKHOLDERS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No past,
present or future director, officer, employee, incorporator or stockholder of the Company, as such, will have any liability for any obligations of the Company under this Indenture or the Notes or for any claim based on, in respect of, or by reason
of, such obligations or their creation. By accepting any Note, each Holder waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.06. G<SMALL>OVERNING</SMALL> L<SMALL>AW</SMALL>; W<SMALL>AIVER</SMALL> <SMALL>OF</SMALL> J<SMALL>URY</SMALL> T<SMALL>RIAL</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS INDENTURE AND THE NOTES, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS INDENTURE OR THE NOTES, WILL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EACH OF THE COMPANY AND THE TRUSTEE IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT
OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED BY THIS INDENTURE OR THE NOTES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.07.
S<SMALL>UBMISSION</SMALL> <SMALL>TO</SMALL> J<SMALL>URISDICTION</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any legal suit, action or proceeding arising out of or based
upon this Indenture or the transactions contemplated by this Indenture may be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York, in each case located in the City
of New York (collectively, the &#8220;<B>Specified Courts</B>&#8221;), and each party irrevocably submits to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any such suit, action or proceeding. Service of any
process, summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#8217;s address set forth in <B>Section</B><B></B><B>&nbsp;11.01</B> will be effective service of process for any such
suit, action or proceeding brought in any such court. Each of the Company, the Trustee and each Holder (by its acceptance of any Note) irrevocably and unconditionally waives any objection to the laying of venue of any suit, action or other
proceeding in the Specified Courts and irrevocably and unconditionally waives and agrees not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.08. N<SMALL>O</SMALL> A<SMALL>DVERSE</SMALL> I<SMALL>NTERPRETATION</SMALL> <SMALL>OF</SMALL> O<SMALL>THER</SMALL>
A<SMALL>GREEMENTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this Indenture nor the Notes may be used to interpret any other indenture, note, loan or debt
agreement of the Company or its Subsidiaries or of any other Person, and no such indenture, note, loan or debt agreement may be used to interpret this Indenture or the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.09. S<SMALL>UCCESSORS</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All agreements of the Company in this Indenture and the Notes will bind its successors. All agreements of the Trustee in this Indenture will
bind its successors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 85 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.10. F<SMALL>ORCE</SMALL> M<SMALL>AJEURE</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee and each Note Agent will not incur any liability for not performing any act or fulfilling any duty, obligation or responsibility
under this Indenture or the Notes by reason of any occurrence beyond its control (including any act or provision of any present or future law or regulation or governmental authority, act of God or war, civil unrest, local or national disturbance or
disaster, act of terrorism or unavailability of the Federal Reserve Bank wire or facsimile or other wire or communication facility). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.11. U.S.A. PATRIOT A<SMALL>CT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company acknowledges that, in accordance with Section&nbsp;326 of the U.S.A. PATRIOT Act, the Trustee, like all financial institutions, in
order to help fight the funding of terrorism and money laundering, is required to obtain, verify and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The Company
agrees to provide the Trustee with such information as it may request to enable the Trustee to comply with the U.S.A. PATRIOT Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.12.
C<SMALL>ALCULATIONS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in this Indenture, the Company will be responsible for making all
calculations called for under this Indenture or the Notes, including determinations of the Last Reported Sale Price, the Daily Conversion Value, the Daily Cash Amount, the Daily Share Amount, the Daily VWAP, the Trading Price, accrued interest on
the Notes (including any Additional Interest or Special Interest), the Redemption Price, the Fundamental Change Repurchase Price and the Conversion Rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will make all calculations in good faith, and, absent manifest error, its calculations will be final and binding on all Holders.
The Company will provide a schedule of its calculations to the Trustee and the Conversion Agent (if other than the Trustee), and each of the Trustee and the Conversion Agent may rely conclusively on the accuracy of the Company&#8217;s calculations
without independent verification. The Trustee will promptly forward a copy of each such schedule to a Holder upon its written request therefor. For the avoidance of doubt, the Trustee will not be obligated to make or confirm any calculations called
for under this Indenture or the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.13. S<SMALL>EVERABILITY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of this Indenture or the Notes is invalid, illegal or unenforceable, then the validity, legality and enforceability of the
remaining provisions of this Indenture or the Notes will not in any way be affected or impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.14.
C<SMALL>OUNTERPARTS</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties may sign any number of copies of this Indenture. Each signed copy will be an original, and
all of them together represent the same agreement. Delivery of an executed counterpart of this Indenture by facsimile, electronically in portable document format or in any other format will be effective as delivery of a manually executed
counterpart. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 86 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.15. T<SMALL>ABLE</SMALL> <SMALL>OF</SMALL> C<SMALL>ONTENTS</SMALL>,
H<SMALL>EADINGS</SMALL>, E<SMALL>TC</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table of contents and the headings of the Articles and Sections of this Indenture
have been inserted for convenience of reference only, are not to be considered a part of this Indenture and will in no way modify or restrict any of the terms or provisions of this Indenture. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;11.16. W<SMALL>ITHHOLDING</SMALL> T<SMALL>AXES</SMALL>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Holder of a Note agrees, and each beneficial owner of an interest in a Global Note, by its acquisition of such interest, is deemed to
agree, that if the Company or other applicable withholding agent (including the Trustee) pays withholding taxes or backup withholding on behalf of such Holder or beneficial owner as a result of an adjustment or the
<FONT STYLE="white-space:nowrap">non-occurrence</FONT> of an adjustment to the Conversion Rate, then the Company or such withholding agent, as applicable, may, at its option, withhold from or set off such payments against payments of cash or the
delivery of other Conversion Consideration on such Note, any payments on the Common Stock or sales proceeds received by, or other funds or assets of, such Holder or the beneficial owner of such Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<B><I>The Remainder of This Page Intentionally Left Blank; Signature Page Follows</I></B>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 87 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties to this Indenture have caused this Indenture to be
duly executed as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">G<SMALL>UARDANT</SMALL> H<SMALL>EALTH</SMALL>, I<SMALL>NC</SMALL>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John G. Saia</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: John G. Saia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Legal Officer and Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">U.S. B<SMALL>ANK</SMALL> T<SMALL>RUST</SMALL> C<SMALL>OMPANY</SMALL>, N<SMALL>ATIONAL</SMALL> A<SMALL>SSOCIATION</SMALL>, <SMALL>AS</SMALL> T<SMALL>RUSTEE</SMALL></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Jason</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Jason</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Indenture] </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>FORM OF NOTE </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Insert
Global Note Legend, if applicable</I>] </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Insert Restricted Note Legend, if applicable</I>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Insert Affiliate Resale Legend</I>] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GUARDANT HEALTH, INC. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>0%
Convertible Senior Notes due 2033 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP No.: [<U>&#8195; </U>][<I>Insert for a </I><I>&#8220;</I><I>restricted</I><I>&#8221;</I><I> CUSIP number</I>: <SUP STYLE="font-size:75%; vertical-align:top">1</SUP>]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Certificate No. [<U>&#8195; </U>]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ISIN No.:&#8194;&#8201; [<U>&#8195; </U>][<I>Insert for a &#8220;restricted&#8221; ISIN number</I>: <SUP STYLE="font-size:75%; vertical-align:top">1</SUP>]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Guardant Health, Inc., a Delaware corporation, for value received, promises to pay to [Cede&nbsp;&amp; Co.],
or its registered assigns, the principal sum of [<U>&#8195;</U>] dollars ($[<U>&#8195;</U>]) [(as revised by the attached Schedule of Exchanges of Interests in the Global Note)]<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> on May&nbsp;15,
2033 and, to the extent applicable, to pay Special Interest and Additional Interest thereon, as provided in the Indenture referred to below, until the principal and all accrued and unpaid interest, if any, are paid or duly provided for. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest Payment Dates: May&nbsp;15 and November&nbsp;15 of each year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest Record Dates: &#8194;May&nbsp;1 and November 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional provisions of this Note are set forth on the other side of this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<B><I>The Remainder of This Page Intentionally Left Blank; Signature Page Follows</I></B>]
</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Note will be deemed to be identified by CUSIP No. [<U>&#8195; </U>] and ISIN No. [<U>&#8195; </U>] from
and after such time when the Company delivers, pursuant to Section&nbsp;2.12 of the within-mentioned Indenture, written notice to the Trustee of the deemed removal of the Restricted Note Legend affixed to this Note. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Insert bracketed language for Global Notes only. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, Guardant Health, Inc. has caused this instrument to be duly
executed as of the date set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">G<SMALL>UARDANT</SMALL> H<SMALL>EALTH</SMALL>, I<SMALL>NC</SMALL>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195; </U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRUSTEE&#8217;S CERTIFICATE OF AUTHENTICATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Bank Trust Company, National Association, as Trustee, certifies that this is one of the Notes referred to in the within-mentioned Indenture. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195; </U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GUARDANT HEALTH, INC. </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>0% Convertible Senior Notes due 2033 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized issue of notes of Guardant Health, Inc., a Delaware corporation (the &#8220;<B>Company</B>&#8221;),
designated as its 0% Convertible Senior Notes due 2033 (the &#8220;<B>Notes</B>&#8221;), all issued or to be issued pursuant to an indenture, dated as of November&nbsp;7, 2025 (as the same may be amended from time to time, the
&#8220;<B>Indenture</B>&#8221;), between the Company and U.S. Bank Trust Company, National Association, as trustee. Capitalized terms used in this Note without definition have the respective meanings ascribed to them in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture sets forth the rights and obligations of the Company, the Trustee and the Holders and the terms of the Notes. Notwithstanding
anything to the contrary in this Note, to the extent that any provision of this Note conflicts with the provisions of the Indenture, the provisions of the Indenture will control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B>Interest</B>. This Note will not bear regular interest, and the principal amount of this Note will not accrete. Special Interest and
Additional Interest will accrue on this Note in the circumstances, at the rates, and payable on the dates, set forth in Sections 2.05, 7.03 and 3.04 of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B>Maturity</B>. This Note will mature on May&nbsp;15, 2033, unless earlier repurchased, redeemed or converted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B>Method of Payment</B>. Cash amounts due on this Note will be paid in the manner set forth in Section&nbsp;2.04 of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B>Persons Deemed Owners</B>. The Holder of this Note will be treated as the owner of this Note for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B>Denominations; Transfers and Exchanges</B>. All Notes will be in registered form, without coupons, in principal amounts equal to any
Authorized Denominations. Subject to the terms of the Indenture, the Holder of this Note may transfer or exchange this Note by presenting it to the Registrar and delivering any required documentation or other materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B>Right of Holders to Require the Company to Repurchase Notes upon a Fundamental Change</B>. If a Fundamental Change (other than an
Exempted Fundamental Change) occurs, then each Holder will have the right to require the Company to repurchase such Holder&#8217;s Notes (or any portion thereof in an Authorized Denomination) for cash in the manner, and subject to the terms, set
forth in Section&nbsp;4.02 of the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B>Right of the Company to Redeem the Notes</B>. The Company will have the right to
redeem the Notes for cash in the manner, and subject to the terms, set forth in Section&nbsp;4.03 of the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B>Conversion</B>.
The Holder of this Note may convert this Note into Conversion Consideration in the manner, and subject to the terms, set forth in Article 5 of the Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B>When the Company May Merge, Etc</B>. Article 6 of the Indenture places limited
restrictions on the Company&#8217;s ability to be a party to a Business Combination Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B>Defaults and Remedies</B>. If an Event
of Default occurs, then the principal amount of, and all accrued and unpaid interest, if any, on, all of the Notes then outstanding may (and, in certain circumstances, will automatically) become due and payable in the manner, and subject to the
terms, set forth in Article 7 of the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B>Amendments, Supplements and Waivers</B>. The Company and the Trustee may amend or
supplement the Indenture or the Notes or waive compliance with any provision of the Indenture or the Notes in the manner, and subject to the terms, set forth in Section&nbsp;7.05 and Article 8 of the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B>No Personal Liability of Directors, Officers, Employees and Stockholders</B>. No past, present or future director, officer, employee,
incorporator or stockholder of the Company, as such, will have any liability for any obligations of the Company under the Indenture or the Notes or for any claim based on, in respect of, or by reason of, such obligations or their creation. By
accepting any Note, each Holder waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <B>Authentication</B>. No Note will be valid until it is authenticated by the Trustee. A Note will be deemed to be duly authenticated only
when an authorized signatory of the Trustee (or a duly appointed authenticating agent) manually signs the certificate of authentication of such Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B>Abbreviations</B>. Customary abbreviations may be used in the name of a Holder or its assignee, such as TEN COM (tenants in common),
TEN ENT (tenants by the entireties), JT TEN (joint tenants with right of survivorship and not as tenants in common), CUST (custodian), and U/G/M/A (Uniform Gift to Minors Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B>Governing Law</B>. THIS NOTE, AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS NOTE, WILL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To request a copy of the Indenture, which the Company will provide to any Holder at no charge, please send a written request to the following
address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guardant Health, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3100 Hanover Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Palo Alto, CA
94304 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Chief Financial Officer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE<SUP
STYLE="font-size:75%; vertical-align:top">*</SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INITIAL PRINCIPAL AMOUNT OF THIS GLOBAL NOTE: $[___] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following exchanges, transfers or cancellations of this Global Note have been made: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&#8195;&#8195;Date&#8195;&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount&nbsp;of&nbsp;Increase<BR>(Decrease) in<BR>Principal
Amount<BR>of this Global Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal&nbsp;Amount&nbsp;of<BR>this Global Note<BR>After Such
Increase<BR>(Decrease)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature&nbsp;of<BR>Authorized<BR>Signatory&nbsp;of&nbsp;Trustee</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000">&nbsp;</P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Insert for Global Notes only. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONVERSION NOTICE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GUARDANT HEALTH, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0%
Convertible Senior Notes due 2033 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms of the Indenture, by executing and delivering this Conversion Notice, the undersigned Holder of
the Notes identified below directs the Company to convert (check one): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the entire principal amount of </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$<U>
</U><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U><SUP STYLE="font-size:75%; vertical-align:top">*</SUP> aggregate principal amount of </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Notes identified by CUSIP No.<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U> <U></U><U></U><U></U><U></U>and Certificate No.
<U></U><U></U><U></U><U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges that if the Conversion Date of a Note to be
converted is after an Interest Record Date and before the next Interest Payment Date, then such Note, when surrendered for conversion, must, in certain circumstances, be accompanied with an amount of cash equal to the Special Interest and Additional
Interest, if any, that would have accrued on such Note to, but excluding, such Interest Payment Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">(Legal Name of Holder)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Signature Guaranteed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Participant in a Recognized Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guarantee Medallion Program</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Must be an Authorized Denomination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FUNDAMENTAL CHANGE REPURCHASE NOTICE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GUARDANT HEALTH, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0%
Convertible Senior Notes due 2033 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms of the Indenture, by executing and delivering this Fundamental Change Repurchase Notice, the
undersigned Holder of the Notes identified below is exercising its Fundamental Change Repurchase Right with respect to (check one): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the entire principal amount of </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$ <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U><SUP STYLE="font-size:75%; vertical-align:top">*</SUP> aggregate
principal amount of </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Notes identified by CUSIP No.<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U> <U></U><U></U><U></U><U></U>and
Certificate No. <U></U><U></U><U></U><U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges that this Note, duly endorsed for
transfer, must be delivered to the Paying Agent before the Fundamental Change Repurchase Price will be paid. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">(Legal Name of Holder)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Signature Guaranteed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Participant in a Recognized Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guarantee Medallion Program</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Must be an Authorized Denomination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">GUARDANT HEALTH, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">0%
Convertible Senior Notes due 2033 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms of the Indenture, the undersigned Holder of the Notes identified below assigns (check one): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the entire principal amount of </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$<U> </U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>
aggregate principal amount of </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Notes identified by CUSIP No.<U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>
<U></U><U></U><U></U><U></U>and Certificate No. <U></U><U></U><U></U><U></U><U>&#8195;&#8195;&#8195;&#8195;&#8195;</U>, and all rights thereunder, to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Social security or tax identification number:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoints: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as
agent to transfer the within Note on the books of the Company. The agent may substitute another to act for him/her. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">(Legal Name of Holder)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Signature Guaranteed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Participant in a Recognized Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guarantee Medallion Program</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Must be an Authorized Denomination. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRANSFEROR ACKNOWLEDGMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the within Note bears a Restricted Note Legend, the undersigned further certifies that (check one): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Such Transfer is being made to the Company or a Subsidiary of the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Such Transfer is being made pursuant to, and in accordance with, a registration statement that is effective under the Securities Act at the time of the Transfer.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Such Transfer is being made pursuant to, and in accordance with, Rule 144A under the Securities Act, and, accordingly, the undersigned further certifies that the within Note is being transferred to a Person that the undersigned
reasonably believes is purchasing the within Note for its own account, or for one or more accounts with respect to which such Person exercises sole investment discretion, and such Person and each such account is a &#8220;qualified institutional
buyer&#8221; within the meaning of Rule 144A under the Securities Act in a transaction meeting the requirements of Rule 144A. <B>If this item is checked, then the</B> <B>transferee must complete and execute the acknowledgment contained on the
next</B> <B>page</B>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Such Transfer is being made pursuant to, and in accordance with, any other available exemption from the registration requirements of the Securities Act (including, if available, the exemption provided by Rule 144 under the
Securities Act).</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dated:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">(Legal Name of Holder)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">Signature Guaranteed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Participant in a Recognized Signature</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Guarantee Medallion Program)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRANSFEREE ACKNOWLEDGMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned represents that it is purchasing the within Note for its own account, or for one or more accounts with respect to which the undersigned
exercises sole investment discretion, and that and the undersigned and each such account is a &#8220;qualified institutional buyer&#8221; within the meaning of Rule 144A under the Securities Act. The undersigned acknowledges that the transferor is
relying, in transferring the within Note on the exemption from the registration and prospectus-delivery requirements of the Securities Act of 1933, as amended, provided by Rule 144A and that the undersigned has received such information regarding
the Company as the undersigned has requested pursuant to Rule 144A. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Dated:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">(Name of Transferee)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT <FONT STYLE="white-space:nowrap">B-1</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>FORM OF RESTRICTED NOTE LEGEND </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE OFFER
AND SALE OF THIS NOTE AND THE SHARES OF COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND THIS NOTE MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL INTEREST HEREIN, THE ACQUIRER: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">REPRESENTS THAT IT AND ANY ACCOUNT FOR WHICH IT IS ACTING IS A &#8220;QUALIFIED INSTITUTIONAL BUYER&#8221;
(WITHIN THE MEANING OF RULE 144A UNDER THE SECURITIES ACT) AND THAT IT EXERCISES SOLE INVESTMENT DISCRETION WITH RESPECT TO EACH SUCH ACCOUNT; AND </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">AGREES FOR THE BENEFIT OF GUARDANT HEALTH, INC. (THE &#8220;COMPANY&#8221;) THAT IT WILL NOT OFFER, SELL,
PLEDGE OR OTHERWISE TRANSFER THIS NOTE AND THE COMMON STOCK, IF ANY, ISSUABLE UPON CONVERSION OF THIS NOTE, OR ANY BENEFICIAL INTEREST HEREIN PRIOR TO THE DATE THAT IS THE LATER OF (X)&nbsp;ONE YEAR AFTER THE LAST ORIGINAL ISSUE DATE HEREOF OR SUCH
SHORTER PERIOD OF TIME AS PERMITTED BY RULE 144 UNDER THE SECURITIES ACT OR ANY SUCCESSOR PROVISION THERETO AND (Y)&nbsp;SUCH LATER DATE, IF ANY, AS MAY BE REQUIRED BY APPLICABLE LAW EXCEPT ONLY: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">TO THE COMPANY OR ANY SUBSIDIARY THEREOF; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PURSUANT TO A REGISTRATION STATEMENT THAT IS EFFECTIVE UNDER THE SECURITIES ACT; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">TO A PERSON REASONABLY BELIEVED TO BE A QUALIFIED INSTITUTIONAL BUYER IN COMPLIANCE WITH RULE 144A UNDER THE
SECURITIES ACT; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PURSUANT TO THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT; OR
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">PURSUANT TO ANY OTHER AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BEFORE THE REGISTRATION OF ANY SALE OR TRANSFER IN ACCORDANCE WITH (2)(D) OR (E)&nbsp;ABOVE, THE
COMPANY, THE TRUSTEE AND THE REGISTRAR RESERVE THE RIGHT TO REQUIRE THE DELIVERY OF SUCH CERTIFICATES OR OTHER DOCUMENTATION OR EVIDENCE AS THEY MAY REASONABLY REQUIRE IN ORDER TO DETERMINE THAT THE PROPOSED SALE OR TRANSFER IS BEING MADE IN
COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT.<SUP STYLE="font-size:75%; vertical-align:top">*</SUP> </P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">*</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This paragraph and the immediately preceding paragraph will be deemed to be removed from the face of this Note
at such time when the Company delivers written notice to the Trustee of such deemed removal pursuant to Section&nbsp;2.12 of the within-mentioned Indenture. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT <FONT STYLE="white-space:nowrap">B-2</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>FORM OF GLOBAL NOTE LEGEND </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS IS A
GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS THE OWNER AND HOLDER OF
THIS NOTE FOR ALL PURPOSES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (&#8220;DTC&#8221;) TO
THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT
HEREON IS MADE TO CEDE&nbsp;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF,
CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL NOTE WILL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC, OR
TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR&#8217;S NOMINEE, AND TRANSFERS OF PORTIONS OF THIS GLOBAL NOTE WILL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN ARTICLE 2 OF THE INDENTURE HEREINAFTER REFERRED TO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B2-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT <FONT STYLE="white-space:nowrap">B-3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>FORM OF AFFILIATE RESALE LEGEND </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ANY
AFFILIATE (AS DEFINED IN RULE 144 UNDER THE SECURITIES ACT) OF THE COMPANY THAT ACQUIRES THIS NOTE OR ANY SHARE OF COMMON STOCK ISSUED UPON CONVERSION OF THIS NOTE (OR ANY INTEREST IN ANY OF THE FOREGOING) MAY NOT RESELL SUCH NOTE OR SHARE (OR
INTEREST THEREIN), AS APPLICABLE, UNLESS IN A TRANSACTION THAT IS REGISTERED UNDER THE SECURITIES ACT OR PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IN A TRANSACTION IMMEDIATELY FOLLOWING WHICH SUCH RESOLD NOTE
OR SHARE (OR INTEREST THEREIN), AS APPLICABLE, IS NOT A &#8220;RESTRICTED SECURITY&#8221; (AS DEFINED IN RULE 144 UNDER THE SECURITIES ACT). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B3-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d66171dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 5.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107073754191.jpg" ALT="LOGO" STYLE="width:6.57569in;height:0.996528in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">November&nbsp;7, 2025 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3100 Hanover Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Palo Alto, California, 94304 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinion with respect to certain matters in connection with the sale and issuance by Guardant Health, Inc., a Delaware corporation (the
&#8220;<B><I>Company</I></B>&#8221;), of up to an aggregate of 3,833,332 shares (the &#8220;<B><I>Shares</I></B>&#8221;) of the Company&#8217;s common stock, par value $0.00001 per share (the &#8220;<B><I>Common Stock</I></B>&#8221;) (including up
to an aggregate of 499,999 Shares that may be sold pursuant to the exercise of an option granted by the Company to the underwriters), pursuant to (i)&nbsp;a shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-272121)</FONT> (the &#8220;<B><I>Registration Statement</I></B>&#8221;) filed with the Securities and Exchange Commission (the &#8220;<B><I>Commission</I></B>&#8221;) under the Securities Act of 1933, as
amended (the &#8220;<B><I>Act</I></B>&#8221;), on May&nbsp;22, 2023, which became automatically effective upon filing (the &#8220;<B><I>Base Prospectus</I></B>&#8221;), as supplemented by the prospectus supplement, dated November&nbsp;4, 2025, filed
with the Commission pursuant to Rule 424(b) under the Act (the &#8220;<B><I>Prospectus Supplement</I></B>&#8221; and together with the Base Prospectus, the &#8220;<B><I>Prospectus</I></B>&#8221;) and (ii)&nbsp;an underwriting agreement, dated
November&nbsp;4, 2025, entered into by and among the Company and Goldman Sachs&nbsp;&amp; Co. LLC and Jefferies LLC, as representatives of the several underwriters (the &#8220;<B><I>Underwriting Agreement</I></B>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined and relied upon the Registration Statement and the Prospectus and the originals or copies certified to our
satisfaction of such other documents, records, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. With your consent, we have relied upon certificates and
other assurances of officers of the Company as to factual matters without having independently verified such factual matters. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the conformity to
originals of all documents submitted to us as copies thereof and the due execution and delivery of all documents where due execution and delivery are a prerequisite to the effectiveness thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act,
and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares. Our opinion is limited to the matters
stated herein and no opinion is implied or may be inferred beyond the matters expressly stated. Our opinion herein is expressed solely with respect to the federal laws of the United States and the General Corporation Law of the State of Delaware
(the &#8220;<B><I>DGCL</I></B>&#8221;). Our opinion is based on these laws as in effect on the date hereof, and we disclaim any obligation to advise you of facts, circumstances, events or developments which hereafter may be brought to our attention
and which may alter, affect or modify the opinion expressed herein. We are not rendering any opinion as to compliance with any federal or state antifraud law, rule or regulation relating to securities, or to the sale or issuance thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g11a53.jpg" ALT="LOGO" STYLE="width:6.45903in;height:0.710417in;">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the foregoing and the other matters set forth herein, it is our opinion that when the Shares to
be issued and sold by the Company are issued and paid for in accordance with the terms of the Underwriting Agreement, such Shares will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#8220;Legal Matters&#8221; included in the Prospectus and to the filing of this opinion as an
exhibit to the Company&#8217;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed with the Commission on November&nbsp;7, 2025. In giving such consent, we do not thereby admit that we are in the category of persons whose
consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Gunderson&nbsp;Dettmer&nbsp;Stough&nbsp;Villeneuve&nbsp;Franklin&nbsp;&amp;&nbsp;Hachigian,&nbsp;
LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GUNDERSON DETTMER STOUGH</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">VILLENEUVE FRANKLIN&nbsp;&amp; HACHIGIAN, LLP</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d66171dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107072725352.jpg" ALT="LOGO" STYLE="width:2.99097in;height:0.635417in;">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guardant Health Announces Pricing of Upsized Public Offering of Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO ALTO, Calif. </B>November&nbsp;5, 2025 &#8211; Guardant Health, Inc. (&#8220;Guardant Health&#8221;) (Nasdaq: GH), a leading precision oncology
company, today announced the pricing of an upsized underwritten public offering of 3,333,333 shares of Guardant Health&#8217;s common stock at a public offering price of $90.00 per share (the &#8220;common stock offering&#8221;). The size of the
common stock offering was increased from the previously announced $250.0&nbsp;million of shares of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Guardant Health granted the
underwriters an option to purchase up to an additional 499,999 shares of common stock at the public offering price, less underwriting discounts and commissions. The common stock offering is expected to close on November&nbsp;7, 2025, subject to the
satisfaction of customary closing conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC, Jefferies, Leerink Partners and Guggenheim Securities are acting as the
joint book-running managers for the common stock offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health estimates that the net proceeds from the common stock offering will be
approximately $284.4&nbsp;million after deducting underwriting discounts and commissions and estimated offering expenses payable by Guardant Health, excluding any exercise of the underwriters&#8217; option to purchase additional shares. Guardant
Health intends to use the net proceeds from the common stock offering, together with the net proceeds from Guardant Health&#8217;s concurrent convertible notes offering (as defined below), if consummated, for general corporate purposes, which may
include, depending on market conditions, repurchasing a portion of Guardant Health&#8217;s 0% convertible senior notes due 2027 (the &#8220;2027 notes&#8221;). General corporate purposes may also include the acquisition of complementary products,
technologies, intellectual property or businesses; however, Guardant Health currently does not have any agreements or commitments to complete any such transactions. This press release is not an offer to repurchase any 2027 notes and the common stock
offering is not contingent upon the repurchase of any 2027 notes. There can be no assurances that Guardant Health will repurchase any 2027 notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a
separate press release and concurrently with the common stock offering, Guardant Health also announced today the pricing of its previously announced offering of $350.0&nbsp;million aggregate principal amount of its convertible senior notes due 2033
(the &#8220;notes&#8221;) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;concurrent convertible notes offering&#8221;). The size of the concurrent
convertible notes offering was increased from the previously announced $300.0&nbsp;million aggregate principal amount of notes. Guardant Health also granted to the initial purchasers in the concurrent convertible notes offering an option to
purchase, within a <FONT STYLE="white-space:nowrap">13-day</FONT> period beginning on, and including, the date on which the notes are first issued, up to an additional $52.5&nbsp;million aggregate principal amount of notes. The concurrent
convertible notes offering is expected to close on November&nbsp;7, 2025, subject to the satisfaction of customary closing conditions. The completion of the common stock offering is not contingent on the completion of the concurrent convertible
notes offering, and the completion of the concurrent convertible notes offering is not contingent on the completion of the common stock offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
common stock offering is being made pursuant to a shelf registration statement, including a base prospectus, that was filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on May&nbsp;22, 2023, and became automatically effective
upon filing. The common stock offering is being made only by means of a prospectus supplement and the accompanying prospectus. Before you invest, you should read the prospectus supplement and the accompanying prospectus in the registration statement
and the other documents Guardant Health has filed or will file with the SEC for more complete information about Guardant Health and the common stock offering. You may get these documents for free by visiting EDGAR on the SEC&#8217;s website at
www.sec.gov. Alternatively, copies of the preliminary prospectus supplement, the final prospectus supplement, when available, and the accompanying prospectus may be obtained by contacting Goldman Sachs&nbsp;&amp; Co. LLC, Attention: Prospectus
Department, 200 West </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Street, New York, New York 10282, telephone: (866) <FONT STYLE="white-space:nowrap">471-2526,</FONT> or by emailing <FONT STYLE="white-space:nowrap">prospectus-ny@ny.email.gs.com;</FONT>
Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, telephone: (877) <FONT STYLE="white-space:nowrap">821-7388,</FONT> or by emailing prospectus_department@jefferies.com; Leerink Partners
LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, telephone: (800) <FONT STYLE="white-space:nowrap">808-7525,</FONT> ext. 6105, or by emailing syndicate@leerink.com; or Guggenheim Securities, LLC, Attention: Equity
Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017, telephone: at (212) <FONT STYLE="white-space:nowrap">518-9544,</FONT> or by emailing GSEquityProspectusDelivery@guggenheimpartners.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities being offered in the offerings, nor shall
there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Guardant Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health is a leading
precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives
disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and
treatment selection for patients with advanced cancer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the timing and completion
of the offerings on the anticipated terms, or at all, market conditions and statements regarding the expected net proceeds of the common stock offering and the anticipated use of proceeds from the offerings, including any potential repurchases of
the 2027 notes, each of which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current
expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health&#8217;s financial and
operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operation&#8221; and elsewhere in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024, its Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31, 2025, June&nbsp;30, 2025 and September&nbsp;30, 2025 and in its other reports filed with or furnished to the SEC thereafter. The forward-looking statements in this press
release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events,
conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health&#8217;s views as of any date subsequent to the date of this
press release. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Investor Contact: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zarak
Khurshid </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@guardanthealth.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Media Contact:
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Meaghan Smith </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">press@guardanthealth.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Guardant Health, Inc. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>d66171dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g66171g1107072725352.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO ALTO, Calif. </B>November&nbsp;5, 2025 &#8211; Guardant Health, Inc. (&#8220;Guardant Health&#8221;) (Nasdaq: GH), a leading precision oncology
company, today announced the pricing of its upsized offering of $350.0&nbsp;million aggregate principal amount of 0% convertible senior notes due 2033 (the &#8220;notes&#8221;) in a private offering (the &#8220;convertible notes offering&#8221;) to
persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The aggregate principal amount of the convertible notes offering was increased
from the previously announced offering size of $300.0&nbsp;million.&nbsp;The issuance and sale of the notes are scheduled to settle on November&nbsp;7, 2025, subject to customary closing conditions. Guardant Health also granted the initial
purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $52.5&nbsp;million principal amount of notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will be senior, unsecured obligations of Guardant Health. The notes will not bear regular interest, and the principal amount of the notes will not
accrete. The notes will mature on May&nbsp;15, 2033, unless earlier converted, redeemed or repurchased by Guardant Health. Before February&nbsp;15, 2033, noteholders will have the right to convert their notes only in certain circumstances. From and
after February&nbsp;15, 2033 until the close of business on the second scheduled trading day immediately before the maturity date, noteholders may convert their notes at any time at their election. Guardant Health will settle conversions by paying
or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Guardant Health&#8217;s election. The initial conversion rate is 8.2305 shares of common stock per $1,000 principal amount of
notes, which represents an initial conversion price of approximately $121.50 per share of common stock, and will be subject to customary anti-dilution adjustments. The initial conversion price represents a premium of approximately 35.0% over the
public offering price per share of Guardant Health&#8217;s common stock in the concurrent common stock offering (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes will not be
redeemable at Guardant Health&#8217;s election at any time before November&nbsp;20, 2029. The notes will be redeemable, in whole or in part, for cash at Guardant Health&#8217;s option at any time, and from time to time, on a redemption date on or
after November&nbsp;20, 2029 and on or before the 25th scheduled trading day immediately before the maturity date, but only if the last reported sale price per share of Guardant Health&#8217;s common stock exceeds 130% of the conversion price for a
specified period of time. The redemption price will be equal to the principal amount of the notes to be redeemed, plus accrued and unpaid special interest and additional interest, if any, to, but excluding, the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a &#8220;fundamental change&#8221; (as defined in the indenture for the notes) occurs, then, subject to limited exceptions, noteholders may require
Guardant Health to repurchase their notes for cash. The repurchase price will be equal to the principal amount of the notes to be repurchased, plus accrued and unpaid special interest and additional interest, if any, to, but excluding, the
applicable fundamental change repurchase date. In addition, following certain corporate events that occur prior to the maturity date of the notes or if Guardant Health delivers a notice of redemption, Guardant Health will, in certain circumstances,
increase the conversion rate of the notes for a holder who elects to convert its notes in connection with such a corporate event or convert its notes called (or deemed called) for redemption during the related redemption period, as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health estimates that the net proceeds from the offering will be approximately $339.1&nbsp;million (or approximately $390.0&nbsp;million if the
initial purchasers fully exercise their option to purchase additional notes), after deducting the initial purchasers&#8217; discounts and commissions and estimated offering expenses. Guardant Health intends to use the net proceeds from the
convertible notes offering, together with the net proceeds from Guardant Health&#8217;s concurrent common stock offering (as defined below), if consummated, for general corporate purposes, which may include, depending on market conditions,
repurchasing a portion of Guardant Health&#8217;s 0% convertible senior notes due 2027 (the &#8220;2027 notes&#8221;). General corporate purposes may include the acquisition of complementary </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
products, technologies, intellectual property or businesses; however, Guardant Health currently does not have any agreements or commitments to complete any such transactions. If the initial
purchasers exercise their option to purchase additional notes, then Guardant Health intends to use the net proceeds from the sale of the additional notes for general corporate purposes. This press release is not an offer to repurchase any 2027 notes
and the convertible notes offering is not contingent upon the repurchase of any 2027 notes. There can be no assurances that Guardant Health will repurchase any 2027 notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a separate press release and concurrently with the convertible notes offering, Guardant Health also announced today the pricing of its previously announced
underwritten public offering of 3,333,333 shares of its common stock at a public offering price of $90.00 per share (the &#8220;concurrent common stock offering&#8221; and, together with the convertible notes offering, the &#8220;offerings&#8221;).
Guardant Health estimates that the gross proceeds from the concurrent common stock offering will be approximately $300.0&nbsp;million before deducting underwriting discounts and commissions and estimated offering expenses payable by Guardant Health.
The size of the concurrent common stock offering was increased from the previously announced $250.0&nbsp;million of shares of common stock. Guardant Health also granted to the underwriters of the concurrent common stock offering a <FONT
STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 499,999 shares of common stock at the public offering price, less underwriting discounts and commissions. The concurrent common stock offering is expected to close on
November&nbsp;7, 2025, subject to the satisfaction of customary closing conditions. The completion of the convertible notes offering is not contingent on the completion of the concurrent common stock offering, and the completion of the concurrent
common stock offering is not contingent on the completion of the convertible notes offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The notes sold in the convertible notes offering were only
offered to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act by means of a private offering memorandum. The offer and sale of the notes and any shares of common stock
potentially issuable upon conversion of the notes have not been, and will not be, registered under the Securities Act or any other securities laws, and the notes and any such shares cannot be offered or sold except pursuant to an exemption from, or
in a transaction not subject to, the registration requirements of the Securities Act and any other applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release is not
an offer to sell nor a solicitation of an offer to buy any of the securities being offered in the offerings or any shares of common stock issuable upon conversion of the notes, nor shall it constitute an offer, solicitation or sale of any securities
in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Guardant Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health is a leading
precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives
disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and
treatment selection for patients with advanced cancer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the timing and completion
of the offerings on the anticipated terms, or at all, market conditions, statements regarding the expected net proceeds of the common stock offering and the anticipated use of proceeds from the offerings, including any potential repurchases of the
2027 notes, each of which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current
expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health&#8217;s financial and
operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operation&#8221; and elsewhere in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2024, its Quarterly Reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31, 2025, June&nbsp;30, 2025 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and September&nbsp;30, 2025 and in its other reports filed with or furnished to the SEC thereafter. The forward-looking statements in this press release are based on information available to
Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such
statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health&#8217;s views as of any date subsequent to the date of this press release. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Investor Contact: </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zarak Khurshid </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@guardanthealth.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Media Contact: </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Meaghan Smith </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">press@guardanthealth.com</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Source: Guardant Health, Inc. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>gh-20251104.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 11/8/2025 2:20:01 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:gh="http://guardanthealth.com/20251104"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://guardanthealth.com/20251104"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20251104_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20251104_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>gh-20251104_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 11/8/2025 2:20:01 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>gh-20251104_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 11/8/2025 2:20:01 AM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gh-20251104.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g66171g1107072725352.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107072725352.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ 1L# 2(  A$! Q$!_\0
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MQ\<Z.-^K^&UFA7[SPJ1@?[REA^E=+X<\?:+XC98(Y&MKP_\ +O/P6_W3T/\
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ME>;:+(MY\9M9NH2&A@MRCN#P" BG]0?RJ>73?B1J$?V2?4["UB88>:'AR/;
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L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g66171g1107073754191.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107073754191.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !> FX# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]H__ $$5RUY.45?HV=="*C-VZI'+V<=MJ_Q#U[^T8DG&G00QVT4JAE56!9F
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ML:*B*%51@ = *6BAMO<$DM@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M;3V>E6UO=3>=/&@5Y,D[C^-7*SM!NY+_ $*SNY7#O+&&+ 8!K1J'N6@HHHI
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@08"[@V!^(!^HJU;6L-G;I;V\:QQ)]U5Z#O4U%%P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g66171g1107200226628.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200226628.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P '4# 2(  A$! Q$!_\0
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M6C+OV,02I#JR,"0/O*<=1BJ^J>%_[5TM;&76=2CRRM-/&8=\^WH&W1E0OLH
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M]UXCN%O;N.QTY;R"RC$ER1<!)3E=P$:$8;C^\RCZUNQ.TD*.R;&902N<X]J
M$M[B&ZMXKBWFCF@E0/'+&P974C(((X(([T5)10 4444 %%%% !1110 4444
M%%%% &'XPL;O4O"M]:62;YI%'[O./,4,"RY]P"/QK)OWE\5:9;Z-96-];6;,
M@OI;JU>#9&I!,:AP"Y; &5!&,\]*[*B@#A;_ ,^\U/2Y[+3K^QUR*55=Q;,(
MFM=WS+))S&PV\A=VX'' YKJY=5BAU..R,,S;L!IU"^7&Q^ZK<YR><8!'J1D9
GOUF3:9-+JJW"W:K:G:\L'EDLSK]TA]W ]1@YP.1SD TZ*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g66171g1107200226853.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200226853.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I (@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BJM_J-I
MIEOY]W,L2%@JYZLQZ #N?:JEKX@L[J7R1'=17!C:18)K=DD95QDA2.1D@?C0
M!JT5@:)XQTG7KE(+3[4DDB/)$+BW:+S C;7V[AS@D UOT %%%5;_ %&TTRW\
M^[F6)"P5<]68] !W/M0!:HK*M?$%G=2^2([J*X,;2+!-;LDC*N,D*1R,D#\:
MJZ)XQTG7KE(+3[4DDB/)$+BW:+S C;7V[AS@D T ;]%%% &9JNLQZ;+:VJ1/
M<WUVQ6WMHR 6QRS$G@*!U/T')(!SD\3SV=W>6>M6,=O<V]FU\@M)S.LL2G#8
M)52&!QP1CD8)YQ!J*7&F>.%UJ6SN;NSDT\6L9MHC(T+[RS?*.<,-O/\ LU'#
M:ZD-:G\17-@[23A+.&U!#-#:@EF8_P"TQ.2!V"CK0,U-+U?4+N:W2ZTV*..Y
MC::.>WN1+&$&W 8X4[CNZ $<'YJUKBXBM8Q),VU2ZH#C/+,%'ZD5S7A*TEMK
MW5'MK>YM-%E9&M+6Y0H8W^;S-JGE4/RX'3.<<58\2:'=:BJRV^K:E#^^A_<6
MYCV "1<M\R$Y YZ]J!(Z*N>?7[V#Q-=:9=6-M%:I:BXM[C[2Q>?)V[0FS@@X
MS@G[RXSGB^ ^B:3(\LVH:D8SNR4$DS9[ (HS^5<MJ<EW_;/A[Q&^FW\LFZ2-
M[:*T+M;P.G.[C(?<$S^('J0#J]'N-4N;$2ZM86]C<$\0PW)F 'NVU>>O S]:
M*T <C-% '':K/#;_ !(TZ;576*QBT^0VDDIQ&)RX#9)X#;,8SZM5_P 0>(=-
MTS1;K55G@,L<316TA< 2.^,*IZ')"UO3V\-S'Y<\,<J==LBAA^1J.2QLY84A
MDM('B3[J-&"J_0=J ZG >'D@\/7<T>KWAO+K1K-?L0B4 O;.JEG"@_,VY&R?
M0>]=WJ<DR:5<26QE$P3*&*(2-GV4D9^E0ZMI@O=,N8;9+>.ZDMV@CEDCSL!&
M.V#CGIFK\(D6"-92ID"@.4& 3WQ[4,#C]+U#79=3MTN)M4,+/AQ+I*1KCW8.
M<?6G:K/#;_$C3IM5=8K&+3Y#:22G$8G+@-DG@-LQC/JU=C4<]O#<Q^7/#'*G
M7;(H8?D: ,'Q!XATW3-%NM56> RQQ-%;2%P!([XPJGH<D+6%X0L8M-U@V.J:
MA'<7NEVJK8MP@:VD52S@?Q$LC GV'K7;R6-G+"D,EI \2?=1HP57Z#M1+8VT
MP.Z&,,8S$'"C<JD8P#V% $>GZE#J43O$LJ;&P5E7:V.QQZ$<BLJU^T_;(O-\
M_P#LOS/]&SG=N[;^^STS[9K0TFRNK1)'O9XYKA]J[HD*KM7A>">O<^YK1H R
M+W4-9@O)([30OM4"XVS?:T3=P,\$9'.1^%5_[6\0_P#0L?\ D_'_ (5;U_64
MT/3#<^49YGD2&WA4X,LKG:J^W)Y/8 UC:A?:UH5SI5U>7\=RE[>16DMHD 54
M+Y&Y&^]P>>2>,T 7O[6\0_\ 0L?^3\?^%']K>(?^A8_\GX_\*HP:GJU[J]_!
M#>Q17-M.(_[.EB'^H+@><&ZME<GKC/%=:>!0!@?VMXA_Z%C_ ,GX_P#"C^UO
M$/\ T+'_ )/Q_P"%:]A="^T^WNPA031K(%)SC(SBN9AEUJ;6=8TC^VW6X1HI
MK9_LL>(H&SSTYY5UY]![T ;^F7>H77F_;],^P[<;/](67?USTZ8X_.BKL:LL
M:J[EV  +$8W'UHH =1110 4444 %%%% !1110 4444 8GB31[C5(K">R>-;S
M3[M;N%9<A)" RE6(Y (8\X.#@X-59-'U35KV'4=3-M!+9HYL[6&1I$CF92OF
MLY"EB 2 -HQD]>W2T4 <PNC:I>^(=+OM0CLXQIBMMN()&,ESN0J05(&Q<G=C
M<W('-;.IZ-INLQ)'J-C!=)&=R+,@8*?49J]10!B>'?#6G>'[&%;6PM8+KR5C
MFDA3&\@<\XYYJOX?L-7BUO6=1U>ULHFNVC$!MKAI2L:+@(<HO<LV?]KVKHZ*
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g66171g1107200226984.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200226984.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I )P# 2(  A$! Q$!_\0
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MX5!I&KW7_"1>(+6_N@]G:B.>WD9%7;&V\,,CJ R$9/-8%]KGB.]M-=U.SO\
M^SK>TN4M+* VZ2>:QV#+%AG)9\8'3% '3?VMXA_Z%C_R?C_PK?K%CCU.74K1
M8]39K:T0K=DP)_I$G&,''RXYSCU ]:VJ "BBB@ HHHH **** "BBB@ HHHH
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?O);L1Q[]^THH C@@CMH%AC&%4<9.2?<^]2444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g66171g1107200227117.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200227117.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I )P# 2(  A$! Q$!_\0
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M?^A8_P#)^/\ PK?HH P/[6\0_P#0L?\ D_'_ (5OT44 %%%% !1110 4444
M%%%% !1110 4444 %9^I+J?FP3:=]G<1AS)!,[()21\HW ';@\YP?IWK0HH
MX*?POK0T>>RM[73MFI:B+R]@^U.B1)E"T<?[L[MVPY)"_>/'/'=1PQ19\N-$
2SUVJ!FGT4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g66171g1107200227251.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200227251.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  I (4# 2(  A$! Q$!_\0
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KG4=4U2SO];%M"EBQDM[.VD,BB0@C>SE5W$ D ;1C)Z\8Z*B@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g66171g1107200227383.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g1107200227383.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O +P# 2(  A$! Q$!_\0
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MS8V4B@@#=L.&QZ\E!C\:Y7P/I-W_ &A;G48;>SN]#@>U:&!R_GM.$E>4L57
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&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g66171g11a53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g66171g11a53.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !# F,# 1$  A$! Q$!_\0
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M1PIP3M0%L#U  '<F@"6Q^(7A_4Y(8[/6;2Z,MG]OC-O)OWVXQF0'T^93Z\T
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M4@L7!=0&'0$'BDY(#Z+M4$<(52=H  &3P  !UY_.ES("<=*+W&+2 * "@ H
M* "@ H * "@ H * "@!1UIH3'51(AZ4F-#:DH* "@ H * "@ H * "@ H *
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MD!12%)!! QG )/0]:.5@9UY\5/#EI)HJP:A%JXU6]73[>739$N(_-(W*&96
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MG4^;"45(OE &TJBA2/4'UK-^0CUQ/NCC'MC&*0#J!A0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M=V:O^7D==3,JT8W27X_YFCXK_P""@GCG1(;=K;0O#I:1B")HIR.!GC$HJJ&
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MAV;?,3'^OW9R?NXQSD=>%Q'U:;G:^AQXK#_6:?L[V/F+QG_P2L_X2^TL8/\
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MBA8\?^R_?<^??R_X)UO_  R@?^AJ_P#*?_\ ;:XI>\=]/"\C3YC+\6?L:_\
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M*GVO2/L/_"4;?E"^9_9^>A]/-KEI<+^S=_;?^2__ &QYD.(N2HY^R_\ )O\
M@%JX_9B^T:;<6G_"2[?-"C?]@Z8]O,K9<.6I5*?MOCM]G:S3[^1R3SOFQ$:_
ML]NE_)KMYB-^S!NL#;?\)-UB\O=]@]L9QYM8/A?W^?VW_DO_ -L:PS[DES>R
MZWW_ . <AJ?[$/\ :.H:?=#QGY7V2=IMO]E9W90KC/G<=<UZ<,DY(<GM/P_X
M)["XNM'E]A_Y-_\ :G3I^RMLT>:Q_P"$HSYD;Q^9_9_3<,9QYM>7_JM[ZE[;
M9W^'_P"V/-?$5ZD9^RV=_B_X!A6/[%PLM+M[/_A, _E+MW_V7C/7MYWO732X
M<]G5E4]KO_=_X)W1XLM4<_8?^3?_ &I1TS]AO^S;F[E'C7?]H;=C^RL;>2?^
M>W/6NF.1<M_WGX?\$ZY<9\T;?5__ ";_ .U-:\_8Y^URZ8Y\7;?L1E./[,SO
MWA1_SVXQM]^M<;X:O)OVW_DO_!.&/%7*Y/V'Q?WO_M1MQ^QL)VW?\)=MXQ_R
M#/\ [=6]'A_V*M[6_P#V[_P32GQ9[.FJ?L/_ ";_ .U)_$7[(']OVMQ#_P )
M;Y!EMOL^[^S=V/DVY_UH^N*TJY%[6NJWM=NEO^"<5#B/V*:]C>\F_B[N]MCD
M+O\ 8!-UX(M?#W_">E?(8-]H_L?.<$G[OG^_K50R/DQ/UCVG2UK?\$[5Q9:7
M-[#_ ,F_^U-'P!^PO_P@VOWFI_\ ";_;OM%NL'E?V3Y>W# YSYYSTZ8K*OD'
MMHJ/M;6\O3S\B,3Q5]8:_<6M_>\[_P HGC3]A;_A+]%TG3_^$W^R?8-O[S^R
M=_F8SV\\8Z^]*AP_["3E[6]_+_@DT^*/9S<_8[_WO_M2#QK^P;_PF%HD'_"<
M_9 JE<_V1OSR#_SW'I2H</\ L).7M;_]N_\ !+I\5^SA*'L-_P"]_P#:AXI_
M8,_X26ZT&;_A.?LW]EV@M<?V1N\W ^]_KQCZ<UM3R+D4U[7XO+U\Q4>*O8MO
MV%[_ -[_ .U*&F_\$]SI]MJD/_"?[_MT<L>?[&QLWXY_X^.<8]J'D5W%^TV\
MO^"=,N,.;_F'_P#)O_M34B_84\OPPFD'QONVVXM_..D^V,[?/_3-:SR;G;?M
M/P_X(1XQLO\ =_\ R;_[4W/A#^QS_P *J^(^F^*_^$O_ +4^Q^;_ *)_9GD[
M]\+Q_?\ .;&-^>AZ8K3"Y3]6K1K<][>7E;N<.9<3_P!H82>%]CR\UM>:^S3V
MY5V/I*OH3X8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
* "@ H * "@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001576280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  04,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GUARDANT HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-4139254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3100 Hanover Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-8887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d66171d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d66171d8k.htm">d66171d8k.htm</File>
    <File>gh-20251104.xsd</File>
    <File>gh-20251104_lab.xml</File>
    <File>gh-20251104_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d66171d8k.htm": {
   "nsprefix": "gh",
   "nsuri": "http://guardanthealth.com/20251104",
   "dts": {
    "inline": {
     "local": [
      "d66171d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gh-20251104.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gh-20251104_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gh-20251104_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-11-04_to_2025-11-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d66171d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-11-04_to_2025-11-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d66171d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://guardanthealth.com//20251104/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001193125-25-272592-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-272592-xbrl.zip
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M-7$'IF'SRV #V*)JY/Y7'#;WS?<!'[O>[/#&'8N(78H[=A6,N7]$U^XDY+W
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M0C$)PIB5]7?!P3824<S$+8Q4EX6S<UCL>FAI\94,K'-I=SU8;$@G$$5'?.C
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M'"(@8E-LKOCC_"QA#A_D_$Q>;K5(5K5III[H8]P(Q0!Q+G/'P--83 ;;.)W
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MKX17U'K<"^LGEU/4PH:Y5G\%>%&1Z JK7!/2%[>H;J89?BV(>Y>D>-/B2/%
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M',RQP53E29H6'#>S EWR5WS,=6B(=MKBL/$<MW,7T<;EJ:(/#>TPN F9>.*
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M!6*IX@ \)1-1H1@&ID*Y"5*,9:!/H^MCRK!+876)6;F<F86)#P$P XPVO(W
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M%.>(W%58<I_=[2QS9W:[J5" J;Q)YJ]E<D$%L&R6V!IU'!:95RZUL_;VIS>
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M8[X#C(W;F5Y$+L-MIIDQ+$ZE*3AGI<"06(("C(_R,/7759@YGQ!Z ,>.V7S
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M8)TMEVJ=8<-TN Z*;/K.Y8]KFO"E+;6X#\&1J=##E%[:]BJKSV9^!= SG$?
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M%(8L-$G,B"\M6VRT7<Y7A-@M-5]O_#&#)KHQ^45O\J1U-)OD5+]%,AX-XV3
M.D_,.G6R^* 0[^>:Y08P#YCD4W-LDBO9'V*T7"APSA6(DKW8GN[Q[LXCUSX4
M5TJ%%'5=$O;>P@5-;;K+Y]^.9V8[^E#(%,;)L\M799-*+-S&''G"CG"9P6H0
MEFL;6V.P;_>YJOA=GMV^[WH[>O*-DX #27H_T)C#$,.E9]5,@$&E+R?Y8&LJ
ME11$!\Y,JK1KO<!_('LT>>]A>6<LH#5BTP>F($G54TT@1N1OX'MR<(DIWJLB
MD"<8LT8-U'V^[]*MIF!WU9EKD<3 G/ ORE:B+LX(-H0^XS]=TP+M*44NLJ_6
MT7OXS=%[O8Y>:F#BO112!$QWU'H0O*G"EV7OHV$4R2G0*-II4;%:3-B<JK7L
M@*ZHS011%<#<=%&)0<5"C(=%2<"-"28TGE/Q%O5\WGOP7\Z>:DI,5>.W<5[+
MJG'PJFW6D<$5GN&EQUH:N &$ !T-<;C0N8I:@DASNX96M1MQKK4J;UBK4J07
M.0$1(6] Y"I!-A+%4O#>!>(H4LQ]U'6GV3)30:XJ5Y<9@@3J\,'N)M>H;) D
M)OWR>:<>2*SA>V+Q.&NU9<MH%,RJI4;[Q!+-!NO\R TA4HF$&@SXT^\_/^.R
MI.B8'%ZVT>RMVH,9V8._LS;U1B +AU*@ETOIS%&DC<<W=/FJW>+031B'F$9]
M77ADW@PZ$T^R6*2R,)VKV*-?P+[_>07HT#X(8],ET6.#\G$U5,AAK$^,:'V!
MT*!XF[^ $_G CD<MNW[)$8Z!JS"4?I9G"%]N F"2E(>('PY4U-P/5*-?)?4L
M^>OV/:^Y@ M0E3RO^^FJXV3D*M9UFE3FYO<70&\L@NK-9(FM&]:KG;FICD[;
M+BGGM7.NW]A4:MK"?Z<^3VW*.,@'WR]-']DW/D;T.HH?,6!N6NVQ-#@>%F/
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MCB1,ACY4MF VL6B0H8I5IPVC/!@.6T?WM/W+/2QX5P6IZNH4UGW:W@OB'LC
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M/^=UWH/'5 '^ GZ]*'RS122R$T1@$W!3KOW^[)=4RE/:L^LI3N_"F6D!.AI
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M:ZEP!)SS;/"B;Z ,-IPL/@&2(HVF<Q,D+W*"Z&%RMW@*9=M4J=F*%1$N12
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M01 Q?/^PMGN%$LO!D9@-8;*+8SEE(3$6K^>1V!<<8*[<H3A2G^GB^K_.RC2
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M"!S0J/I>6KZ^!,FD 5;"11PU*,2'/.]<Q1@A"MH"9R<&:U.'@X2PUD-]M(K
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MJZ'>;SMI=DE$>EF>]"GXK=HS]*?*K,^-LIJU2.77$$E*[06%NA+*X7#TU%X
M-5DSZNL$B; Z10*+B'@*2**39S!22@;[9*C6K[G?:IP+,X55C4Z1"94I.3P'
ME:IZ/==;F*G[<YC0VAR:AUW8_;Z['2GSMSYPKM[&J? SJFF1'E*%[^Y3!\5K
M_;4P^/;MVQJ6VN-X*6UIOB Y;LX:"12_*3W6JQ84F;5@D]+IRTN43\=G7(/W
MUDUOK"]*Z33]PJJ1),0N#^3I"4+>?3HLNZ;)%8;$Z0$Y-2>9BYWU3><.O!KD
MFICN4!6F*@*_G.F;8"T4D$67,N]CYH;+8PP7A[H6G66/HHI>G)8J2[78-Y9
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MB/>K*W1*&'G.2X=Z*^@BXWF)Z7O^&*J)8=S/2M0+W>6E;G*=Y1T5:D1Q7^7
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MK03AEO!'#HY.3B[/>P?'IY__ZY>=7^CO\][AH?K;6<B/9Q>'1Q=T7<; 5U[
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MT69_W^S^LKO_^\IV_R0 ?C#<;/SSV/C=G95M_%7JQ]D(A ()B*,?@QL_O@Y
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M;E'J8&8+:'5:-5+;O.2Q6]5Z3/.;)(7'AMYA$"<*\JVT'EWO#E'C@<(GN*E
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M@)]Q#51U'*W D N[686RRB\;YL:ZHO.PX#J98T9K8O%LM<M5F43_X;)DV_L
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M#RR=P)8QOULZN J=,%\0O6*HK5QS16)(BN<4HV9;IO">-) )IQ@Q'LHHY05
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M94-,.VD%- NFVVIHHP#0'NR*5H4IXB2M<$VK*OM0YT2,$L=;1K!U4C9.J*K
M:=!5ETUA+>-,DM:C<*QZYH;H59>D&'G-5A_]B'[&:L$88ZA4PP.:'SLIN<T
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MP?BG96;/9\RP?RKC8A?! 2M\GY[K^APVC=]91"^MJD2L"<A8481J]L&AA$)
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M6;0%7&AE\I2FN 5#, X-40_X"&5 17;'=[Z!M SJ4JZ0^89.OU50'$W4SB9
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MTBTP/@NY>'9@I"[#O\1TD.K)%,1T:#R([G"[%FJ&#4<FMQ<GM^!7"PBY=6+
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MN\57@9:[95O;2\3]+QFS9+UGI&L6_ Q=R]<CQNG05ZX]83R"TVVJ6&N,\":
MPR39EZH<81'%P_R1SKBWN_MV9\?K;7_=[M*C?R;I=^\ ]3\.O27B92BY'^GJ
M? \DWXC1&[%CSD7]9_=D+$!P2!B+6D*8K>3?&R CQ[E)FT)C$ZS^TF?(R)#(
M69@IX\+2!O(BL0YY 4F>61"/;.:H$F^Z!4TK[:UD#VN[Q2Y6_&R7(V"P!UXX
M!CL,(_U8^<.@[E'195GMB;7';PW>4KPUJ>IW\0ET7+Z"\0)+%Q?JTAQL3:L
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M-A/8MZA;OW[^]ND<^5M]U+A=#W2J,) ?C[]_NBI5J9U=7)U_/#\)$T1N) T
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M>,4-\KC:9W>3)7!NGL/^W7?7XZ!O>B*-YL%7-I:(_?M>;W=WMZ:%>UWB1$-
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M!,!%J53+^)H)_P4$K=G^,2/:F.Y_ \1C)=-3(S8H5%$5>'.='ZX:MUCZVZV
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M-2ZR,>&4*#\GMM$@P4H ,,5ZC:(M K(NJ!LL>(*=_3?5N'0)K"R1P)H#^+(
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MS$@:F1KK[]C2,UJOI,B$QP(A=<-H4&DW#*2<LA(=]@L1:<7?8@_ ^UH7N6G
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M1QLNF1ML&Z808&B?2-TXZ-)U&AP5V[JRO7$>LO>T26!(=NX2TJ?&((FOL_N
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MV^8GN7%GY,9=Q3^D'O!TA@0'5F&)"(S(:B$2'$#.J@BA"CO&.1Q!,'_O)L3
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M**T^T47H,,S:5IXZ5^A\^)RBU;)(X%<:C8E>7![4<[CK^;(_D>/P26#&'PT
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M_- 37,I?T;!8Q0-=DXZ[N^/"X3BZST:P6QBM[@O(:9)GF-]9QTZM12-0B,B
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MLB4HT^_=W'S=&MO:<_S+OYCB7[CWW0-WR1DFE"E&V.[4$E7?E =)FO'98O.
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M;#[!VRN40JB'KRKK//]4-B$NOG[]6-=^1JFN3\?GGS<<X+05SZT4%? U#0(
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M=:GB?.$KD7,CW)QW*NAA-V5SUEF9=1,&3X M #>42:G;?;$JI0[S-Y<62&Q
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M8U (HQV8&8RK8ET>E9PR?NURG<>HJY&])4#1JNQ.W2N!!2:E]W%,]<DVCMA
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MT#6)[$(:AH1^BU%V-CG=9$QC1D_GD[Z$DLHERQ+6/]N6M,Z^ +?JW9!V,&P
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MX@!5#>.VT(Q98-R==NJ]7(JMG)@Q7'P=8Q=I%T>G[L8Q-G.K&.YT1\Y/'8M
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M>@H^0LE%>,F1]& JM&0#0DC6]04.0:DF%3,UEI)3D2JOF%TH1<QTF3F)F8R
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MF?8T=K9C<%J*GS5;U/',#*40Z"J,W^(S9$ETJ>!,^%?,R$D0!3BXD<H.N.;
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MH?H$98,<#CGF9O/M=QL'C6KG*^^Y]N''8G,\[.;8?X*;X_2L Y*X10I#52R
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MAH2T*DD8%*H=Z8<82#?0V0Z#DTE3>F@HH:X4:S^A;IJZ^U;OFI$HV4$6<ZO
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M^,#'I--^WM_>ZM(WSLN+EE94[&U]15\7%L'9Y[E,0QEGXHV24386QW%L\CC
M:^]3'>AX),Q0_)[0!J%XGP\B'8BKX5"E_M&)F4Q,+&XR$]R5P=K@9@[7?VL#
M*?W^^/**G'S5%"=(U&&;=WYG[M5DH%(7[NVFZ'5ZV^*G'W9[W>Z!6#*T*2[B
MH"V>TN->YV#I*7_;/?A9/'TG;2C_VA?G;WYN"BDB)4.R/$E5H*V&Y28.3&1&
MLWHM,)-$QK.FR$PH9T)Z3X8B&RN\4'I3QB+W#LWC4*735&>9BD7BO&LJWNTW
M^WW^)^Q8IO #OENC:G?GP(K 1<)R)&0&99<%D@Z*1#S9Z[0['9&HU,D53TE%
M[XH%.<6[A4/:XA8K27F2@[?8[-7U8BJMT'&0*FEAYS U$^\&=:]-;J.J?Y[T
MMJ&/"QMB'K%;AQ63JUNT'S@D7R?!+F(APU!G4*.Y[&TQ2O'!Q;1>*\.G4DMA
M-0F]A/C#]6DPANF(-'V4<Y$R$EM[>\V]O;T-!E+LV%7KHM=$!EH[SQMZ$&H;
MP),9J1"R*&TI-:T+UOKX:"O4IT0%;(L1062@+)8M'J(==XB:PN:#CUA,2]ER
M*S-MAS+(?*R"'/+A^!E+H@T"$SN#[;>/V+F)0OP@;F0PMD[SG^0D.0 ZM<7E
MY4E3_*+8<&6;XE*1!^[$>YEFL0M<B#"/1BH&*D_$C0IR\BRVH*-!-L(<I#,;
M_M%H),/ F+M6FL<Q/<+.<D2"AB;ER*WU^'?PPE*J*IOIB<P4:>YS*E89\L@$
M2H5V?B@WG&"<1#& R3+!*Y]8%([MD][N5GMK\;#*(4Z "%68.V<]+CWY<Z%D
M.-^8\C*V4#N1,SF(E!C,5M%;?0JBG*$8D(M/*@4>%Z DJ@?3 ^2ZPUDYD^XL
MMLN-ZC7O181;Q? 6WLOQRA=ZD8K!2.%Q"G]"VOK7-T-ZC%Q,4:WIQWN59IK\
M$9N,8</[ZRER,U1#4+T0\8K,%)5*$Z;$-I^P;YN<FDAPE<+4P*2)2?$].2+!
MN<>AF(YU,$8&HHP!M>%9($VH$ =V,<Q"<MZIK'*JFR)5WI$<!0&9!1ILLJ?S
MXX(=5L4:>CESPEP1UNPLU"+^@I_/"]#Y1C-(?Q!7:X2W@=TM@[]RE.H2J5"E
M(S6!3PFM$ =*6MNLUS(5C&,JY8P2%/8H N3EV JK4"NSF8"V@QSV H.5/1!C
M,U6P9K5*^*CAN(0&>L$",9;WBG-5CE+%^UL2Q^<A<Q\)AUF[S*VT.6*2H>!8
M![0,Z !N%%'4@%1%5%P)R4D^E1_*"))21L;)F7N1C]QRLM9KU:I LA D.KJ4
M=WE"9P9O5&0RAZF*Y4(#K R@Q(#R$W!I<R@>%."S[" &EXUJ?I\:CRJF$NDR
M:,&C#J?B>1#+H[OAC"];QSE8X7_,!Y=8H,[L>C94Y7]/^JO,2(Z00".G-?)<
M)TA0.2&$+<1^YHSU^_5:]9 MG"_&1Z FX3.1-X#C .H!5S12G;D"(OQ73K1;
MX[.. >!9[E%TD,^H$"*L-B=_8/5U#BVZ6UO'#I39#942>QRPVMT]\%PJLA)'
M 85DB9$^ @8W,M1**(FL;H31+V*L_<X7QL7G]=I,*3DEDRLH =<0ZOC#D9)>
M2Y8\5 ^J1+1>*Z0T.8LA2(K#UU?O;LO.=(PJV;*)#-1^;*:I3!I'W7X+&7OX
MC-8=43IH0Z4%)RYVY:#)9\2AK*MRT"XDV[&KJR5<Z1SF !F&.K49X,7F5(W6
MD>(G:)ZW_X9';Q\?X?^*\XHOH[R>>1.8^_6;F=8JZIHBWJL"UF5 O;9H:;.*
M\X^2L,95CU?I?\)V;S?WGE!^H!PS#]4"&$GP/!4-@6PC;5%9V0Z;(<6H C?G
M&8V5 RH%J/R6,B:W35?(""6&.D(&E46AVC# [6>?<-[@,QZ-.*J[@&8W9R<E
MV.+16SES>=?K<>+U7? &*@ 4"IE3CF4ZD!$ B)H8Y-\]M9Y4EZ$(^_K!-J_B
M"A,3E,_$1(%3<!FO&(A\3SPS*M-'!GZHX1K08FE;O%)@E$K,3 Z?W8/$-_EG
M.S9Y%%+A**8>?T-Z@7;K@X1^Q+]NF%:')L@=?5K&UG$9*I,ZPD&?*G$[.V%>
M/"%+2N*EXR$-2GE3.3#Y*G=9QZ$JB?\!?B B"MI/RY!$<Q5INR'H'P7AGDDI
M+#\[/3^^+LZ7SPZFRU,UP!+X"49/I].V54%[9.[;XCA"8Q-+RH1HUH0BB79S
M!%^P(CW1L:>WJ_YW:(U^P3';=0NF8P7K[Z6.J %K?C9B9"]H@1EDTK4A,X8.
MWSM_OCT_I@$8N7Q?O"^EUFNGQ,\RIU*OTQ%_(-&$'S ^.[WXQ]'A,S_'KM<$
M_SU,$(]9I!8!1TU6\(:^2M"VMP9(UKO6@/-Y7T93.;,- ->SA#9Y<RUN+OX$
M?/4;A5R>L^__L,=_&N*/B]/;-R\:W4[GQW*\>G+V[O;L^O]NT@[A-QF2#\ZD
M+S^8]&[^D^AV>KM ('0]*AF;6.V+I[O/G__\>;*PM=-M];9[SYL%7Z F"5@U
MD8Q.GQ<PSZ-6/'L9S]K\:GMDVTBV R^U7BM'."LI<X8&#\W9S0SE-R"Z,,\A
M44VA[5X'<!MJD%IQ?*_B7&WP1*>W[(F=G4=X L>VM=/?W=WDB;FA_PI+M5Y^
M+.QB<U?&4_7:LKES.Q>,ZXL;PDA1Q'BK ZQZ'1F#_O25 4J!M;T]%IU>M[.W
M9%VG\QCK.KNMG6T0H\(Z]2EKB^?=#JC2DJ&VT/!EY*QQIF'5VCE;<T-$D:]K
M3>WW5^.X.S>V$M(/%,SNSH*Y*.)/>]W>(RS>[NZV]K:WMC;%\_S&Z3E/MU-
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MR AW$7"J@LIPMM_E(=E6DW?\#3%'9! 6MZE=VA4-Q(/[_K:\[U].H/5[OY6
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M263M10 AOJ>TIS7J-\0*"K44=XJ%[Y/4-DZG&WLS.LLH 2:43Y(4&=$5&6,
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ML9Y_,%84@JP2Y*60/N-KT8;E0SY7+^4=EWK+_-Z)?!?-?ON"WO,?4$L#!!0
M   ( #F*9UO'70HZM 0  'PJ   3    9V@M,C R-3$Q,#1?<')E+GAM;-6:
M78_B-A2&[U?:_^"F-ZW4$,+,='?0L"O*S%2H\R5@VZHW*Y,<P*IC1[89X-_W
M.. 5@3 +TVT5<P'!\7O\^CR.DSBY^KC,.'D&I9D4G2!N- ,"(I$I$]-.,-<A
MU0EC =&&BI1R*: 3K$ ''S^\?7/U71B2Z]O^ PG)S)A<MZ-HL5@TT@D36O*Y
MP9"ZD<@L(F'HZO=&G\COZ^;:9  <J ;2NHA;Y)<YXVF[U6Q=--^U6HUX6Z2
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M  !D-C8Q-S%D97@Q,2YH=&U02P$"% ,4    "  YBF=;(/TF(4)- 0"V; D
M#P              @ 'CQ@  9#8V,3<Q9&5X-#$N:'1M4$L! A0#%     @
M.8IG6T\':8A3"@  FQ\   \              ( !4A0" &0V-C$W,61E>#4Q
M+FAT;5!+ 0(4 Q0    ( #F*9UO,)^+DM X  +@M   0              "
M =(> @!D-C8Q-S%D97@Y.3$N:'1M4$L! A0#%     @ .8IG6^G)?>9"$
MMC<  !               ( !M"T" &0V-C$W,61E>#DY,BYH=&U02P$"% ,4
M    "  YBF=;1?\P83X#  !*"P  #P              @ $D/@( 9V@M,C R
M-3$Q,#0N>'-D4$L! A0#%     @ .8IG6]9;"%Y9!@  O$,  !,
M     ( !CT$" &=H+3(P,C4Q,3 T7VQA8BYX;6Q02P$"% ,4    "  YBF=;
MQUT*.K0$  !\*@  $P              @ $92 ( 9V@M,C R-3$Q,#1?<')E
:+GAM;%!+!08     "0 ) "T"  #^3 (    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>d66171d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gh-20251104.xsd" xlink:type="simple"/>
    <context id="duration_2025-11-04_to_2025-11-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001576280</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-440">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-11-04_to_2025-11-04"
      id="Hidden_dei_EntityCentralIndexKey">0001576280</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-451">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-452">2025-11-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-453">GUARDANT HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-454">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-455">001-38683</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-456">45-4139254</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-457">3100 Hanover Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-458">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-459">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-460">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-461">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-462">698-8887</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-463">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-464">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-465">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-466">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-467">Common Stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-468">GH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-469">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-11-04_to_2025-11-04" id="ixv-470">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
